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Abstract
Hemodynamic forces, namely shear stress and cyclic strain, have been well 
characterised as modulators of vascular endothelial function, and have been assigned an 
important role in the maintainance of vascular tone, haemostasis, and regulation of 
vascular growth and health. They exert their influence in part by effecting changes in the 
production and release of vasoactive compounds by the endothelium, and by effecting 
changes in the levels and activity of various enzymes. Thimet oligopeptidase 
(EC3.4.24.15, EP24.15) and neurolysin (EC3.4.24.16, EP24.15) are closely related zinc 
metalloendopeptidases that have been shown to be expressed and active in the vascular 
endothelium. Their substrates include the vasoactive peptides bradykinin and angiotensin
I, which have been identified as important regulators of both blood pressure and 
angiogenic processes. Other related peptidases, namely endothelin converting enzyme 
(ECE) and angiotensin converting enzyme (ACE), have been shown to be regulated by 
hemodynamic forces in the vascular endothelium. As such EP24.15 and EP24.16 are 
likely candidates for regulation by hemodynamic forces.
In this regard we have investigated the effect of cyclic strain on the expression and 
activty of EP24.15 and EP24.16 in cultured bovine aortic endothelial cells (BAECs). We 
have shown that exposure to cyclic strain significantly increases the mRNA expression as 
well as both the cellular and secreted activity of both enzymes. We have demonstrated 
that up-regulation of both enzymes is dependent on Gi-protein mediated signalling, 
although with varying Gia/G(3y subunit specificity for either enzyme. Using
TV
immunocytochemistry, we have also demonstrated a strain-dependent increase in 
EP24.15 protein expression within the nucleus and cytoplasm in parallel with an increase 
in membrane associated EP 24.15
The effects of strain on the ability of BAECs in culture to cleave both Ang I, and 
BK in an EC24.15/EC24.16 specific manner was also studied. We observed that exposure 
to cyclic strain induces a significant increase in the EP24.15 specific hydrolysis of both 
exogenously added BK and Ang I.
The potential of the observed effects of cyclic strain on EP24.15 to effect changes 
in endothelial cell function were also examined. Use of the dual EP24.15/EP24.16 
inhibitor, cFP-AAF-pAB, and the EP24.15 specific antisense, FLIP, was seen to 
significantly attenuate cyclic strain-induced endothelial cell tubule formation and 
migration. We also found that the effects of FLIP transfection on cyclic strain-induced 
endothelial cell tubule formation could be largely reversed by addition of exogenous 
Ang-(l-7). Taken together these results suggest that strain-induced endothelial cell 
angiogenesis and migration putatively involves EP24.15 cleavage of vasoactive peptide 
substrates.
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A bbrev ia tions;
ACE Angiotensin Converting Enzyme
ADAM A Disintegrin and M elalloproteinase
ANG I Angiotensin I
ANG II Angiotensin 11
ANG 1-7 Angiotensin 1-7
AP 1 Activating Protein 1
AP 2 Activating Protein 2
BAEC Bovine Aortic Endothelial Cell
BCA Bicinchoninic acid
BK Bradykinin
BK 1-5 Bradykinin 1-5
cDNA Com plimentary DNA
DMSO Dimethylsulfoxide
DNA Deoxy Nucleic Acid
EC Endothelial Cell
ECE Endolheiin Converting Enzyme
ECM Extra Cellular Matrix
EDTA Ethyienediam ine Tetracetic Acid
EGF Epidermal Growth Factor
EGFR Epidermal Growth Factor Receptor
eNOS Endothelial Nitric Oxide Synthase
ERK Extracellular Regulated Kinase
VT
ET-1 Endothelin
FAK Focal Adhesion Kinase
FBS Fetal Bovine Serum
FGF Fibroblast Growth Factor
FGFR Fibroblast Growth Factor Receptor
GAPDH Glyceraldehyde Phosphate Dehydrogenase
GFP Green Fluorescent Protein
GPCR G-protein Coupled Receptor
GnRH Gonadotrophin Releasing Hormone
Grb-2 Growth Factor Binding Protein 2
HBSS Hanks Buffered Saline Solution
HPF High Powered Field
HPLC High Perform ance Liquid Chromatography
ICAM -1 Intracellular Adhesion M olecule-1
iNOS Inducible Nitric Oxide Synthase
JN K c-Jun-Terminal Kinases
LB Luria Bertram
LD H Lactate Dehydrogenase
M A PK M itogen Activated Protein Kinase
M APK K M itogen Activated Protein Kinase Kinase
M APKKK M itogen Activated Protein Kinase Kinase Kinase
MCP-1 M onocyte Chem oattractant Protein I
M M P Matrix M etalloproteinase
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mRNA M essenger Ribonucleic Acid
NAPD(P) Nicotinamide Adenine Dinucleotide Phosphate
NOS Nitric Oxide Synthase
PA1-1 Plasminogen Inhibitor-1
PBS Phosphate Buffered Saline
PDG F Platelet Derived Growth Factor
PDG FR Platelet Derived Growth Factor Receptor
PTK Protein Tyrosine Kinase
PTX Pertussis Toxin
QFS Quenched Fluorescent Substrate
RNA Ribonucleic Acid
ROS Reactive Oxygen Species
RTK Recpetor Tyrosine Kinase
RT-PCR Reverse Transcriptase Polym erase Chain Reaction
SAPK Stress Activated Protein Kinase
She Src Homology/Col lagen
SiRNA Small Interfering RNA
SOS Son of Seveniess
SSRE Shear Stress Response Element
TBS Tris Buffered Saline
TF Tissue Factor
TGF-ß Transforming Growth Factor ß
THOP Thimet Oligopeptidase
VTTT
TIMP Tissue Inhibitor of Metalloproteinases
TNF-a Tumour Necrosis Factor a
t-PA Tissue Plasminogen Activator
u-PA Urokinase Plasminogen Activator
VCAM-1 Vascular Cell Adhesion Molecule 1
VEGF Vascular Endothelial Growth Factor
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h Hours
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Chapter 1; Introduction
I
1.1 The Vascular Endothelium
The vascular endothelium, once simply considered a physiologically inert lining of 
the blood vessel, is both a complex multifunctional organ in its own right and an essential 
component of every other organ in the body. The endothelial monolayer forms a lining of 
the entire inner surface of the vascular system, and has been shown to act as a dynamic 
interface between the circulating blood and the underlying tissues. Its location, at the 
interface between the circulating blood and the vessel wall, allows it to monitor and 
respond to changes in blood flow and biochemical composition. It is for this reason that it 
plays an important role in the maintenance of vascular tone in response to changes in 
blood flow and pressure and in the progression of diseases such as hypertension and 
atherosclerosis. The endothelium also provides a selective permeable blood brain barrier 
and is involved in the regulation of hemostasis and the inflammatory response, while 
endothelial cell migration, proliferation and tube formation are essential for the growth of 
new vessels (Angiogenesis).
The endothelial cell can be activated by both physical and chemical stimuli; it can 
respond to changes in both shear stress and pulsatile cyclic strain, the hemodynamic 
forces associated with blood flow, as well as a variety of so-called vasoactive peptides 
(e.g. angiotensin, endothelin I), reactive oxygen species (ROS), and nitric oxide (NO). 
Activation of the endothelium can result in the expression of specific genes, cell 
migration and proliferation, and the release of various substances, which can in turn alter 
vascular function (Duffy et al., 2004).
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It is the purpose of this part of the introduction to give an overview of the structure of the 
vascular endothelium, and the means by which it responds to changes in blood flow and 
composition.
1.1.1 Organisation and Structure
The vascular endothelium is composed of a monolayer of endothelial cells, which 
have a luminal surface constantly in contact with the circulating blood, an abluminal 
surface which interacts with the sub-endothelial matrix composed of pericytes and 
smooth muscle cells, and a lateral surface, adjacent to the surrounding cells which 
provides an area for cell-cell bridging.
The luminal surface provides an interface between the circulating blood and the 
vascular endothelial cell. The presence of multiple surface receptors and adhesion 
molecules allow the stimulation of second messenger molecules, leading to changes at 
the level of gene expression and cellular function. Vascular permeability, coagulation, and 
the inflammatory response are governed by stimulation of the luminal surface, as are 
changes in vascular endothelial cell fate decisions regulating these functions.
The abluminal surface rests upon the subendothelium, an extracellular matrix 
com posed of proteins, including collagen type IV, elastin, laminin, fibronectin, 
thombospondetin, and von Willebrand factor (vWF), which are predominantly secreted 
by the abluminal surface of the endothelial cell (see Fig 1.1J (Duffy et al., 2004)
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The lateral surfaces of the endothelial cell provide an area for cell-to-cell 
bridging, with intercellular clefts, approximately 6-7 nm wide, forming between adjacent
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Figure 1.1 Diagram  representing the structure of the vascular endothelium showing molecules 
involved in secretion, cell-cell interaction, and in the endothelial cell cytoskeleton.
cells (Guyton et al., 1996). Bridging the cells and thus joining adjacent endothelial cells 
together is a specialized complex consisting of gap junctions, demosomes, adherens 
junctions and the tight junctions. Adherens and tight junctions provide contact with the 
actin cytosekeleton, allowing changes in the shape and size of the cell to occur, and 
providing adhesive intercellular connections which strengthen the endothelial barrier and 
affect cell polarity (Dejana et al., 1995). They form a selectively permeable barrier, 
allowing the passage of certain solutes, with their selectivity also varying with
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pathological and physiological changes (Baida et al., 1998; Hunt et al., 2002). Their 
distribution varies along the vascular tree, showing a greater frequency in larger arteries, 
which require greater permeability control (Duffy et al., 2004). Gap and adherans 
junctions also provide contact points for cell-cell interaction both between adjacent 
endothelial cell and the pericytes and intimal smooth muscle cells of the subendothelial 
matrix (Baldra et al., 1998, Duffy etal., 2004).
The entire surface of the endothelial cells is coated with a large number of 
glycoproteins, who’s asymmetric, cell-surface specific, distribution accounts for the 
polarity exhibited by the endothelium. The luminal glycocalyx lining also contains a 
layer of immobile plasma and is thought to adsorb plasma proteins (Copley et al., 1983). 
The resulting combination of glycocalyx, plasma, and plasma proteins is known as the 
endothelial surface layer. This endothelial surface layer is thought to help regulate a 
number of physiological responses, such as shear stress mechanotransduction, oxygen 
diffusion across capillaries, capillary permeability, coagulation and interaction with 
immune cells (Davies et al., 1997; Secomb et al., 1999; Henry et al., 1997; Linjen et al., 
1997; Silvestro etal., 1994).
Intercellular tethering forces of cell-cell and cell-matrix junctions exist in 
equilibrium with the intracellular contractile forces generated and maintained by the 
actin-myosin interactions. Constitutive tension exists within the cell with a basal actin- 
myosin interaction, which allows the cell to be poised to respond to changes in its 
biological environment. Stim ulation of the endothelial cell due to changes in
5
haemodynamic forces, or disease, can lead to an alteration of cell shape due to a 
reorganization of contractile proteins. Changes in endothelial cell morphology are 
associated with a number of disease states such as atherosclerosis (see section 1.2.2.4) 
(Garcia et al., 1995).
The endothelial cell membrane also possesses a large number of flask shaped 
luminal invaginations, generally 50-100 nm in diameter, which are known as caveolae. 
Caveolae are involved in the endocytosis and transcytosis of macromolecules. Caveolae 
are suspected to be a site of plasminogen activation by urokinase and tissue plasminogen 
activator (uPA and tPA) (Anderson et al., 1993). They also have been implicated in the 
direct transduction of luminal forces to the cytoskeleton through actin-associated 
signaling molecules. In addition two key structural components of caveolae, calmodulin 
and caveolin, are known to regulate the activity of endothelial nitric oxide synthase 
(eNOS) (Duffy et al., 2004).
1.1.2 Functions of the Endothelium
The endothelial cells internal structure, location and intercellular arrangement 
allows it to respond to a wide variety of stimuli and allows it to fill a number of unique 
roles within the vasculature, namely the maintenance of a selectively permeable blood 
tissue barrier, regulation of hemostasis, regulation of inflammation and maintenance of 
vascular tone. It is intended to give a brief overview of each of the above-mentioned
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functions with particular reference to role of hemodynamic forces in the maintenance of 
vascular tone in this section.
1.1.2.1 Selectively Permeable Barrier
With the larger vessels serving the role of major conduits, the majority of transfer 
of water, gases and solutes to and from the circulation occurs primarily across the 
capillaries and post-capillary venules. The vascular endothelium forms a semi-permeable 
barrier that selectively allows specific substances to move between the blood and the 
inters titium.
Low molecular weight hydrophilic and lipid soluble molecules such as C 0 2 and
0 2 move virtually unimpeded though the lateral clefts of the endothelium. The 
endothelium maintains its selective barrier to macromolecules through several distinct 
mechanisms (Garcia et al., 1995); firstly, the negatively charged glycocalyx provides an 
electrostatic repellant, preventing negatively charged macromolecules from crossing the 
endothelium; secondly, there is evidence to suggest serum albumin can cross the 
endothelium via a vesicular transport system; and thirdly, the tight junction and adherans 
junction proteins govern the size of the intercellular cleft and therefore solute 
permeability (Lui etal., 1997).
In addition some capillaries, such as the renal glomerular tufts, contain 
fenestrations up to 100 nm wide, which increase the passage of water across the
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endothelium without affecting transendothelial transport of macromolecules. Also in 
some regions of the vasculature, such as the bone marrow, liver and spleen, the 
endothelial lining of the vessel is discontinuous allowing for the free passage of solutes 
(Wisse et al., 1983).
Barrier function is maintained by the regulated apposition of tight junction and 
adherans protein complexes between adjacent endothelial cells. The organization of these 
protein complexes is controlled by a number of physiological and pharmacological 
mediators. The proteins that form tight junctions linking adjacent cells include occludin, 
claudin family members, junctional adhesion molecules 1-3 (JAMs), cingulin, 7H6, 
spectrin and linker proteins such as the zonula occludins family members (ZO-1/2/3), the 
latter linking these proteins to each other and the actin cytoskeleton (Alexander et al., 
2002; Furuse et al., 1993; Furuse et al., 1993; Gardner et al., 1996; Hirase et al., 1997). 
Adherans junctions contain trans-membrane cadherins and their cytoskeletal linkers, 
catenins (D aniel et al., 1997; Kaibuchi et al., 1999). A lthough spatially and 
biochemically distinct, functional interaction between adherans junctions and tight 
junctions has been demonstrated (Rubin et al., 1999).
The barrier function of the endothelium can vary in disease states, with increased 
micro-vascular permeability to macromolecules and water being the basis of edematous 
tissue injury and a hallmark of inflammation and atherosclerosis (Duffy et al., 2004). 
Hemodynamic forces can also lead to changes in vessel permeability (see section 1.2).
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The majority of this increased transport appears to be paracellular, i.e. due to 
widening of the inter-endothelial junctions (Garcia et al., 1995). This widening can be 
either leukocyte independent or dependent. Leukocyte independent widening is thought 
to reflect contraction of the cytoskeleton and recoil of the cell-cell borders. Leukocyte 
dependent widening is associated with increased display of luminal selectins, which leads 
to greater recruitment of leukocytes on the luminal surface. It is suspected that leukocyte 
proteases such as elastase and metalloproteinases may break down junction elements, 
allowing leukocyte infiltration to the subendothelial matrix and damaging the overall 
endothelial barrier function (Alexander et al., 2002; Hunt et al., 2002).
1.1.2.2 Hemostasis
Hemostasis is defined as the maintenance of a balance between pro- and anti­
coagulant forces in the circulation. A dynamic ongoing interaction exists between the 
endothelium, blood cells, plasma coagulation factors, fibrinolytic factors, and their 
inhibitors. In its normal state the endothelium favours anticoagulant mechanisms, which 
preserve blood fluidity. Firstly the endothelial cell monolayer provides a smooth covering 
which prevents the activation of the clotting cascade by the subendothelial matrix. In 
addition the negatively charged glycocalyx layer can repel coagulation factors and 
platlets in the circulation (Duffy et al., 2004).
Hemodynamic forces also play an important role in hemostasis. The maintenance 
of normal blood flow, through the maintenance of vascular tone, allows activated 
products to be carried away from the local area, eliminating an environment condusive to
9
thrombosis. Endothelium derived products such as, prostaglandins, NO, and tissue factor 
pathway inhibitor (TFPI) also favour anticoagulation (see section 1.1.2.4 and 1.2) 
(Bunting et al., 1976; Marcum et al., 1985).
The membrane protein thom bomodulin, constitutively expressed by the 
endothelial cells of most vascular beds, can dramatically inhibit the catalytic activity of 
thombin, a pro-coagulant protease, by removing it from circulation and concentrating it at 
the endothelial cell surface where it is internalized and degraded (Heeb et al., 1994). The 
anticoagulant activity of the endothelium includes fibrinolysis as well as inhibition of 
platelets and serine proteases. Inactive plasminogen can be converted to plasmin by the 
plasminogen activators, tPA and uPA. The activated plasmin then degrades fibrin into 
fibrin degradation products (Levine et al., 1982). The formation of a fibrin clot is the end 
product of the thombogenic pathway. Destruction of the endothelial lining allows direct 
contact between the circulating platelets and the subendothelial collagen. This leads to 
primary hemostasis, the stimulation of platelet adherence and aggregation. Activated 
serine proteases then initiate a cascade of reactions, which result in fibrin formation 
(secondary hemostasis). The resultant fibrin clot, in normal conditions, combines with 
transient vasoconstriction to reduce blood flow, allowing endothelial repair (Duffy et al 
2004; Hunt et al 2002).
1.1.2.3 Inflammation
Injury to the vascular endothelium not only stimulates hemostatic events, but also 
leads to a localized inflammatory response in order to potentiate the healing process.
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Chemotactic mediators, which are released from damaged tissue, white blood cells and 
pathogens initiate the response, which leads to an increase in the recruitment and 
adhesion of leukocytes to the endothelial surface. This leukocyte recruitment occurs via 
adhesion molecules expressed on both leukocyte and endothelium such as selectins 
located on the endothelium, integrins primarily located on endothelial cells, and 
immunoglobulins primarily located on endothelial cells (Duffy etal., 2004).
In the initial stages of adhesion leukocytes roll rapidly along the endothelial 
surface, interacting with the endothelial cells via P-selectin and E-selectin on endothelial 
cells and L-selectin on leukocytes (Geng et al., 1990; Bevilacqua et al., 1987). 
Leukocytes that are not swept away by the shear stress resulting from the blood flow 
become activated by signals either originating either from the luminal or extravascular 
space, or at the endothelial surface. Activation leads to an increased affinity for 
endothelial ligands of the immunoglobulin superfamily (IgSF), the vascular cell adhesion 
molecule (VCAM-1), and the intercellular adhesion molecules 1 and 2 (ICAM 1 & 2) 
(Pober et al., 1986). Interaction between the leukocyte and the IgSF leads to initiation of 
leukocyte spreading, followed by interaction between platelet-endothelial adhesion 
molecules located on both endothelial cells and leukocytes, leading to the trans­
endothelial migration of the leukocyte to the sub-endothelial matrix.
1.1.2.4 Maintenance of Vascular Tone
Vascular tone is one of the main determinants of blood flow. The ability of the 
vessel to respond to changes in the microenvironment to maintain optimal flow is a result
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of a finely tuned balance of vasodilator and vasoconstrictor stimuli. Systemic control of 
vascular tone is directed and maintained by the nervous system via the smooth muscle 
layer which makes up the bulk of the blood vessel wall, however the specific needs of 
individual vascular beds are directed by local mediators produced in the endothelium, for 
example prostacyclin (PGI2), nitric oxide (NO), Endothelin 1 (ET-1), Bradykinin (BK), 
and Angiotensin I (Ang-I)(Duffy et al., 2004; Hughes, 2002).
Prostacyclin (PGI2) is a member of the prostacyclin family of lipid mediators. 
PGI2, as with other prostaglandins, is a 20-carbon unsaturated carboxylic acid with a 
cyclopentane ring. Within the vasculature it is produced in endothelial cells from 
acrachnadonic acid by two constitutively expressed enzymes, prostacyclin synthase and 
cyclooxygenase-1 (COX-1) (Weksler et al., 1977). Circulating PGI2 has an anti­
thrombotic effect, via interaction with its IP receptor on platelets. Interaction with the IP 
receptor on smooth muscle cells leads to vasodilation. PGI2 production increases in 
response to hypoxia, histamine, thrombin and hemodynamic forces (Baenziger et al., 
1980; Duffy et al., 2004; Vane et al., 2003).
Nitric oxide is produced constitutively at a low level in the endothelium by 
calcium dependent endothelial nitric oxide synthase (eNOS), from molecular oxygen and 
L-arginine. Like PGI2 it acts primarily as a vasodilator, causing local smooth muscle 
relaxation. An increase in NO production occurs in response to BK, thrombin, histamine, 
vasopressin, serotonin, and hemodynamic forces. An additional source of NO in the 
endothelium results from the actions of inducible nitric oxide synthase (iNOS), which is
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expressed in response to inflammatory cytokines, and unlike eNOS, is non-calcium 
dependent (Duffy et al. 2004; Hughes 2002.).
Endothelin, as its name suggests is predominantly found in the vascular 
endothelium, though it is also present in tissues such as the kidney. It is the most potent 
vasoconstrictor peptide known. The predominant isoform of endothelin in the vasculature 
is Endothelin-1. Its is produced as preproendothelin-l(ppET-l), which is converted to 
Big-Endothelin 1, which is in turn converted to Endothelin-1 (ET-1) by the endothelin 
converting enzyme (ECE). Big-Endothelin 1 is approximately 100 times less potent a 
vasoconstrictor than ET-1, and its rapid extracellular conversion in conditions such as 
heart failure may provide biologically significant quantities of ET1. Two receptors of ET- 
1 exist within the vasculature; ETB is found predominantly on endothelial cells, while ETA 
predominates in vascular smooth muscle cells. Its is though the ETA receptor that ET-1 
causes vasoconstriction, while its interaction with the ETB receptor leads to release of NO 
and PGI2 and consequent vasodilation (Levin 1995). The expression of ppET-1 mRNA 
and release of ET-1 are stimulated by interleukin-1, Ang-II, hypoxia, and hemodynamic 
forces (Yoshiumi et al., 1989; Yoshizumi et al., 1990; Hughes 2002; Levin, 1995).
Angiotensin (Ang-II) is produced prim arily from Ang-I (Ang-I) by the 
angiotensin converting enzyme (ACE). Although Ang-I has only slight vasoconstrictive 
properties, Ang-II is a potent vasoconstrictor, mediating the release of ET-1 though the 
ATI receptor (Duffy et al., 2004). The inhibition Ang-II mediated vasoconstriction, either 
through blockade of the ATI receptor or inhibition of ACE, has been explioted as a
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successful clinic treatment for hypertension (Randall etal., 2003; Bakris et al., 2001). As 
will be discussed later Ang-II also plays an important, though not yet fully elucidated role 
in other important vascular endothelial processes, such as migration and angiogenesis. In 
addition angiotensin (1-7) (A ng-(l-7), the product of cleavage of Ang-I by 
metalloendopeptidases such as thimet oligopeptidase (EP24.15), neurolysin (EP24.16) 
and neutral endopeptidase (NEP). Numerous studies implicate Ang-(l-7) as acting in an 
oposing fashion to that of Ang-II, evoking vasodilation through release of NO. (Fetterik 
et al., 2000; Duffy et al., 2004; Turner et al., 2002; Ferrario et al., 1998). It has also been 
shown by Chappell and co-workers, that infusion of Ang-(l-7) considerably potentiates 
the antihypertensive effects of ACE inhibition and ATI receptor blockade in the rat 
hindlimb (Chappell et al., 2000).
Bradykinin (BK) is a nine amino acid peptide which acts as a vasodilator by 
activating eNOS via the B2 receptor in endothelial cells. It can also cause contraction in 
smooth muscle cells, and is associated with the induction of pain and the recruitment of 
inflamatory cells. Like Ang-II it is believed to influence endothelial cell migration and 
angiogenesis. BK is cleaved to a number of inactive fragments by EP24.15, EP24.16, 
ACE, and NEP (Duffy et a.,12004; Meini et al., 2004; Venema et al., 2002).
Hemodynamic forces, namely shear stress and cyclic strain are, as has been 
mentioned above, im portant stimuli for the production of numerous vasoactive 
substances. It is intended, in the following section to give an overview of the
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hemodynamic forces and the mechanisms by which endothelial cells transduce these 
stimuli.
1.2 Hemodynamic Forces and the Endothelium
Hemodynamic forces have been well established as important modulators of 
vascular tone and vascular remodeling. The interplay between hemodynamic forces and 
endothelial cell function also plays a critical role in a number of diseases, most 
importantly atherosclerosis.
Figure 1.2(a); Laminar Shear Stress occurs as a result of the frictional forces exerted on the vessel wall 
by blood flow, (b); Pulsatile cyclic strain is the deformation of the vessel wall in a direction perpendicular 
to blood flow which occurs due to the pulsatile nature of blood flow.
There are two major components of hemodynamic force; wall shear stress, 
resulting from the drag force exerted on the endothelium by the flowing blood, and cyclic 
mechanical strain or stretch, which occurs due to the pulsatile nature of the blood flow 
(see Fig 1.2 a, b). In healthy tissue, alterations in the magnitude of cyclic strain or shear 
stress invariably produce transformations in the vessel wall that accommodate the new
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conditions and ultimately restore basal levels of blood pressure. (Lehoux et al., 1998; 
Topper et al.\ 1999; Poston, 2002).
1.2.1 Cyclic Strain
1.2.1.1 Effects of Cyclic Strain on the Vessel Wall
The relationship between circumferential (cyclic) stress and the vessel wall has 
been extensively studied. It has long been known that blood pressure is the determining 
factor in vessel wall thickness; for example the comparison between the pulmonary artery 
and the aorta. Both have walls of a similar thickness in utero as they experience similar 
blood pressure. However after birth the aorta thickens with increasing blood pressure 
while the pulmonary artery undergoes atrophy due to a relative fall in blood pressure 
(Leung et al., 1977). It has also been observed that increases in blood pressure can lead to 
an increase in smooth muscle cell (SMC) size (hypertrophy) and increase in extracellular 
matrix (ECM) production, with decreases in blood pressure conversely leading to vessel 
atrophy (Bomberger et al., 1980). A normal level of mechanical straining of VSMCs may 
also be essential for the maintenance of their differentiated state; in vitro studies using 
cultured rabbit aortas showed that an abnormally low level of intraluminal pressure (10 
mm Hg) over a period of 3-6 days led to a decrease in smooth muscle marker proteins h- 
caldesmon and filamin in the vessel wall. This was despite the presence of fetal calf 
serum, a noted mitogen. This decrease in marker proteins was reversed in aortic segments 
kept at physiological intraluminal pressure (80 mm Hg). In segments maintained at high
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intraluminal pressures (150mm Hg) there was an overall increase in protein production 
(Lehoux e ta l ,  1998).
Cyclic strain is a powerful stimulus and can regulate cell fate decisions both in 
endothelial and smooth muscle cells. Exposure of vascular smooth muscle to cyclic strain 
leads to apoptosis via a p53 dependent pathway, conversely cyclic strain can suppress EC 
apoptosis via Akt phosphorylation (Mayr et al., 2002; Persoon-Rothert et al., 2002; Haga 
etal., 2003).
1.2.1.2 Effects of Cyclic Strain on the Endothelium
The significant role of cyclic strain in determining SMC development and 
structure is coupled with a less obvious, but no less important, effect on the endothelium. 
Cyclic strain has been shown to induce the alignment of actin microfilaments in the 
direction of strain, and to modulate the sensitivity of endothelial cells towards shear stress 
(Zhao et al., 1995). Recent studies have also demonstrated that cyclic strain can induce 
an increase in the migratory and angiogenic capabilities of endothelial cells in vitro (Von 
Offenberg-Sweeney et al., 2005).
1.2.1.3 Cyclic Strain as a Modulator of Gene Expression
Mechanical strain is a potent stimulator of gene expression in both ECs and 
SMCs, as has been demonstrated. DNA microarray analysis with human vascular SMC
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showed that COX-1, PAI-1 and tenascin were all un-regulated in response to cyclic strain 
while matrix metalloproteinase-1 (MMP-1) and thombomodulin were down-regulated; 
suggesting a response of defense against excessive deformation (Feng et al., 1999).
Table 1.1 Genes regulated by cyclic strain within the vasculature: eNOS; endothelial Nitric Oxide 
Synthase, ppET-1; pre-pro-Endothelin-1, COX-I; Cyclic Oxygenase I, COX-II; Cyclic Oxygenase II, 
PDGF-BB; Platelet Derived Growth Factor-BB, MMP-1, -2, -9, and -14; Matrix Metallopeptidase-1, -2, -9, 
and -14, MCP-1; Monocyte Chemoatractant Protein, PAI-1; Plasminogen Activator Inhibitor-1, uPA; 
Urokinase Plasminogen Activator. Up-regulation is indicated by ft, and down-regulation by JJ. References: 
1; Feng et al., 1999. 2; Awoleski et al., 1995. 3; Cheng et al., 1996. 4; Cheng et al., 1996. 5; de Jonge et 
al., 2002. 5; Sumpio et al., 1998. 6; Wang et al., 2003. 7; Wung et al., 2001. 8; Wung et al., 2001. 9; Von 
Offenberg-Sweeney et al., 2004. 10; Von Offenberg-Sweeney et al., 2005.
Vascular Tone Growth/
Remodling
Adhesion/
Chemoattraction
Coagulation
fteNOS2 ft PDGF-BB4 ftMCP-14 ftPAI-ll
It PPET-15 ¿M M P-11 {(.Thrombomodulin1
ftCOX-II8 ft MMP-29 fuPA 10
ftCOX-11 ftMMP-143
ft MMP-99
In endothelial cells cyclic strain has been demonstrated to up-regulate the 
expression of nitric oxide synthase (NOS), matrix metalloproteinase-2 (MMP-2), matrix 
metalloproteinase-14 (MMP-14), monocyte chemotactic protein-1 (MCP-1), platelet 
derived growth factor-BB (PDGF-BB), endothelin-1 (ET-1), intracellular adhesion 
m olecule-1 (ICA M -1), plasm inogen activator inh ib ito r-1 (PAI-1), m atrix
metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (uPA) (Awoleski et 
al., 1995; Cheng et al., 1996; Cheng et al., 1996; de Jonge et al., 2002; Sumpio et al., 
1998; Wang etal., 2003; Wung etal., 2001; Von Offenberg-Sweeney etal., 2004; Von
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Offenberg-Sweeney et al., 2005). The release of NO from endothelial cells in response to 
changes in mechanical strain was one of the first responses identified (Leung et al., 1977; 
Galis et al., 1998). Other molecules secreted in response to cyclic strain include 
endopeptidases, Et-1, PAI-1, IL-8 and MCP-1 (Sumpio et al., 1998; Cheng et al., 1996; 
Okada et al., 1998). Intra-cellularly cyclic strain is responsible for the recruitment of a 
variety of signaling molecules including the MAPK kinase family. Sumpio and co­
workers reported that cyclic strain increases the tyrosine phosphorylation of focal 
adhesion kinase (FAK) and paxillin in ECs with a concurrent cell elongation and the 
alignment of F-actin, FAK and paxillin. Cyclic strain has also been found to activate 
extracellular signal-regulated kinase (ERK), c-jun N-terminal kinases (JNK), and p38 
(Wung et al., 1999; Kito et al., 2000; Li et al., 1999). As will be discussed further, this 
family of enzymes is involved in activating the transcription of a number of cyclic- and 
shear strain-induced genes. The various signal transduction mechanisms and downstream 
effects of these strain induced changes have not yet been fully elucidated but the ability 
of cyclic strain to influence changes in expression in the endothelium is believed to play a 
role in a number of pathologies including atherosclerosis, and hypertension.
1.2.1.4 Cyclic Strain and Vascular Health
The effects of cyclic strain on the vessel wall are believed to play a major role in 
the development of hypertension. The ability of increased intra-luminal pressure, and 
thus increased cyclic strain, to induce hypertrophy and hyperplasia (increase in cell 
numbers) in SMCs is believed to be a contributing factor in essential or primary
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hypertension; an increase in blood pressure leads to an increase in the medial segment of 
the vessel, and a consequent reduction in the luminal radius. If one considers the equation 
T=Pr/H, where T is the tensile stress of the vessel, in order to maintain normal T  in cases 
of increasing P, it is necessary to increase the thickness of the vessel H, leading to a 
reduction in vessel radius, leading to a further increase in P (Lehoux et al., 2003). Even 
small changes in luminal radius can greatly affect overall blood pressure as flowrate is 
proportional to vessel radius (Schachter, 2002).
The oxidative state of the blood vessel is a major contributor to vascular 
remodeling and the progression of disease. Under pathological conditions levels of 
reactive oxygen species (ROS) have been found to be increased (e.g. from the 
macrophage foam cells). M oreover the interaction of NO with these ROS such as 
superoxide may result in the formation peroxynitrite, a highly reactive intermediate found 
in vunerable atherosclerotic plaques (Rajagopalan et al., 1996). Cyclic strain has been 
shown to increase the levels of ROS. ROS are believed to be an important mediator in 
modulating signaling pathways and gene expression by redox sensitive molecules such as 
PYK2 (Cheng et al., 2002). Mechanical stretch was found to increase expression of 
MMP-2 via a mechanism involving reactive oxygen species derived form NAD(P)H 
oxidase (Grote et al., 2003). Cyclic strain-induced increases in ROS have been linked to 
the regulation of a number of vasoactive compounds, signaling molecules and 
transcription factors (Awoleski et al., 1995; Chien et a l, 1998; Cheng et al., 1998; Cheng 
etal., 1996; Wang et al., 2001, Wung et al., 2003).
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Cyclic strain has also been linked to inhibition of proliferation in addition to 
increases in Angiogenesis associated with TGF-(3, MMP-2 and VEGF (Rivilis et al., 
2002; Zheng et al.; 1999; Vahile et al., 1996; Banai et al., 1994). These and other studies 
clearly demonstrate the importance of cyclic strain in coordinating and regulating cell 
function by mediating changes in gene transcription, signaling pathways activation and 
the release of vasoactive compounds.
1.2.1.5 Modeling of Cyclic Strain In  Vitro
Circumferential stress on ECs has been investigated in vitro by applying 
equibiaxial cyclic stretch to endothelial cells cultured on an elastic membrane mounted in 
a stretch device, such as that shown in Fig 1.3. In this approach endothelial cells are 
grown on flexible membranes, which can be precisely deformed by a microprocessor- 
controlled vacuum, providing equibiaxial tension. This allows the cells to be subjected to 
defined levels of cyclic strain, in a variety of wave patterns, including those which 
directly model cardiac output (Banes et a l, 1985).
Figure 1.3 In Vitro Cyclic Strain Device; The Flexercell™ Tension Plus™ FX-4000T™ system (Flexcell 
International Corp. - Hillsborough, NC)
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1.2.2 Shear Stress
1.2.2.1 Shear Stress and the Endothelium
Shear stress is primarily sensed by the endothelium. The endothelial cell, located 
at the interface between the blood flow and the vessel wall, acts as an effective biological 
mechanotransductor which senses the physical stimuli of the shear forces associated with 
blood flow and converts these to intracellular biochemical signals (Poston etal., 2002). 
The nature of the shear stress experienced by endothelial cells is a function of the blood 
flow patterns throughout the vasculature generated by the cardiac cycle. The typical level 
of shear stress experienced by the endothelium is in the range 0-50 dynes/cm2. In roughly 
linear areas of the vasculature, blood flows in a smooth pulsatile pattern, subjecting the 
endothelium to laminar shear stress with fluctuations in magnitude that yields a net 
positive shear stress. Cells exposed to positive shear stress undergo re-orientation and 
elongation in a direction parallel to the direction of blood flow, leading to a streamlining 
effect, which decreases the effective resistance and shear stress (Flaherty et al., 1972; 
Barbee et al., 1995). In areas of the vasculature where the laminar blood-flow pattern is 
disrupted, such as at branch points and bifurcations, the flow can become reversed and 
oscillatory resulting in low mean shear stress. In these conditions the endothelial cells do 
not reorient, and may be exposed to high shear gradients, as there is an absence of the 
membrane streamlining evident in areas of positive mean shear stress (Davies et al., 
1986).
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1.2.2.2 Shear Stress as a Modulator of Vascular Tone
It has long been observed that in healthy vessels increases in shear stress is an 
important regulator of vascular tone; it was first observed in 1933 by Schetzenmayr that 
the femoral artery in the dog hind limb dilates in response to the stimulus of increased 
blood flow (Schetzenmayr, 1933). Relaxation due to flow is widely considered to result 
from the release of NO and to a lesser extent PGI2, although NO independence has 
occasionally been reported (Poston, 2002). The involvement of PGI2 and NO has been 
demonstrated by the flow-induced synthesis of 6-ketoprostagladin-fla, a stable metabolite 
of PGI,(Heckler et al., 1993), and the fact that inhibitors of NO synthase blunted flow 
induced vasodilation (Cooke et al., 1990). Shear stress is the most potent physiological 
stimulus for NO production in endothelial cells. Acute changes in NO production are due 
to posttranslational activation of eNOS, while chronic alterations in eNOS expression are 
due to changes in gene expression (Traub et al., 1998). Shear also effects the levels of 
vasoconstrictors such as ET-1; It has been demonstrated that low levels of shear stress (4­
5 dyn/cm2) transiently up-regulates ET-1 mRNA expression, with a peak at 2 h and a 
return to baseline by 4h (Yoshizumi et al., 1989). In contrast higher levels, (15-25 
dyn/cm2), were shown to induce a mild increase (within first hour), followed by a five­
fold sustained decrease in ET-1 mRNA in a force-dependent manner in both bovine aortic 
(Malek et al., 1993) and human umbilical vein endothelium (Sharefkin et al., 1991). It 
has been suggested that this up-regulation of ET-1 at low shear levels may be in order to 
increase blood presure via vasoconstriction in hypotensive environments. The resulting 
increase in pressure and flow causes a down regulation of ET-1, removing its potent vaso­
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constrictive effect. The expression of other shear stress activated genes is also known to 
be a function of shear magnitude; for example t-PA expression is only increased above 5 
dynes/cm2 (Diamond et al., 1990).
1.2.2.3 Shear Stress Modulates Gene Expression
As alluded to previously, shear stress may alter the transcription rate of a specific 
subset of genes. One of the best charcterised reponses is the regulation of endothelial 
nitric oxide synthase (eNOS). Shear stress is the most potent physiological stimulus for 
NO production. Although rapid increases in NO production are due to post-translational 
modification of eNOS, exposure to chonic increases in shear stress leads changes in 
eNOS gene expression (Traub et al., 1998). A selction of genes known to be important 
for a variety of vascular functions and known be regulated by shear stress are shown in 
Table 1.2.
A motif present in the promoters of many shear regulated genes is the so called 
shear stress response element (SSRE), which has the sequence GAGACC. This was first 
identifed in 1993 by Resnick and co-workers in the platelet derived growth factor-B 
(PDGF-B) promotor (Resnick et al., 1993). Some genes have an apparently functionless 
GAGACC sequence, such as MCP-1, while others are shear regulated in the apparent 
absense of this sequence, such as PDGF-A (Reisnick et al., 1995). Alternative SSRE 
sequences have also been identified, such as the MCP-1 gene which has a shear stress 
element with the sequence TGACTCC which is a divergent TRE (phorbol ester tissue 12-
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O-teterdecanoylphorbol 13 acetate responsive element), the site that binds AP-1 (Chien et 
a l, 1998).
Table 1.2 Genes Regulated by Shear Stress in the Endothelium CNP; C-type naturic peptide. bFGF; 
basic fibroblast growth factor. HB-EGF; heparin binding epidermal growth like factor. VCAM-1; vascular 
cell adhesion molecule 1. TF; tissue factor. T-Pa; tissue plasminogen activator. SOD; superoxide dismutase. 
(Adapted from Chien et al., 1998). ff indcicates up-regulation, while 1). indicates down-regulation. 
References: 1; Kuchan et al., 1994. 2; Yoshizumi et al., 1989. 3; Masatugu et al., 2003. 4; Frangos et al., 
1985. 5; Okahara et al., 1995. 6; Chun et al., 1997. 7; Reider et al., 1997. 8, 9; Hsieh et al., 1991. 10; 
Malek et al., 1993. 11; Ohno et al., 1995. 12; Morita et al., 1993. 13; Nagel et al., 1994. 14; Tsuboi et al., 
1995. 15; Shyy et al., 1994. 16; Lin et al., 1997. 17; Diamond et al., 1990. 18; Malek et al., 1994. 19, 
20; Topper et al., 1996. 21; Inoue et al., 1996. 22; Hsieh et al., 1993. (adapted from Chien et al., 1998).
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1.2.2.4 Shear Stress and Vascular Health
There is considerable evidence to suggest that laminar shear stress exerts an 
atheroprotective effect on the vessel wall; steady laminar shear stress promotes release of 
factors from endothelial cells that inhibit coagulation (il'PGI2 NO), migration of 
leukocytes, and smooth muscle cell proliferation (ftNO), while simultaneously promoting
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endothelial cell survival. On the contrary, in areas of low shear stress and flow reversal, 
such as at bifurcations and branch points in the vessel, the profile of secreted factors and 
expressed surface molecules shifts towards one that favors increased coagulation (Jj.NO), 
leukocyte adhesion (fl'MCP-1, ft VC AM -1), endothelial cell apoptosis and smooth muscle 
cell proliferation (ft'Ang-II, ffPDGF, f|'ET-I) (Frangos et al., 1985; Morgi et al., 1995; 
Kaiser et al., 1997; Traub et al., 1998).
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Figure 1.4 Diagram of the formation of an atherosclerotic plaque; showing accumulation of lipids in 
foam cells, monocyte infiltration and smooth muscle cell migration (www.peprotech.com)
The interplay between hemodynamic forces and the endothelium plays a major 
role in a number of vascular diseases, such as atherosclerosis. Atherosclerosis is a 
progressive disease characterised by the accumulation of lipids and fibrous elements in 
large arteries. Early lesions consist of subendothelial accumulations of cholesterol-laden 
macrophages called foam cells. These fatty streaks develop over time into plaques 
comprising of a lipid rich necrotic core and typically have a fibrous cap consisting of 
SMCs and ECM (see Fig 1.4). Plaques become increasingly complex and can grow
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sufficiently large enough to occlude blood flow. One of the more common clinical 
complications is thombis formation as a result of the rupture of a plaque and consequent 
vessel occlusion. (Traub et al., 1998).
There is a strong correlation between areas of low mean shear stress and 
oscillatory flow and endothelial dysfunction leading to the formation of atherosclerotic 
plaques (Traub et al., 1998; Topper et al., 1999). M anifestations of dysfunctional 
endothelium can be readily observed in certain areas of the arterial tree such as branch 
points, which experience low mean shear stress and flow reversal. These sites exhibit 
factors that favor the development of atherosclerotic plaques, such as increased uptake of 
lipoproteins, the expression of leukocyte adhesion molecules, and the secretion of growth 
factors which cause the proliferation of local macrophages and smooth muscle cells (Ku 
et al., 1985; Ross et al., 1990). Smooth muscle cells synthesise a connective matrix 
composed of elastic fibers, proteins, collagen, and proteoglycans, and the accumulation 
of lipids and free and esterified cholesterol follows, leading to the formation of a plaque 
(Ross et al., 1990, Hunt et al. 2002).
Even allowing for the presence of pro-atherogenic risk factors such as diabetes 
and hyperlipidemia, the earliest lesions of atherosclerosis show a striking prediliction for 
the sites associated with major arterial branch points and curvatures (see Fig 1.5) 
(Cornhill et al., 1977, Topper et al., 1999).
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Figure 1.5 Non-random localization of early atherosclerotic lesions in a Watanabe heritable 
hyperlipidemic (YVHHL) rabbit. This strain of rabbit has a natural mutation in the gene encoding its low- 
density lipoprotein receptor and, as a result, develops severe hypercholesterolem ia and spontaneous 
atherosclerosis. The aorta has been stained with Oil-Red-O, which shows lipid-rich atherosclerotic lesions 
in the arterial wall. Despite the systemic nature of the hyperlipidemia, the lesions in this animal are largely 
confined to areas around curvatures and branch points, suggesting that patterns of blood flow are important 
in localizing this disease. The upper arrow indicates the arch of the thoracic aorta, which has been opened 
up to display the intimal lining enface. The lower arrow indicates the localized nature of the atherosclerotic 
lesions adjacent to the paired ostia of the intercostal arteries originating from the descending thoracic aorta 
(Topper et al., 1999).
1.3 Means by which Endothelial Cells Transduce Hemodynamic Forces
?.R
Both cyclic strain and shear stress can induce changes in the endothelium both at 
an autocrine and paracrine level, allowing the vessel to respond and adapt to changes in 
the hemodynamic environment with the goal of maintaining steady state homeostatic 
conditions.
The various mechanisms by which endothelial cells sense and transduce the 
frictional and stretch forces resulting from the shear and cyclic stresses associated with 
blood flow, respectively, have yet to be fully elucidated. For obvious reasons the putative 
sensory structures involved must be in a position to directly respond to changes in the 
blood flow, either by physical displacement (conformational change), or indirectly by 
mass transfer gradients (which change ligand-receptor interactions). Such membrane- 
associated receptors include ion channels, integrins, caveolae, tyrosine kinases and G- 
protein coupled receptors (GPCR) (Papadaki et al. 1997). Another possible mechanism 
by which shear stress may be transduced is via interactions of activated receptors with 
cytoskeletal elements, for example at focal adhesion sites and cell-cell junctions (Poston, 
2002).
1.3.1 Ion Channels as Mechanosensors
Ion Channels were first suggested as potential mechanosensors based on the 
observation that shear stress evokes an immediate increase in current though endothelial 
cell potassium channels (Nakache et al. 1988, Cooke et al., 1991). It has been 
demonstrated that exposure of endothelial cells to a physiological level of shear stress for 
10 sec activated a K+ channel, which was not rapidly desensitized, and the magnitude and
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duration of which was shear stress dependent (Alevriadou et al., 1993, Oleson et al., 
1988). The immediacy of this response, one of the fastest recorded responses to shear 
stress, led many to suggest that K+ channels may be effective mechanosensors (Poston, 
2002). Studies which demonstrated that the shear stress induced increase of transforming 
growth factor (31 (TGF-p 1) could be attenuated by blockage of K+ channels lent weight to 
the theory that K+ channels play a role in flow stimulated gene expression (Ohno et al.,
1995). This shear stress sensitive K+ channel seems to be endothelial cell specific, as it 
was not found in vascular cell smooth muscle cells or atrial myocytes (Papadaki et al.,
1997).
Sodium channels have also been implicated in shear-mediated responses. For 
example Traub et al. (1999) have suggested a tonic inhibition of flow-mediated MAP 
kinase (ERK) stimulation by Na+ channels, since shear-mediated ERK1/2 stimulation was 
enhanced by addition of the Na+ channel inhibitor, tetrodoxin. The hyperpolarisation 
associated with increased K+ channel opening is believed to account for the transient rise 
in cell calcium reported in response to shear (Schwartz et al., 1992; Shen et al., 1992; 
Corson et al., 1996). This increase in endothelial cell calcium was originally considered 
to be the reason for the increased NO release associated with increasing flow, as eNOS is 
strongly activated by Ca2+ (Luckhoff et al., 1990). However it has since been shown that 
NO-mediated relaxation in endothelial cells is largely calcium independent (Ayajiki et al., 
1996; Poston, 2002).
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1.3.2 Integrins as Mechanosensors
Integrins are basal membrane associated glycoproteins composed of a  and (3 
subunits; of which some 18 a  and 8 (3 subunits have been identified, arranged in 24 
possible combinations. Each subunit has a large extracellular domain, a transmembrane 
spanning region and a short cytoplasmic domain (Shyy, et al., 2002). The cytoplasmic 
domains of both the a  and (3 subunits interact with signaling molecules, and cytosekeletal 
and extracellular components such as fibronectin, vitronectin and collagen (Lehoux et al.,
1998).
Integrin signaling is a crucial component in development, maintenance and 
function of the vascular system. Binding of an extracellular ligand (such as fibronectin or 
collagen) to the integrin results in localized clustering of integrins in the basal plasma 
membrane. Integrins have the unique characteristic that they can signal through the cell 
membrane in either direction, essentially forming a bridge between the ECM and the 
cytoskeleton. Integrins can also act like a traditional receptor in binding an agonist and 
activating an intracellular response. The cytoplasmic tail of integrins, though devoid of 
intrinsic enzyme activity, transduces signals via adaptor proteins such as CAS, She, and 
paxicillan connecting it with cytoplasmic kinases, transmembrane growth factors and the 
cytoskeleton (Giancotti et al., 1999; Shyy et al., 2002).
A role for integrins as mechanosensors is supported by the observation that 
inhibition of integrin binding to ECM proteins using the RGD peptide inhibitor, 
prevented the shear stress induced dilation o f coronary arterioles exposed to intraluminal 
flow. Similar results were observed with a (3-intergrin neutralizing antibody (Muller et al.,
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1997). Other studies have demonstrated that pretreatment of a confluent endothelial cell 
monolayer with a a v(33 neutralizing antibody blocked shear stress activation of ERK, c- 
jun N-terminal kinase, and the Ik B  complex (Li, et al., 1997; Bhullar et al., 1998).
Integrin-mediated mechanotransduction is believed to include multiple kinases 
(FAK, c-Src, and Fyn), adaptor molecules (p l30CAS and She), gunanine nucleotide 
exchange factors (GEFs) (C3G and SOS) and small GTPases (e.g. rapl and Ras) in 
activating MAPKs such as ERK. Under static conditions the integrin is in an inactive
Static
a |3
Figure 1.6 Representation of Integrin mediated mechanotransduction; Green circles represent adaptor 
proteins, red ovals kinases, white circles GEFs, and white squares GTPases. The black oblong boxes 
represent the portions of the integrin molecule, while phosphorylation is indicated by a red asterix (adapted 
from Shyy et al., 2002).
conformation. Shear stress activates integrins by switching them into an active 
conformation, which increases their affinity and avidity for the cognate ECM proteins.
Shear Stress
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Through specific interaction of the a  and (3 subunits of the activated integrins, the FAK/c- 
Src pathways and the C av-l/Fyn pathways are activated to elicit cascades of 
phosphorylation on various downstream effectors and their assembly through SH2 and 
SH3 interactions, converging at the level of the Raf-MEK-ERK signaling pathway, in 
endothelial cells (see F ig.1.6) (Shyy et al., 2002; Poston et al., 2002; Lehoux et al.,
1998).
1.3.3 Caveolae as Mechanosensors
Another possible candidate for the transduction of hemodynamic forces into 
biochemical signals are caveolae. Caveolae are specialized domains of the plasma 
membrane that are rich in cholesterol. Their high cholesterol content makes them more 
rigid than other portions of the cell membrane. Caveolae are abundant in endothelial cells 
and have been implicated in transcytosis, ion movement across the membrane, and signal 
transduction (Schnitzer et al., 1995). The principle component of caveolae is a 21- to 24- 
kD integral membrane protein called caveolin. Caveolin functions as a scaffold for the 
recruitment and sequestration of signaling molecules. Among signaling molecules known 
to associate with caveloae are G proteins, c-Src-family tyrosine kinases, ras, PKC, eNOS, 
she, Grb2 SOS, Raf-1, and ERK 1/2 (Garcia-Cardena et al., 1996; Couet et al., 1997). 
Based on their biophysical characteristics and interactions with signaling molecules, 
caveolae represent an attractive site for mechanotransduction in the endothelium (Traub 
et al., 1998).
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1.3.4 Hetrotrimeric G- proteins as Mechanosensors
G-protein signaling represents a highly sophisticated molecular system with the 
ability to receive, integrate, and process information from extracellular stimuli. G-protein 
coupled receptors (GPCRs) constitute a large family of single polypeptide chain 
receptors, with seven trans membrane a-helices composed primarily o f hydrophobic 
residues looping between the extracellular and intracellular phases. GPCRs couple to 
hetrotrimeric G-proteins, which consist of a , (3, and smaller y subunits. Most a  and all y 
subunits contain sites for reversible acylations which target G-proteins to the membrane 
compartment which is the principle site of G-protein signaling (Sugden et al., 1997).
In the inactive G-protein heterotrimer, a  subunits exist as GDP ligated forms (Fig 
1.7). The activation of G-proteins occurs as follows; binding of an extracellular agonist to 
a GPCR leads to a conformational change in the receptor and its associated G protein. 
This decreases the affinity of the a  subunit for GDP, and GTP replaces GDP. The GPCR 
disassociates from the hetrotrimer, which in turn disassociates into an a  and Py subunits 
(the latter o f which always remains tightly associated. Both a  and Pydimers then 
activate their different effector molecules (see section 1.3.4.1 and 1.3.4.2). The innate 
GTPase activity o f the a  subunit returns it to a GDP ligated (Fig 1.7) form and aGDP 
reassociates with both py dimers and the subsequently with the GPCR (Sudgen et al., 
1997; Seifert et al., 2003).
More than twenty G-protein a  subunits have been described which have been 
loosely divided into four families based on structural and functional homologies; cxi/0, a s,
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a q and a n .  The majority o f GPCRs are capable of activating more than one G-protein 
sub-type, which leads to initiation of various intracellular signaling cascades. There are 
some characteristic patterns o f G-protein activation by specific receptors, with the 
cellular or physiological effect of a receptor being dependent on which G-protein sub­
type it is coupled to.
sep arate
G a su b u n it h yd ro lyzes  
its  bound G T P  lo G D P  and 
b ecom es inactive
Cocyloht 0 2003  Pear=cn Inc publish nf] as n Cwnrp nge
Figure 1.6 The G-protein binding cycle. G protein-linked receptors contain seven transmembrane 
segments that form a ligand-binding site on the outside of the cell and a G protein-binding site on the 
inside. (1) When the ligand binds, (2) the receptor activates a G protein by causing the Ga subunit to release 
GDP and acquire GTP. (3) The G(alpha) and G(beta/gamma) subunits then separate and (4) initiate signal 
transduction events. (5) The GTP-G(alpha) subunit eventually hydrolyzes its bound GTP, converting the 
subunit back to its inactive GDP-G(alpha) form. (6) The inactive GDP-G(alpha) subunit then recombines 
with G(beta/gamma) to form the inactive G heterotrimer. (© 1999 by Addison Wesley Longman)
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1.3.4.1 The G a Subunits
1. G a s-; there are two members of this family, a s and a 0if , as well as four known splice 
variants. Upon activation, this group stimulates adenylyl cyclase to increase levels of 
intracellular cAMP and to activate calcium channels. a s is ubiquitously expressed while 
cioif is restricted to neuronal cells, specifically olfactory sensory neurons.
2. Giai/o; This family consists o f an , a-,2, an, a 0i, « 02, atrod, a t-Cone, a gust and a Zj all of which 
are highly homologous and have the ability to inhibit adenyl cyclase, in addition to 
activation of potassium channels. The high degree of homology between sub-types may 
suggest partially redundant functions. Expression o f the various a i subtypes may be 
diverse depending on the tissue examined; for example a t2 is predominant in the 
mammalian heart. A defining characteristic o f this family is their sensitivity to petussis 
toxin (PTX), which catalyzes the adenosine diphosphate (ADP)-ribosylation o f a , and a 0 
subunits at a cysteine residue near the C-terminus resulting in the uncoupling of G- 
protein and receptor. An exception to this rule is a z which is pertussis toxin-insensitive.
3. Giaq; This family stimulates phospholipase C in a pertussis toxin-insensitive manner. 
a q and a n  are ubiquitously expressed and receptors activating a q family members do not 
discriminated between a qand a n . ais/i6 are only expressed in hematopoietic cells and a n  
is restricted to the kidneys, lungs and testes.
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4. Giai2 ; a, 12 and a j]  constitute the members of this family and appear to be widely 
expressed. The function of these proteins is somewhat unclear. One recently discovered 
function is the interaction o f these proteins with cadherins causes the release of 
transcriptional activator (3-catenin (Megis et al., 2001, Seifert et al., 2003).
1.3.4.2 The GPy Subunit
This complex is assembled from a repertoire of five (3 subunits and twelve y 
subunits. The sequence similarity is higher between (3 subunits (79-90% homology) than 
y subunits and it is not yet clear how many combinations will actually form stable dimers 
(Clapham et al., 1993). (3y sensitive effectors include adenylyl cyclase, phospholipase C, 
phospholipase A, potassium channels, a calcium pump, and phosphoinositide 3 kinase 
(PI-3 kinase) (Tang et al., 1991; Exton et al., 1996; Yamada et al., 1989; Lotersztajn et 
al., 1992). With a few exceptions there appears to be no major differences between 
different (3y combinations in their ability to activate effector enzymes.
1.3.4.3 G-Proteins as Mechanosensors
A role for G-protein involvement in mechanotransduction was first suggested 
following the observation that intracellular messengers associated with G-protein 
pathways were also activated in response to flow. These included inositol triphosphate 
(IP3), diagycerol (DAG), protein kinase C (PKC) and a rise in cell calcium. Involvement 
of the Gia subunits was suggested by the pertussis toxin-sensitivity of shear-induced NO 
release in some experiments (Poston 2002; Ohno et al., 1993). Later studies by Gudi and
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co-workers demonstrated the rapid activation o f Giaq/au and Giai3/a0 proteins by shear, 
with activation occurring as little as one second after onset o f flow (Gudi et al., 1996). 
This group also demonstrated that treatment of endothelial cells with antisense G a q 
oligonucleotides inhibited shear stress-induced ras-GTPase activity, while scrambled 
oligonucleotide treatment had no effect. Further studies on G-proteins reconstituted on 
liposomes in the absence of protein receptors showed an increase in activity in response 
to shear stress (Gudi et al., 1997; Frangos et al., 1997). Jo and co-workers also 
demonstrated that that the treatment o f endothelial cells with pertussis toxin prevented 
stress mediated activation of ERK1/2 (Jo et al., 1997), indicating a role for Gia; subunit in 
mechanotransduction.
Both the Go, and G(3y subunits o f the G-protein complex can initiate signaling by 
divergent pathways in response to shear. Jo and co-workers demonstrated that expression 
o f the carboxy terminus o f (3-adrenergic receptor kinase (pARK-ct), which acts as a Gffy 
scavenger inhibits the shear stress activation of HA-JNK, whereas blockade of Gi(1i2 with 
the dominant negative mutant o.\2 (G203T) or with antisense G a^  prevented shear 
dependent activation of HA-ERK (Jo et al., 1997).
It is unclear whether G-protein activation is secondary to the deformation of the 
cytoskeleton or to activation o f hitherto unidentified luminal membrane receptors. It has 
been proposed that G-protein activation could be achieved through shear-mediated 
alteration in membrane fluidity (Haideker et al., 2000).
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1.3.5 Tyrosine Kinases as Mechanosensors
Tyrosine kinases (PTKs) play an important role in the signaling pathway which 
leads to the activation of MAPKs, as indicated by the finding that genistein, a PTK 
inhibitor, can attenuate the shear stress activation of ERK and JNK (Li et a l, 1997; Jo et 
al., 1997; Takahasi et al., 1996). PTKs are also critical in the shear stress-regulation of 
endothelial cell shape and stress fibres (Chien et al., 1998), as well as in the early phase 
of flow-dependent NO production (Corson et al., 1996). Reports also indicate that the 
activities of PTKs in cardiac myocytes, platelets, and ECs are increased by mechanical 
stimuli such as cyclic stretch and shear stress (Sadoshima et al., 1997; Ishida et al.,
1996). It has been shown that shear stress induced a rapid and transient tyrosine 
phosphorylation of FLK-1 and its concomitant association with the adaptor protein She in 
endothelial cells (Labrador et al., 2003; Ravichandran et al., 2001). The adaptor protein 
She is implicated in signaling via many different types of receptors, such as growth factor 
receptors, G-protein coupled receptors, hormone receptors, integrands and tyrosine 
kinases. (Lopez-Ilasaca et al., 1998).
PTKs can be divided into two major categories; receptor and non-receptor 
tyrosine kinases.
39
1.3.5.1 Receptor PTKs
These PTKs distinguished as a sub-class from other enzyme linked membrane 
receptors by the presence of an intrinsic tyrosine kinase activity within the receptor 
molecule itself. Receptors of this class generally respond to circulating hormonal stimuli 
which trigger the activation of intracellular signaling pathways leading to cell shift in 
metabolism proliferation and/or differentiation. Members of this family include the 
insulin-like growth factor receptor (ILGFR), the epidermal growth factor receptor
Figure 1.8 Activation of Ras by receptor tyrosine kinases; binding of an agonist (Ag) to a single chain 
receptor PTK causes dimerization of the receptor and stimulates its tyrosine kinase activity. This results in 
phosphorylation of tyrosine residues (Y) on the intracellular domains of the receptor, allowing it to bind to 
the adaptor proteins Grb2 and Sos, and leading to the subsequent activation of RAS. (Adapted from Sudgen 
etal., 1997).
(EGFR) and the platelet-derived growth factor receptor (PDGFR). Many of these 
receptors exist as monomers in the cell membrane (e.g. EGFR) (see Fig 1.8J. Agonist 
binding to the extracellular portion leads to the dimérisation of two receptors, and a 
subsequent conformational change, which causes the autophosphorylation of the 
cytoplasmic domain, creating binding sites for intracellular adaptor molecules such as
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Sos and Grb2. These adaptor molecules subsequently bring other signaling molecules, 
such as Ras, into close proximity to the receptors intercellular domain, leading to 
activation of a signaling cascade (Stone et al., 1998; Sugden et al., 1997).
1.3.5.2 Non-receptor PTKs
The so-called non-receptor PTKs include molecules such as FAK and c-Src, these 
represent cellular enzymes that have intrinsic kinase activities but do not possess 
extracellular domains. FAK and c-Src, for example are present in focal adhesion sites and 
are tyrosine phosphorylated in response to cell adhesion and the stimulation of a number 
of growth factors (Schaller et al., 1994). Focal adhesion associated kinases such as FAK 
and c-Src are rapidly activated in ECs by shear stress (Li et al., 1997).
1.3.6 Intracellular Signaling Pathways; The Role of Mitogen Activated Protein 
Kinases and Small GTPases in the Transduction of Shear Stress Responses.
The proposed mechanosensors discussed previously fulfill the first step in 
mechanotransduction; namely the transmission of an extracellular physical response to an 
intracellular biochemical signal. This intracellular signal needs to recruit and activate 
further effector molecules in order to induce changes at the level of transcription.
The family of kinases termed mitogen activated protein kinases (MAP kinases) 
are potential candidates as second messengers in mediating some of the effects of shear
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stress on endothelial cells. MAP kinases are ubiquitously expressed serine/threonine 
protein kinases that are activated in response to a variety of extracellular stimuli involved 
in cell growth, transformation and differentiation. The extracellular signal related kinases 
(ERK1/2), and the stress activated c-Jun NH(2)-terminal kinase (JNK) are members of 
the MAP kinase family and have many potential substrates, including other protein 
kinases (p90rsk, AP-1, Raf-1, MEK), transcription factors (c-myc, c-jun, c-fos, p62TCF), 
enzymes (cPLA2), and cell surface proteins (EGF receptor) and thus have many effects on 
cellular physiology and gene expression (Traub et al., 1998; Berk et al., 1995; Go et al.. 
1999; Poston et al., 2002).
The pathway for ERK1/2 activation in response to growth factors has been well 
characterized. The MAP and ERK kinase (MEK-1) is a dual specificity kinase that 
phosphorylates ERK1/2 on T-E-Y. MEK-1 itself is regulated by a MAP kinase kinase 
kinase (MAPKKK), Raf-1. Raf-1 is mediated by translocation to the membrane and 
association with the small GTP binding proteins Rho, Rapl and ras. The GTPase activity 
of Rap 1 and ras is regulated by a complex which involves the so called adaptor proteins 
Grb2 and Sos which are recruited and activated by tyrosine kinase receptors (Pelech et 
al., 1992; Shyy et al., 2002).
It has been demonstrated that ERK 1/2 is activated by shear stress in endothelial 
cells in a time- and force-dependent manner (Tseng et al., 1995). Shear stress stimulation 
of ERK1/2 was unaffected by treatment with the Ca2+ chelator BAPTA-AM, indicating 
that the response was Ca2+ -independent. These findings, combined with observations that
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eNOS contains multiple sites for phosphorylation by a number of kinases, suggested that 
this pathway was a likely candidate in the stimulation of sustained NO production in 
response to shear stress (Berk et al., 1995). More recent work by Davis and co-workers 
has indicated, however that the immediate activation of eNOS in response to shear 
involves the c-Src, with the increase in eNOS mRNA expression observed in response to 
prolonged shear stress exposure was shown to involve the c-Src activation of Raf, 
MEK1/2, and ERK1/2 (Davis et al., 2001; Davis et al., 2003). ERK1/2 has also been 
shown to mediate the cyclic strain dependent up-regulation of MMP-2 in the 
endothelium. Von-Offenberg Sweeney and co-workers demonstrated that use of PD98059 
to selectively inhibit ERK1/2 significantly attenuated the effects of cyclic strain on 
MMP-2 (Von-Offenberg Sweeney et al., 2004).
Another member of the MAPK family, which has been shown to be regulated by 
shear stress, is the stress-activated protein kinase JNK (Jo et al., 1997). Studies have 
demonstrated that shear stress inhibits tumor necrosis factor-stimulated JNK activity in 
endothelial cells (Surapisitchat et al., 1998), a finding consistent with the findings that 
shear stress has an anti apoptotic effect on the endothelium.
Cyclic strain also activates E rk l/2  and JNK in cultured SMC are transiently 
activated in arterial wall by acute hypertension (Xu et al., 1996). Kito and co-workers 
found that cyclic strain activated E rkl/2 , JNK and p38 in pulmonary ECs with 
subsequent A P-l/TRE activation and was found to modulate the Egr-1 transcription 
factor (Kito et al., 2000).
43
1.3.7 Downstream Effectors of ERK1/2 Activity; the Protein Kinase C (PKC) Family
PKCs are well-characterized serine/theonine kinases that are activated by a 
variety of stimuli. The dominant isoforms in endothelial cells are believed to be PKCa, 
PKCe and PKCt, (Traub et al., 1998).
The requirement of PKC for ERK1/2 activation has been demonstrated by the fact 
that pretreatment of endothelial cells with staurosporine, a PKC inhibitor, attenuated 
ERK1/2 activation by shear stress (Tseng et al., 1995). In further studies using antisense 
oligonucleotides to inhibit expression of various PKC isoforms, PKCe was identified as 
the isoform responsible for the activation of ERK1/2 in response to shear stress (Traub et 
al., 1997).
Studies by Cai and co-workers, demonstrated the mechanism by which PKC 
mediates ERK1/2 activation. These investigations demonstrated that activation of Raf-1, 
a key mediator of ERK 1/2 activation is dependent on several criteria; 1) recruitment of 
Raf-1 to the plasma membrane; 2) activation of Raf-1 by the GTP-bound form of ras; 3) 
tyrosine phosphorylation of Raf-1 by c-Src or c-Src family kinase; and 4) 
phosphorylation of Raf-1 on serine and threonine residues. Both PK Ca and PKCe were 
directly responsible for the phosphorylation of serine and threonine residues on Raf-1 in 
response to various stimuli. This redundancy in PKC signaling allows for signaling 
regardless of a rise in intracellular Ca2+, as PKCe is Ca2+-independent (Cai et al., 1997).
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1.3.8 Transcription factors
Transcription factors or “third messengers” are proteins typically located in the 
cytosol or in the plasma membrane. These readily available elements are activated post 
translationally by second messengers and can rapidly regulate the expression of selective 
immediate early genes (IEG). Shortly after the cell is stimulated IEG are transcribed and 
code for immediate early proteins, which play a regulatory role in the transcription of 
other late response proteins (Davies et al., 1995; Papadaki et al., 1997). Endothelial IEGs 
transiently up-regulated by shear stress are c-myc, c-fos, and c-jun (Hsieh et al., 1993). c­
fos, and c-jun encode proteins that belong to nuclear activator protein 1 (AP-1), while c- 
myc protein can associate with other proteins to form other transcription factors. Two 
transcription factor families present in endothelial cells are stimulated by a number of 
defined stimuli which includes shear stress. These are the AP-1 and i?e/-related nuclear 
factor kappa B (NFkB) (Papadaki et al., 1997).
1.3.8.1 AP-1
The AP-1 complex is formed from the dimérisation of Fos/Jun families of 
proteins through so-called leucine zipper (Nollert et al., 1992). AP-1 can bind to cis 
acting elements in the promoter region of genes, such as the TRE [TGACTCA], and the 
cAMP responsive element or CRE [TGACGTCA], The c-fos/c-jun dimer shows a higher 
binding affinity for the TRE than c-jun/c-jun, while c-fos/c-fos is unable to bind properly 
(Papadaki et al., 1997).
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It has been demonstrated that c-jun/c-jun homodimer is the activator of the AP- 
1/TRE in endothelial cells exposed to arterial levels of shear stress, with latent c-jun 
being activated though the ras-MEKK-JNK pathway and translocating to the nucleus 
where c-jun/c-jun homodimers form and activate the TRE (Li et al., 1996). Although a 
number of genes possess the TRE/CRE motif in their promoter region, only one, MCP-1, 
has a well-studied response to shear stress (Chien et al., 1998; Poston, 2002).
1.3.8.2 NFkB
NFkB is a pluripotent transcription factor, activated by a number of stimuli, 
which is found in the cytosol of inactivated cells as a heterodimer of a p50 and a p65 
protein, bound to an inhibitory cytoplasmic I k B  protein (Lan et al., 1994). Upon 
activation the p50/p60 protein complex rapidly dissociates from IkB, allowing transport 
of free NFkB to the nucleus where it can bind to specific NFkB consensus sites 
[GGAAGATCCT], NFkB is also known to bind to the SSRE [GAGACC], and has been 
shown to be involved in the shear stress-dependent up-regulation of a number of genes 
including PDGF-B (Resnick et al., 1993) and eNOS (Davis et al., 2003). It is generally 
considered that the activation of NFkB occurs via phosphorylation by protein kinases, 
including PKC, c-Src, and MEK1/2 (Papadaki et al., 1997; Davis et al., 2003).
1.3.9 Hemodynamic Forces and mRNA Stability
Evidence suggests that mechanical forces may alter protein levels, not at the level 
of transcription, but by altering the mRNA stability of certain genes. It has been proposed
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that a shear-induced loss in mRNA stability may be the process by which shear down- 
regulates expression of certain proteins (Papadaki et al., 1997). A suggested mechanism 
for this is via the presence of AUUUA repeats in the untranslated regions of the gene, 
which are known to cause mRNA instability in certain genes. For example VCAM-1, 
which is down-regulated by shear stress, contains some six such repeats in the 3 ’ 
untranslated region. In comparison, genes up-regulated by shear, such as tPA and PDGF- 
B have only one such sequence, while the constitutively expressed glyceraldehyde 
phosphate dehydrogenase (GAPDH) gene has none. However these motifs may, have 
other functions, i.e. involvement in the transport of mRNA to the cytoplasm, and VCAM- 
1, or indeed any other gene down-regulated by shear stress, might be regulated at the 
transcriptional level (Patrick et a l, 1995, Poston 2002).
1.4 Thermolysin Like Zinc Metallopeptidases
Metal dependent proteases constitute one of the four major types of protease, the 
others being aspartic, serine and cysteine proteases. This classification is based on the 
catalytic mechanism and the critical active site amino acid residues involved. In the case 
of metallopeptidases, an activated water molecule complexed to the divalent cation, 
usually Zn2+, serves as the nucleophile, attacking the carbonyl group of the targeted 
peptide bond. Rawlings and Barrett proposed a classification system based not only on 
the catalytic mechanism, but also the evolutionary links between enzymes (Rawlings and 
Barrett, 1993). Most mammalian metallopeptidases fall into one of four clans or sub 
clans.
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By far the largest group, Clan MA, is distinguished by the active site HEXXH 
motif, where the two histidine residues, together with a third distant residue, bind the zinc 
atom. This clan is divided into two major sub-clans: MA(E), the “gluzincins”, where the 
third ligand is a glutamate, and MA(M), “metzincins” , where a third histidine or an 
aspartate residue serves this purpose. This latter group is typified by the matrix 
m etalloproteases and their relatives, including the ADAMs (a rfisintegrin ¿znd 
metalloprotease). The gluzincins are further divided into families based on homology. 
The families most relevant to mammalian signaling systems are M l (aminopeptidases), 
M2 (angiotensin converting enzyme family), M3 (EP24.15/thimet oligopeptidase and 
EP24.16/neurolysin), and M13 (neutral endopeptidase family, which also includes 
endothelin converting enzyme). The metallocarboxypeptidases belong to the clan MC, 
while a smaller group of peptidases, in which the active site motif is reversed (HXXEH; 
the so-called “inverzincins”) and typified by insulin-degrading enzymes (insulysin), 
belong to the M16 family within the ME (Rawlings and Barrett, 1993; Lew, 2004).
Given the multifunctional roles of ACE, ECE, NEP, Neurolysin and THOP, the 
possibility that the expression and function of these metallopeptidases might be sensitive 
to hemodynamic stimuli has been considered. Inspection of the promoter regions of the 
genes coding for THOP, ACE, ECE-1 and NEP all display the shear stress response 
element SSRE [GAGACC], a motif, which as discussed previously frequently occurs in 
the promoters of mechanosensitive genes (McCool et al., 1998; McCool et al., 2000; Li 
et al., 1995; Shinoki et al., 1998).
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1.4.1 Endothelin Converting Enzymel (ECE-1)
Endothelin converting enzyme (ECE-1, EC3.4.24.71) in involved in the 
production of one of the most potent vasoconstrictors known, endothelin-1, from its 
parent peptide big ET-1. The physiological significance of ET-1 within the vasculature 
has been discussed previously (see section 1.1.2.4). ECE-1 is expressed primarily in the 
endothelium (Levin, 1995). ECE-1 is known to exist in various isoforms; namely (ECE- 
la , ECE-lb and ECE-1 c in humans). A closely related peptidase, ECE-2 has also been 
identified, however it is thought that unlike ECE-1 which operates at the cell membrane, 
ECE-2 is likely to operate intracellularly (Lew, 2004).
The ability of hemodynamic forces to modulate the ECE and ET-1 has been 
demonstrated previously. Yoshizumi and co-workers found that low levels of shear stress 
(4-5 dyn/cm2) transiently up-regulates ET-1 mRNA expression, with a peak at 2 h and a 
return to baseline by 4h (Yoshizumi et al., 1989), in contrast higher levels, (15-25 
dyn/cm2), were shown to induce a mild increase (within first hour), followed by a five­
fold sustained decrease in ET-1 mRNA in a force dependent manner in both bovine aortic 
(Malek et al., 1993) and human umbilical vein endothelial cells (Sharefkin et al., 1991). 
This suppression of ET-1 mRNA has been shown to be attenuated or abolished by 
inhibition of tyrosine kinase, disruption of cytoskeletal components (F-actin), chelation of 
intracellular calcium, and inhibition of stretch activated ion channels (Malek et al., 1999). 
A reduction in the production of ET-l in response to high shear stress is an unsuprising 
result, as a reduction in the levels of ET-1 would aid vasodilation and thus lead to a
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reduction in blood presure. Cyclic or pulsatile strain has also been shown to elevate levels 
of ET-1 mRNA expression and secretion. (Chenga et al., 1998). This up-regulation in 
response to strain involved reactive oxygen species, as pre-treatment with catalase was 
shown to abolish the strain induced increase in transcription and secretion. Further 
studies indicated the involvement of a Ras/Raf/extracellular Signal-regulated pathway 
(Chenga et a/,2001).
Hemodynamic forces have also been shown to regulate levels of ECE-1. 
Masatsugu and co-workers demonstrated a significant and force dependent decrease in 
expression of both E C E -la  and ECE-1(3 mRNA in response to shear stress in both human 
umbilical vein endothelial cells (HUVECs) and bovine aortic endorthelial cells(BAECs) 
cultured in a parallel plate flow chamber. This occurred with a similar decrease in levels 
of ET-1 mRNA. These responses to shear appeared to occur through oxidative stress, as 
treatment with an antioxidant attenuated the response to shear (Masatsugu et al., 2003). 
Similar studies by Morawietz and co-workers showed a 63.8% and 37.8% decrease in 
levels of E C E -la  and ECE-113 mRNA in HUVECs in response to chonic laminar shear 
stress. A decrease in ET-1 expression and release was also demonstrated and shown to 
occur in a protein kinase C insensitive and eNOS sensitive manner. In contrast an 
eNOS/PKC dependent and tyrosine kinase independent increase in levels of the ETB 
receptor in response to chonic laminar shear stress was also observed in this study 
(Moraweitz et al., 2000).
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The down-regulation of both ET- I expression and release and of ECE expression 
in response to high levels of laminar shear stress, would putatively reduce the amount of 
ET-1 available within the vasculature. In Vivo, in response to high blood flow rates and 
consequent high blood pressure, the reduction of ET-1 levels may aid the relaxation of the 
vessel wall, with a concomitant reduction in blood pressure.
1.4.2 Angiotensin Converting Enzyme (ACE)
ACE (EC.3.4.15.1) is a well characterised membrane bound metallopeptidase 
known to play a crucial role in cardiovascular homeostasis. ACE is involved primarily in 
the production of the potent vasoconstrictor Ang-II from Ang-I, but is also involved in 
the conversion of A ng(l-9) to A ng-(l-7) and the further degredation of Ang-(l-7) to 
inactive peptide fragments. ACE is also involed in the inactivation of the vasodilator BK 
(BK) by converting it firstly to BK(l-7) and then to BK(l-5) (Duncan et al., 1999; Guy 
et al., 2004). ACE is not only interesting because of its physiological and pathological 
characteristics, but also because it is the only known metallopeptidase with two active 
sites, undoubtedly the result of gene duplication (Lew, 2004). The two display distinct 
substrate and inhibitor affinities, a phenomenon recently exploited in the design of site 
specific inhibitors which lim it the formation of the vasoconstricor Ang-II while 
preventing the degradation of the vasodilator BK (Georgadis et al., 2003). A testes 
specific single site isoform of ACE also has been identified, while the closely related 
ACE2 is believed to function as a carboxypeptidase rather than a dipeptidyl peptidase 
with Ang-II as its substrate (Vickers et al., 2000).
51
Using both in vitro and in vivo shearing pardigms, Rieder and co-workers have 
investigated the mechanosensitive properties of ACE. Employing a cone-plate viscometer 
to expose bovine pulmonary artery endothelial cells (BPAECS) to chonic laminer shear 
stress (20 dynes/cm2, 18h), ACE activity was reduced by 49.5% and ACE mRNA 
expression by 82% (Rieder et al., 1997). The same group modelled in vivo shear stress 
elevations by placing a stainless steel clip over a 12mm region of the rat abdominal aorta. 
This restriction in vessel diameter increased blood flow velocity and caused a reduction 
in vascular ACE activity by 40%. A significant shear-dependent reduction in ACE 
promoter activity was also observed in the same study (Rieder et al., 1997). The 
signalling pathways mediating these events remain to be elucidated; however NO may 
play a significant role. It is well known that shear stress increases the production of NO 
in vascular endothelial cells. In this regard Takemoto and co-workers have demonstreted 
that eNOS inhibition results in an up-regulation of ACE expression in various vascular 
and myocardial tissues (Takemoto et al., 1997), whilst Ackermann and co-workers 
dem onstrated that NO and NO-releasing compounds inhibit ACE activity in a 
concentration-dependent and competetitive manner (Ackermann, et al. 1998). In a later 
study, Gosgnach and co-workers employed a parallel plate flow chamber to expose 
cultured rat vascular smooth muscle cells to chonic shear stress (10 dynes/cm2, 24h) in an 
effort to model SMC exposure to shear in the event of endothelial denudation (Gosgnach 
et al., 2000). They present data demonstrating shear-dependent induction of ACE activity 
and mRNA expression in SMCs, which was mediated in part by basic fibroblast growth 
factor (bFGF), a finding which concurs with earlier studies which demonstrate the over­
expression of ACE in the proliferating neointima following balloon injury (Rakugi, et al.,
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1994). Gosgnach also reports a shear-dependent induction (2.14 fold) of ACE activity in 
rat aortic endothelial cells in the same study, which appears to contrast with the earlier 
findings of Rieder (Reider et al., 1997). This may reflect differences in the cultured 
endothelial cell types used and/or the shearing paradigms employed. The relationship 
between cyclic strain and ACE in some vascular cell types has also been investigated, 
albeit less directly. Studies have demonstrated that strain-dependent SMC collagen 
production and SMC proliferation is mediated inpart via elevated Ang-II production by 
ACE (Li et al., 1997; Li et al., 1998), whilst strain induced activation of p42 and p44 
MAPK in vascular SMCs has also been reported to be Ang-II-and ACE-dependent 
(Hosokawa et al., 2002).
1.4.3 Neutral Endopeptidase (NEP)
Neutral Endopetidase (neprilysin, enkephalinase, EC.3.4.24.11), was first isolated 
from renal epithelial cell brush borders, and is primarily membrane bound. It catalyses 
the degradation of a number of vasodilator peptides arterial natriuretic peptide (ANP), 
brain natriuretic peptide, C-type natriuretic peptide, substance P and BK, as well as 
degrading vasoactive petides such as ET-1 and Ang-II. In addition to degrading 
vasoactive peptides to inactive fragments (eg, BK to BK-(l-7)), NEP also catalyses the 
production of Ang-(l-7), from Ang-I, and the cleavage of big ET-1 to form ET-1 (Ferro et 
al., 1998). Recently an NEP homologue, NEP-2, was identified by three separate groups. 
Termed either neprilysin-2 (NEP-2) (Ouimet et al., 2000), secreted endopeptidase (SEP) 
(Ikeda et al., 1999), or nephilysin like-1 (NL-1) (Ghadder et al., 2000), NEP-2 has a
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similar substrate specificity to NEP-1. However the specific expression pattern of NEP2, 
being absent in the periphery (other than the testis) and restricted to brain regions low in 
NEP, as well as the existence of a secreted isoform, suggests a distinct function yet to be 
identified (Lew 2004).
To our knowledge there have as yet been no studies that indicate a role for 
hemodynamic forces in the regulation of NEP expression or activity in vascular cell 
types. However given its role in the regulation of vascular tone and blood presure, it is 
highly likely that like both ACE and ECE1, it is subject to mechanoregulation by 
hemodynamic forces.
1.4.4 The soluble Metalloendopeptidases; Thimet Oligopeptidase and Neurolysin
The closely related enzymes thimet oligopeptidase (THOP, EC3.4.24.15, 
EP24.15) and neurolysin (EC3.4.24.16, EP24.16) both belong to the clan MA series of 
peptidases, and share similar structural features and substrates with the previously 
discussed ACE, ECE and NEP. Unlike the latter three enzymes they exhibit no distinct 
transmembrane domain. However, it has been demonstrated in numerous tissue types that 
these enzymes can be constituitively secreted and membrane associated (for review see 
Shimpton et al., 2002). They were first purified from the soluble cytosolic fractions of the 
bovine pituitary (THOP, Horsthemke et al., 1980) and rat synaptic membranes 
(Neurolysin, Checler et al., 1986). They have a broad tissue distribution, having been 
identified in neuronal, vascular, pituitary and testicular tissue, and are believed to play a 
role in sexual maturation (THOP), pain perception and opoid processing (THOP),
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neurotensin inactivation (THOP/Neurolysin), blood pressure regulation and renal 
homeostasis (THOP/neurolysin) (Shimpton etal., 2002).
1.4.4.1 Biochemical properties; Thimet Oligopeptidase
THOP was first isolated from the soluble fractions of bovine pituitary and rat 
brain (Horsthemke et al., 1980; Orlowski et al., 1983) and shown to hydrolyse a number 
of biologically relevant peptides with a general specificity for peptide bonds on carboxyl 
side of basic residues (See Fig 1.11).
Isolated brain THOP was shown to be optimly active at a neutral pH, be inhibited 
by metal ion chelators and reactivated by low concentrations of Zn2+ ( Orlowski et al., 
1983). Later atomic absorbtion studies indicated the presence of a tightly bound zinc 
atom at the catalytic core (Tisljar, et al., 1989). This zinc atom is co-ordinated by the side 
chains of the active site histidines (H473, H477), and a glutamate residue located 25 
residues carboxy to the HEXXH motif (E502). A second glutamate residing within the 
active site (E474) also participates in the coordination of the zinc via an activated water 
molecule (Cummins et al., 1999). The recently published crystal structure of human 
THOP showed that the active site is partially blocked by a large shielding element, which 
prevented the hydrolysis of large, folded substrates but allowing the small largely 
unstructured oligopeptides favoured by THOP to bind in an extented conformation along 
the long narrow channel leading to its active site (Ray et al., 2004) (see Fig 1.9,1.11). 
THOP also displays thiol activation at low levels of treatment with dithioltheitol (0.5 M), 
while higher concentrations (5 M) lead to inhibition. This inhibition has been suggested
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Figure 1.9 Overview of the timet oligopeptidase structure and active site density, (a) ribbon diagram of 
thimet oligo peptidase. Indivdual a  helices and p sheets are numbered, and the regions structuraly similar 
to other zinc metallopeptidases is in gold. The active site zinc is shown as a blue sphere, (figure created 
using RIBBONS), (b) Active site of thimet oligopeptidase. Key residues of the HEXXH motif are marked 
along with the third zinc ligand from the protein Glu-502. The active site zinc and catalytic water molecule 
are shown as blue and red spheres respectively (figure created using Swiss-PDB viewer). (Adapted from 
Ray et al., 2004)
to be as a result of the disruption of disulphide bridges in the enzyme and the thiophilicity 
of the catalytic zinc ion (Barret et al., 1990). The activation of THOP by thiols has been 
shown to involve the conversion of an inactive multimer, where the access of substrates 
to the active site is blocked, to an active monomer via disruption of intermolecular 
disulphide bridges (Shimpton et al., 1997). This may allow for the regulation of the 
activity of THOP in vivo by the alteration of inter- and intra- cellular redox potential.
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The purification to homogeneity of THOP from rat testis in 1989 (Orlowski et al., 
1989), and its subsequent cloning from the same source (Pierotti et al., 1990), allowed the 
DNA and protein sequence of the enzyme to be studied in detail. It was revealed to be a 
protein of 78 kDa, with an amino acid sequence comprising 645 amino acids, to be the 
product of a single gene and to lack a secretory signal sequence or a membrane spanning 
domain. In addition putative sites for N glycosylation and phosphorylation were 
identified. Although there is no evidence that THOP undergoes glycosylation, Tullai et al. 
have demontrated that THOP can be phosphorylated by protein kinase A at Ser644, and 
that this modifies it’s kinetic parameters for the cleavage of certain subjects including 
gonadotrophin-releasing hormone (GnRH) (Tullai, et al., 2000). In addition 
phosphorylated forms of THOP were detected in rat PC12 cells and mouse AtT-20 cells, 
both basally and in response to the forkolin stimulation of protein kinase A. Furthermore, 
cleavage of a specific flourescent substrate by THOP was shown to be decreased after 
treatment by cAMP analogs (Ferro et al., 1995).
1.4.4.2 Biochemical Properties; Neurolysin
Neurolysin (EC3.4.24.16, EP24.15) was originally purified and characterised 
from rat synaptic membranes (Orwolksi et al., 1986) on the basis of its ability to cleave 
neurotensin (NT) at Pro10-Tyru , allowing its separation from THOP, which cleaves 
neurotensin (NT) exclusively at Arg8-Arg9 (Checler et al., 1986). The cleavage of NT 
represents one of the few differences in substrate specificity between the two enzymes, 
with most other natural substrate cleaved at identical sites by either enzyme (see 
Fig.1.11), Studies involving highly purified or recombinant enzymes and synthetic
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substrate/inhibitor libraries have revealed only subtle differences in the spécificités of the 
two enzymes (Rioli et al., 1998).
Some distinction between THOP and neurolysin can be made using the inhibtors 
(N-fl^^-carboxyl-S-phenylpropylj-A la-A la-Tyr-p-am inobenzoate (cFP-AAY-pAB), 
which preferentially inhibits THOP (K;[THOP]= 19nM, K ,[N euro lys in ]= 700nM ) and 
Pro-Ile which inhibits neurolysin(K;[THOP]= 5mM, Ki[Neurolysin]=90(.iM) (Dauch et 
al., 1991). However Pro-Ile is not a very potent inhibitor and cFP-AAY-pAB can also 
strongly inhibit neurolysin. Highly potent and specific phosphinic inhibitors, Pro- 
PheW(P02CH2)Leu-Pro-NH2(PFFCLP-NH2 (K,[THOP]= 66.5j.iM, Ki[Neurolysin]=12nM) 
and P ro-PheW  ( P 0 2CH2)-(LD)Arg-Arg-Phe(Z-FPCA R F  ( Ki[THOP]=66.5,uM, 
K ^N eurolysinJs^nM ) have been developed by and Jiracek and co-workers, which 
allow the assement of the distinct funtional role of both THOP and neurolysin (Jiracek et 
al., 1995; Jiracek et al., 1996).
One major difference between the enzymes is the activation of THOP by low 
levels of reducing agents, which as previously mentioned occurs due to the disassociation 
of the multimeric form of the enzyme, while neurolysin is strictly monomeric (Shimpton 
etal., 1997).
Cloning of rat brain neurolysin revealed a 704 amino acid protein that is 
aproximately 60% homologous to THOP (Dauch et al., 1991). It was later shown that 
relatively few of the difference between neurolysin and THOP relate to the substrate
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binding site (Ray et al., 2004). Like the crystal structure of THOP, the crystal structure of 
neurolysin displays a narrow peptide binding channel.
Modeling of the binding of neurolysin to neurotensin suggests that the N terminus 
of the peptide slides into the channel, aligning the cleavage site (Pro10-Tyru) with the 
catalytic zinc ion (see Fig 1.10). The presence of flexible loop elements lining the 
channel were suggested to be responsible for allowing cleavage at multiple sites (Brown 
et al., 2001). This hypothesis was strengthened by the discovery that one of the 
differences in between the binding sites of THOP and neurolysin involve a 
conformational difference in a loop segment between residues 599-611 (Ray et al., 2004).
1.4.4.3 Substrate Specificities
With the exception of the cleavage of neurotensin discussed above, both THOP 
and neurolysin display a similar specificity for a range of natural substrates. Both 
enzymes have been shown to cleave peptides between 6-17 residues long, and to 
preferentially cleave at the carboxyl side of hydrophobic residues. They also display an 
additional preference for an aromatic residue at the P2 and P3’ position, and to favour 
cleavage with the Pj position occupied by Phe, Ala, or Arg (Shimpton et al., 2002).
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Figure 1.10 M odel o f NT bound to the deduced structure of neurolysin. A molecular surface 
representation of neurolysin sectioned to show the large cavity at the bottom of the active site channel is 
shown with the 13-residue substrate NT, with the N-terminus of the peptide at the top (Brown et al., 2001).
Both enzymes hydrolyse BK at the Phe5-Ser6 bond, GnRH at the Try5-Gly6 bond, 
the resulting N-terminal fragment at the His2-Trp3 bond, dynorphin A,_8 at the Leu5-Arg6 
bond, Ang-I at the Pro7-Phe8 bond and somatosatin at both the Phe6-Phe7 and the Th10- 
Phe11 bond. By contrast neurolysin cleaves NT at Pro‘°-Tyru , unlike THOP, which cleaves 
NT exclusively at Arg8-Arg9 (Shimpton et al., 2002). A number of studies have 
demonstrated that both THOP and neurolysin display differing affinities for a range of 
natural substrates. Barrelli and co-workers showed that rat kidney neurolysin displaed a 
greater affinity for NT and Ang-I than BK (IC50[NT] = 2.1,uM, IC50[Ang-I] = 4.1uM,
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Figure 1.11 Cleavage sites o f natural substrates of T H O P and Neurolysin. Sites of cleavage for both 
enzymes are shown by arrows, while the different cleavage site in neurotensin are clearly marked(adapted 
from Shimpton et al., 2002.)
IC50[BK] = 13.2[xM) (Barrelli, et al., 1993). Similar studies with rat testes THOP 
demonstrated that the enzyme had a greater affinity for BK and NT than Dynorphin A,.8 
(Km[BK] = 4.9jj,M, Km[NT] = 2.8luM, and Km[Dynorphin A ^] = 4.9uM) (Lew et al., 
1995). Interesting this study showed that the substrate specificity of rat testes THOP 
differed significantly from that of THOP expressed in the brain, not least of all in its 
inability to efficiently cleave GnRH. This suggested that tissue specific forms of THOP, 
with differing substrate specificities may exist. Comparative studies with recombinant rat 
THOP and porcine neurolysin have also shown that although the rate of hydrolysis of BK 
was roughly similar for both enzymes, neurolysin displays a greater afinity for
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neurotensin and Ang-I than THOP, while GnRH and dynorphin A are cleaved at a greater 
rate by THOP relative to neurolysin (see Table 1.3)(Rioli et al. 1998).
Table 1.3 Relative rates of hydrolysis on naturally occuring peptides of recombinant EP24.15 and 
EP24.16; 100% of hydrolysis represents the EP24.15 cleavage of 16.6 nmol BK in 10 min at 37°C, in 50 
mM Tris-HCL, pH 7.5. (adapted from Rioli et al., 1998).
PEPTIDE % Hydrolysis 
EP24.15
% Hydrolysis 
EP24.16
BK 100 108
NEUROTENSIN 80 95
M ETORPHINAM IDE 130 85
GnRH 15 10
DYNORPHIN 110 60
ANG-I 80 95
1.4.4.4 Subcellular Localisation
The subcellular localisation  of both THOP and neurolysin, as identified 
immunocytochemically, displays variation with cell and tissue type. The initial 
immunocytochemical localisation of THOP in brain with a polyclonal antibody against 
the rat testis enzyme showed that the enzyme was primarily localised to the nucleus 
(Healy et al., 1992). This finding was suprising given that THOP had been associated 
with the soluble cytosolic cellular fraction (Orlowski et al.,1983). More recently, using 
both THOP and neurolysin antibodies it was identified that rat brain THOP is primarily 
nuclear, while rat brain neurolysin was primarily extranuclear, being found particularly in 
the cell processes (Massarelli et al., 1999).
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Other studies with the mouse AtT-20 cell lines have shown that immunoreactive 
THOP stains in a punctate fashion thoughout the cytoplasm and in the cell processes, 
with occasional intense nuclear staining. This contrasted with the staining for neurolysin, 
which was confined to the perinuclear area (Garrido et al., 1999). Co-localisation of both 
THOP and neurolysin with the trans golgi marker syntaxin-6, and with a secretory 
granule associated protein was also demonstrated in mouse AtT-20 cells by Garrido et al., 
suggesting that a portion of these peptidases are putatively secreted. A similar conclusion 
was reached by Ferro and co-workers who found that 15% of total THOP activity and 
immunoreactivity in AtT-20 cells sedimented in the denser fractions of a Ficoll gradient. 
These fractions over-lapped with those containing (3-endorphin immunoreactivity, again 
suggesting localisation within the secretory pathway. This was suprising, considering that 
neither THOP or neurolysin contain a secretory signal sequence. Later studies 
demonstrated that THOP was both secreted and membrane associated in AtT-20 cells 
(Ferro et al., 1999; Crack et al., 1999). More recently it has been demonstrated by Jeske 
and co-workers that THOP is associated with lipid rafts in both mouse AtT-20 cells and 
mouse neuronal GT1-7 cells, and that in GT1-7 cells it is constiutively released from the 
exofacial leaflet of lipid rafts, indicating a putative mechanism by which it may be 
constitutively secreted (Jeske et al., 2003; Jeske et al., 2004).
The secretion of neurolysin activity has also been observed in astrocytes, but not 
neurons, in culture. However, its release is insensitive to a range of agents that affect 
classical secretion. In addition, its release was demonstrated to be temeperature- 
dependent. Despite lacking a secretory signal sequence it seems that neurolysin is
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secreted via a non classical mechanism (Rubartelli etal., 1990). Membrane association of 
the enzyme was also observed in the rat brain (Woulfe et al., 1992).
In addition to cytosolic and plasma membrane localisation neurolysin has been 
shown to exist in the mitochondrial compartment (Tisljar et al., 1990; Serizawa et al.,
1995). The fact that neurolysin is the product of a single gene has raised the question as 
to how it can be located in more than one compartment. The presence of a putative 
mitochondrial target sequence at the N terminus of the preceursor to neurolysin 
(mitochondrial oligo peptidase) was noted by Serrizawa and co-workers. More recently, 
Kato and co-workers have demonstrated the existence of alternative initiation site for 
transcription of neurolysin. The longer transcript contains a cleavable mitochondrial 
target sequence, which directs the enzyme to the mitochondria, whereas the shorter form 
lacking such a signal remains in the cytosol (Kato et al., 1997).
1.4.4.5 Involvement of THOP and Neurolysin in the Vasculature
The ability of both THOP and neurotensin to cleave the vasoactive peptides Ang-I 
and BK suggests that the enzymes may play a role in the maintainence of vascular tone 
and other vascular functions.
In 1991, Genden and Molineaux showed that the infusion of the inhibitor cFP- 
AAF-pAB produced an immediate drop in mean arterial pressure in normotensive rats, 
and that this decrease could be blocked by the administration of B2 BK receptor
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antagonists (Genden et al., 1991). Based on these results the authors suggested that 
THOP, and to a lesser extent neurolysin played a role in the maintainenec of blood 
pressure by the inactivation of the vasodilator BK. However the discovery of the 
instability of cFP-AAF-pAB in vivo and the fact that it could be degraded into cFP-AA, a 
potent ACE inhibitor, led to the suggestion that the results observed by Genden and 
Molineaux may occur as a result of ACE inhibiton (Telford et al., 1995). However later 
studies with the equipotent but more stable inhibitor (N -[l(/? ,S )-carb o x y l-3 - 
phenylpropyl]-AIa-Aib-Tyr-p-aminobenzoate (termed JA-2) demonstrated a potentiation 
of BK induced hypotension in rabbits, without affecting the hypertensive effects of Ang-
II, thereby strengthening the hypothesis that THOP and neurolysin are involved the 
metabolism of circulating vasoactive peptides and blood pressure maintainence (Smith, et 
al., 2000). More recent in vitro studies by Norman and co-workers demonstrated THOP 
and neurolysin specific BK and NT cleavage of that in both the endothelial hybrid cell 
line EA.hy926 and in ovine aortic endothelial cells. Interestingly, it was found that 
neurolysin was responsible for a greater proportion of the cleavage of both substrates 
observed by both membrane and cytosolic fractions than THOP, indicating that in their 
model neurolysin may be the more relevant in the maintainence of blood pressure 
(Norman et al., 2003).
To our knowledge there as yet have been no other studies which demonstrate the 
regulation o f THOP and neurolysin by hemodynamic forces. However, given their 
putative role in the maintainence of blood pressure, and the identification fo the SSRE
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sequence in the EP24.15 promotor, both THOP and Neurolysin are candidates for 
regulation by hemodynamic forces (McCool et al., 1998; McCool et al., 2000).
1.5 Physiological Phenomena Associated with Hemodynamic Forces.
Alterations in physiological hemodynamic forces have long been known to have 
the potential to influence vascular morphology at both the cellular and whole vessel level. 
This obviously has implication for both healthy tissue and disease states.
For example, the reorientation of endothelial cells in the direction of flow, as 
observed in regions of laminar flow and normal mean shear stress, seems to be directly 
correlated with vascular health. In regions of disturbed oscillatory flow and low mean 
shear stress where the cells are non aligned, there is a greater occurence of atherosclerotic 
lesions, increased vascular permeability to leukocyte adhesion and infiltration, and 
potentially a greater likelihood of an apoptotic profile amongst the endothelial cells in 
that region (see section 1.2.2.4). In addition, in regions of low mean shear stress there is 
endothelial production of substances such as ET-1, PDGF and Ang-II, which favour SMC 
proliferation, a phenomenon which has implications for atherosclerotic plaque formation.
1.5.1 Vascular Remodeling; Restenosis and Neointimal Formation
Atherosclerosis is a progressive disease characterised by the accumulation of 
lipids and fibrous elements in large arteries. Early lesions consist of subendothelial 
accumulations of cholesterol-laden macrophages called foam cells. These fatty streaks
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develop over time into plaques comprising of a lipid rich necrotic core and typically have 
a fibrous cap consisting of SMCs and ECM. Plaques become increasingly complex and 
can grow sufficiently large enough to occlude blood flow. One of the more common 
clinical complications is thrombus formation as a result of the rupture of a plaque, 
thrombus formation and consequent vessel occlusion (Traub et al., 1998).
A common treatment for vessel occlusion in humans is balloon Angioplasty. In 
this treatment a balloon catheter is introduced surgically to the affected vessel and 
inflated in situ, with the resulting destruction of the occlusion. In some cases a stent (a 
metal or plastic support) may also be introduced to prevent vessel collapse. However in 
the long term this procedure may often fail due to restenosis (see Fig 1.12), the reduction 
in vessel lumen diameter due to smooth muscle cell growth and resulting intimal 
thickening (termed neointimal formation) (Poston, 2002).
It has been proposed that both endothelial damage and the disruption of flow 
patterns, with resultant reduction in mean shear stress post-angioplasty, may be 
responsible for this phenomenon. It has been demonstrated in a rat model of carotid 
artery angioplasty, in which vascular damage was induced by balloon catheter injury, that 
increasing the blood flow (and thusly the shear stress) was found to reduce early 
neointimal formation (Kohler and Jaiwien, 1992). An important role for endothelium 
derived factors produced by endothelial cells in response to shear stress was also 
indicated by a series of studies which showed that polyurethane vascular grafts seeded 
with endothelial cells and exposed to high shear rates before implantation in rats showed 
a marked reduction of neointimal thickness when compared to grafts not exposed to shear
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(Dardik et a t, 1999). Further studies have demonstrated the importance of factors 
produced by the endothelium in conditions of disrupted flow and low mean shear stress in 
neointimal formation; it was demonstrated that inhibition of the PDGF(3 receptor reduced 
neointimal thickness in baboons implanted with polytetaflurothylene grafts (Davies et a t, 
2000). PDGF, as discussed previously, is produced by the endothelium in conditions of 
low mean shear stress and has a pro-proliferative effect on smooth muscle cells.
Figure 1.12 Diagram showing restenosis and neointimal formation as a result of balloon Angioplasty;
Following treatment for vessel occlusion with balloon angioplasty, damage to the endothelium may result 
in SMC proliferation leading to reduction in lumen diameter, (www.heartcenteronline.com)
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1.5.2 Angiogensis; New Vessel Formation
Angiogenesis is the formation of new capillaries from the pre-existing vasculature by 
controlled migration and proliferation of endothelial cells and it plays a fundamental role 
in the growth survival and function of normal and pathological tissues. The process of 
angiogenesis requires the loosening of intercellular junctions and degradation of the 
pericular matrix by endothelial cells, migration of the endothelial cells towards the 
angiogenic stimulus, sprout formation, formation of a lumen and the joining of sprouts to 
form a new capillary bed (see Fig 1.13XQuarmby et al., 2002).
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Figure 1.13 Diagram showing the stages of Angiogenesis; After the loosening of intercellular junctions 
and degradation of the pericular matrix, ECs migration through the vessel wall in the direction of an 
angiogenic stimulus (e.g. VEGF), forming endothelial sprouts, which eventually grow together to form a 
lumen. Subsequent SMC and pericyte recruitment leads to the development o f a new vessel (Quarmby et 
al., 2002).
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In some conditions angiogenesis may be beneficial; for example, in tissue repair 
after reperfusion of ischemic tissue or cardiac failure. However there are numerous 
clinical instances where angiogenesis is maladaptive, such as cancer and intraplaque 
formation (Carmeliet et a l, 2000).
A clear association between blood flow/shear stress and angiogenesis is supported 
in the literature. High blood flow occurs concomitantly with capillary growth in 
physiological conditions such as exercise or exposure to altitude. Experimental subjects 
subjected to physical training have been shown to have so 20% more capillaries in their 
musculature than untrained controls (Breen et a l, 1996). Angiogenesis is also a feature of 
tumor development, and the restriction of tumor Angiogenesis has been used successfully 
to regulate tumor growth (Quarmby et al., 2002). It has been demonstrated that 
physiological shear stress enhances the enhances wound closure in cultured human 
umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells 
(HCAECS) via the action of endothelial cells spreading and migration (Albuquerque, et 
a l, 2000).
The two most important direct-acting positive regulators of angiogenesis are 
thought to be vascular endothelial growth factor (VEGF) and fibroblast growth factor 
(FGF). It has been demonstrated in vitro that VEGF and FGF positively regulate many 
endothelial cellular functions relevant to angiogenesis, including proliferation, migration, 
extracellular proteolytic activity, and tube formation (Dvorak et a l, 1995).
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Evidence that cyclic strain is a stimulus for angiogenesis comes from both in vitro 
and in vivo studies (Rivilis et al., 2002; Zheng et al., 1999; Vailhe et al., 1996; Banai et 
al., 1994). Conditioned media from cyclically strained myocytes in vitro has been found 
to stimulate tube formation in coronary endothelial cells, a feature of ECs demonstrating 
an angiogenic profile. In vivo studies have demonstrated that short-term exercise, leading 
to increase levels of mechanical load on the vessel wall resulted in increased 
angiogenesis in skeletal muscle of Sprague-Dawley rats. Angiogenesis associated with 
cyclic strain are believed to involve a number of contributors such as MMP-2, VEGF, 
FGF, and TGF-P and may be associated with a number of conditions in which blood flow 
is affected including ischemia and bradycardia (Bani et al., 1994; Ausprunk et al., 1977; 
Pepper et al., 1997; Egginton et al., 2001).
Both NO and prostaglandins are also positive regulators of angiogenesis, though 
their mode of action is believed to be intermediary and indirect. It has been demonstrated 
that inhibition of these so-called intermediary cytokines block cell growth and migration 
in vitro (Quarmby et al., 2002). As both production of NO and prostaglandins is up- 
regulated by increased shear and cyclic strain, it is though likely that they contribute to 
the increase in angiogenic potential observed in endothelial cells exposed to shear stress. 
NO production in particular is an important effector mechanism in angiogenesis and may 
contribute to VEGF-related pathways; it has been demonstrated that the angiogenic 
response to VEGF was impared in mice deficient in the gene coding for eNOS (Murohara 
etal., 1998; Silva-Azevedo et al., 2002).
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In addition to the above mentioned cytokines it has become evident in recent 
years that vasoactive peptides, in particular BK, Ang-II and Ang-(l-7), play an important 
role in angiogenic processes in both healthy and diseased vasculature.
Recent in vivo studies have clearly demonstrated the important pro-angiogenic 
role of BK, in a rat model (Hu et al., 1993), and in several tumor models (Wu et al., 
1998; Ishihara et al., 2002). This BK-induced angiogenesis seems to be mediated largely 
via the B2 receptor, and involves up-regulation of VEGF production (Ishihara et al., 
2002). As BK also stimulates the up-regulation of eNOS via the B2 receptor (Duffy et al., 
2004), it is likely that NO production is involved in the phenomenon. Inhibition of BK 
induced angiogenesis has recently been highlighted as a potential treatment for certain 
cancers; Stewart and co-workers have demonstrated that BK antagonists inhibit lung and 
prostate tumor formation in Nude mice models (Stewart et al., 2005).
In contrast to the clear pro-angiogenic properties of BK, the roles played by Ang- 
II and A ng-(l-7) in angiogenesis is still unclear, with many studies generating 
contradictory findings. Studies have demonstrated that Ang-II stimulates both endothelial 
and smooth muscle cell proliferation in vitro (Stoll et al., 1995), increases vessel density 
in rat ere master muscle (Munzemaier et al., 1996), in the chorioallanic membrane of the 
chick embryo (Le Noble et al., 1993), and in the rat ischemic hindlimb (Radi et al., 
2002). Inhibitors of angiotensin converting enzyme (ACE) have been shown to block 
neovascularisation in the rat cornea (Volpert et al., 1996) and micro vascular growth in 
normotensive rats (Wang et al., 1990). However ACE inhibition was also shown to
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increase vessel density in rat ischemic hindlimb (Silvestre et al., 2001). Recent in vivo 
studies by Desideri and co-workers have also demonstrated that the migratory capacity of 
HUVECs could be inhibited by treatment with Ang-II (Desideri et al., 2003).
It has been suggested that A ng-(l-7) plays an opposing role to Ang-II in 
angiogenesis; Machado and co-workers have demonstrated that while Ang-II stimulated 
angiogenesis in a murine sponge model, treatment with A ng-(l-7) diminishes 
angiogenesis (Machado et al., 1999). Other studies have demonstrated that Ang-(l-7) 
treatment causes the release of NO from the endothelium, a substance which is known to 
promote angiogenesis (Fetterik et al., 2000).
Most actions of Ang-II in the vasculature occur via the ATI rather than the AT2 
receptor. The ATI receptor has been implicated in both pro- and anti-angiogenic 
responses to Ang-II treatment. Numerous studies have demonstrated the involvement of 
VEGF and requirement of eNOS in these events (Tamarat et al 2002; Otani et al., 1998). 
Otani and co-workers have demonstrated that Ang-II potentiated the angiogenic response 
to VEGF in microcapillary endothelial cells, while Tamarat et al. demonstrated that the 
proAngiogenic effect of Ang-II in a mouse hindlimb Ischemia model was linked to 
increase VEGF production and blocked in mice lacking the gene for eNOS (Tamarat et al 
2002; Otani et al., 1998).
Although a universal mechanism for the effects of BK, Ang-II and A ng-(l-7) on 
angiogenesis has yet to be elucidated, it is clear that they play an important role. In
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common with other vasoactive peptides their production and release can be mediated in 
response to hemodynamic forces.
1.6 Summary
Hemodynamic forces, namely shear stress and cyclic strain, have been well 
characterised as modulators of vascular endothelial function, and have been assigned an 
important role in the maintainance of vascular tone, hemostasis, and regulation of 
vascular growth and health. They exert their influence in part by effecting changes in the 
production and release of vasoactive compounds by the endothelium, and by effecting 
changes in the levels and activty of various enzymes.
THOP (EP24.15) and neurolysin (EP24.16) are closely related zinc 
metalloendopeptidases that have been shown to be expressed and active in the vascular 
endothelium. Their substrates include the vasoactive peptides BK and Ang-I, which have 
been identified as important regulators of both blood pressure and angiogenic processes. 
In addition other closely related metallopeptidases, namely ECE and ACE, have been 
shown to be regulated by hemodynamic forces in the vascular endothelium.
Based on these observations THOP and neurolysin are likely targets for regulation by 
hemodynamic forces within the vascular endothelium. It is the purpose of this thesis to 
examine the putative effects of cyclic strain on the expression and activity of THOP and 
neurolysin in cultured bovine aortic endothelial cells (BAECs). It is also intended to
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examine the effects of cyclic strain on the THOP and neurolysisn mediated cleavage of 
both synthetic and natural vasoactive peptide substrates, and the possible functional 
influence this may have on endothelial cells.
N.B. THOP and neurolysin will be subsequently referred to as EP24.15 and EP24.16 
respectively fo r  the remainder o f this thesis.
1.7 Experimental Approach
The experimental approach applied to investigate this hypothesis was as follows 
(See Fig 1.14); a flexercell in vitro culture system which uses vacuum to mechanically 
strain or deform cells cultured on a flexible, matrix-bonded growth surface was employed 
for culturing vascular ECs under conditions of equibiaxial defined cyclic strain (Banes et 
al., 1985). Post-strain levels of secreted and cellular activity were determined for both 
enzymes using a specific fluorescent substrate (QFS). The levels of mRNA for both 
enzymes were also determined using RT-PCR with gene specific primers, and the levels 
of both total and membrane associated EP24.15 were determined immunocytochemically 
using an EP24.15 anti-sera. Both pharmacological and molecular inhibitors of Gia- and 
G(3y-signaling were also employed to determine if this mechanotransduction pathway 
was involved in the transduction of strain-induced changes in enzyme expression and 
activity. The effects of strain on the endopeptidase specific extracellular cleavage of both 
synthetic and natural peptide substrates by BAECs in culture were examined. Both the
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Figure 1.14 Flow Chart Representing Experimental Approach.
main product of EP24.15/EP24.16 cleavage of Ang-I, A ng-(l-7), and BK, which is 
degraded by both enzymes, have been shown to influence endothelial cell fate decisions 
such as angiogenesis and migration (Machado et al., 2001; Ishihara et al., 2002). In order 
to investigate the possible functional consequences of strain-induced increases in 
EP24.15/EP24.16 mediated cleavage of Ang-I and BK in BAECs for endothelial cell fate
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decisions, the effects of EP24.15/EP24.16 inhibition on strain-induced BAEC tubule 
formation and migration was examined.
1.8 Thesis Overview
The research presented in the following chapters examines the regulation of 
EP24.15 and EP24.16 expression, activity, and subcellular location in cultured BAECs by 
mechanical forces. It also details the effect of strain on the ability of cultured BAECs in 
culture to cleave synthetic and natural peptide substrates in an EP24.15/EP24.16 specific 
manner, and examines the functional impact of these events on the cell.
The results of this research had been divided into three main chapters;
Chapter 2; Materials and Methods 
Chapter 3;
Examination of the effects of cyclic strain on EP24.15 and EP24.16 mRNA levels 
and both cellular and secreted enzymatic activity in BAECs.
Chapter 4;
The involvement of Gici and G(3y signaling pathways in the strain mediated 
regulation regulation of EP24.15 and EP24.16 activity by cyclic strain in BAECs.
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Chapter 5;
Examination of the influence of cyclic strain on the cleavage of synthetic and 
natural peptide substrates of EP24.15/EP24.16 in BAECs.
Chapter 6;
Examination of the functional impact of cyclic strain-mediated modulation of 
EP24.15/EP24.16 specific peptide cleavage in BAECs.
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Chapter 2; Materials and Methods
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2.1 M aterials
AGB Scientific (Dublin, Ireland)
Whatmann Chomatography paper
Amcrsham Pharmacia Biotech (Buckinghamshire, UK)
Anti-mouse 2° antibody, HP-conjugated 
Anti-rabbit 2° antibody, HP-conjugated 
ECL Hybond nitrocellulose membrane 
ECL Hyperfilm
Rainbow molecular weight marker, broad range (6-l75kDa)
Antibodies (custom)
Rabbit anti-EP24.15 FAB was the kind gift of Prof. T.J Wu, Dept, of Obstetrics and 
Gynecology, Uniformed Services University of the Health Sciences, MD, USA.
Bachem UK Ltd. (St. Helens, UK)
Pro-Ile peptide
7-methoxycoumarin-4-acety 1-Pro- Leu-Gly-Pro-D-Lys(2,4-dinotrophenyl)
Bio Sciences Ltd (Dun Laoghaire, Ireland)
DMEM
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cINTP’s
D EPC -lreated w ater 
Trizol® reagent
BioRad (CA, USA)
IScript cDNA synthesis kit
Calbiochem (San Diego, CA)
Pertussis toxin 
NF023
Cayman Chemical Company (Michigan, USA)
Anti- rabbit eNOS polyclonal antibody
Chemicon (Temecula, CA)
Anti-MMP-2 antibody 
Recombinant MMP-2/MMP-9 standard
Corriell Cell Repository (NJ, USA)
Bovine Aortic Endothelial Cells (BAECs)
Guthie cDNA Resource Centre (Sayre, PA)
Gial-G202T contract
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Cii,lj-G203T construct 
Gi^-G202T construct
Invitrogen (Groningen, The Netherlands)
Lipofectamine reagent 
Lipofectamine 2000 reagent
M o lecu la r  P ro lîes  (O regon  U SA )
Anti-rabbit antibody, Alexafluor 488 labelled 
DA PI flouresceni stain
M W G  B iotech  (M ilto n  K eyn es, U K )
THOP(EP24.15) primer set 
Neurolysin(EP24.16) primer set 
COXII primer set 
(i-actin primer set 
GAPDH primer set
Inhibitors
CFP-AAF-pAB was the kind gift of Dr. M. Glucksman, Dept, of Biochemistry and 
Biophysics, Rosalind Franklin University of Medicine and Science, IL, USA 
PA L L  C o rp o ra tio n  (D un  L aogh a ire , Ire lan d )
Biotrace nitrocellulose membrane
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Pierce Chemicals (Cheshire, UK)
BCA protein assay kit
Supersignal West Pico chemilumescent substrate 
P lam id s
fS-ARK-ct and GFP were the generous gifts of Dr. John Cullen, Dept, of Surgery 
(University of Rochester Medical Centre, Rochester NY)
EP24.15-FLIP was the generous gift of Dr. M. Glucksmsin, Dept, of Biochemistry and 
Biophysics, Rosalind Franklin University of Medicine and Science, 1L. USA
PromoCell (Heidelberg, Germany)
Human Aortic Endothelial Cells 
Endothelial Cell Growth Media MV
Promega (Madison, WI)
Taq DNA Polymerase 
MLV-RT 
RNaseH 
Oligo dT12.14
Sarstedt (Drinagh, Wexford, Ireland)
T25 tissue culture flasks
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T75 tissue culture flasks 
TI75 tissue culture flasks 
6-vveIl tissue culture plates 
24-well tissue culture plates 
5.1Ü and 25ml serological pipettes 
15 and 50ml coonical centrifuge tubes
Sigm a C h em ica l C o m p a n y  (P o o le , D orset, E n g lan d )
ß-galactosidase 
2-mercaptoethanol 
Acetic Acid
Acctonitrilc(Chomosolv)
Acctonc
Agarose
Ammonium Persulphate 
Ang-1
Ang-Iotensins II 
Ang-(l-7)
Bestatin 
Bisacrylamide 
Bovine Scrum Albumin 
BK
BK 1-5
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B rightl i ne Haemocy tometer
Bromophenol Blue
Captopril
Chloroform
EDTA
EGTA
Ethidium Bromide 
Fibronectin 
Foetal Calf Serum 
Bovine Gelatin 
Glyccrol 
Glycine
Hanks Balanced Salt Solution 
Hydrochloric Acid 
Isopropanol 
Methanol
Penicillin-Streptomycin ( 1 OOx)
Phosphoramidon
Ponceau S
Potassium Chloride
Potassium Iodide
Potassium Phosphate (Dibasic)
Rat tail type I collagen
KS
RPM1-I640
Sodium Chloride
Sodium Hydroxide
Sodium Orthovanadatc
Sodium Phosphate
Sodium Pyrophosphate
SYBERgrecn Jump Start Taq Ready Mix
SDS
TEMED
Tris Acetate
Tris Base
Tris Cl
Triton X-100
Trypsin-EDTA Solution (lOx)
Tween 20
2.2 Cell Culture Methods
All cell culture techniques were carried out in a clean and sterile environment 
using a Bio air 2000 MAC laminar air flow cabinet. Cells were visualized using an 
Olympus CK30 phase contrast microscope.
2.2.1 Culture Of Bovine Aortic Endothelial Cells (BAECs)
BAECs were obtained from the Cornell Cell Repository, New Jersey, USA (CAT 
NO: AG08500). The cells are derived from a one-year-old male Hereford cow. The 
thoracic aorta was removed immediately post-m ortem  on 10/22/85. Cells were 
maintained in RPMI-1640 supplemented with 10% (v/v) fetal bovine serum (FBS), 100 
U/ml penicillin and 100 ug/ml streptomycin in a humidified atmosphere at 5% C02. Cells 
were cultured in T175cm2, T75cm2, T25cm2 and 6 well plates. In the case of cyclic strain 
experiments cells were grown on Bioflex® series culture plates which have a flexible, 
pronectin-bonded growth surface. Cells between passage 8 - 1 7  were used in these 
experiments.
BAECs are a strongly adherent cell line, forming a confluent monolayer with a 
distinct cobblestone-like cell morphology. As such trypsinisation was necessary for sub- 
culturing or harvesting of cells. For trypsinisation, growth media was removed from the 
flask and the cells were gently washed thee times in Hanks Buffered Saline Solution 
(HBSS) to remove a-macroglobulin, a trypsin inhibitor present in FBS. A suitable 
volume of trypsin/ethylenediamine tetracetic acid (EDTA) (10% v/v trypsin EDTA in 
HBSS) was added to the flask and incubated for 5-10 min or until all the cells were 
removed from the flask surface. Trypsin was inactivated by the addition of growth 
medium and the cells were removed from suspension by centrifugation at 3500rpm for 5 
min. Cells were then resuspended in culture medium and typically passaged 1:5 into 
culture flasks, or cryogenically preserved.
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2.2.2 Culture of Human Aortic Endothelial Cells (HAECs)
Human aortic endothelial cells (HAECs) were obtained from PromoCell, 
Heidleberg, Germany (Cat. No.; C-12271). The cells were derived from a 21 year old 
male Caucasian. Cells were maintained in endothelial cell growth medium MVDB131 
supplemented with endothelial supplement mix (5% (v/v) fetal calf serum (FCS), 
lOng/ml Epidermal Growth Factor, lug/ml Hydrocortison, 50 ng/ml Amphotericin B, 
50ng/ml Gentamicin) A 1:5 sub-culture ratio was generally used. Cultured cells were 
maintained in a humidified 5% v/v C 0 2 atmosphere at 37°C.
2.2.3 Cyclic Strain Studies
For cyclic strain studies, BAECs/HAECs were seeded into 6-well Bioflex® plates 
(Dunn Labortechnik GmBH - Asbach, Germany) at a density of approximately 6X105 
cells/well, allowed to adhere and grown to confluence over 24h. After 24 h, the media 
was removed and replaced with fresh media and the cells exposed to varying levels of 
cyclic strain. Bioflex™ plates contain a pronectin-coated silicon membrane bottom that 
enables precise deformation of cultured cells by microprocessor-controlled vacuum. 
When cells had reached approximately 100% confluence, a Flexercell™ Tension Plus™ 
FX-4000T™ system (Flexcell International Corp. - Hillsborough, NC) was employed to 
apply a physiological level o f cyclic strain to each plate (0-10% strain, 60 cycles/min, 0­
24 h) providing equibiaxial tension using the Heartbeat™ Simulation protocol.
88
2.2.4 Cell Counts
Cells counts were performed using a Sigma brightline haemocytometer slide. 
Trypan blue exclusion dye was routinely used to determine cell viability. 20 [¿1 of trypan 
blue was added to 100 ul of cell suspension, and the mixture was left to incubate for two 
min. 20 ul of this mixture was loaded to the counting chamber of the haemocytometer 
and cells visualized by light microscopy. Viable cells excluded the dye while dead cells 
stained blue. The number of cells was calculated using the following equation:
Average Cell No. x 1.2 (dilution factor) x lxlO 4 (area under cover slip mm3) = Viable 
cells/ml
2.2.5 Treatment With Pharmacological Inhibitors
For these experiments, BAECs were grown until approximately 70-80% confluent 
after which the growth media was removed and cells rinsed 3 times in HBSS. Inhibitors 
were diluted in RPMI-1640 supplemented with 5% FBS and antibiotics. For DMSO- 
soluble inhibitors, a suitable stock concentration was prepared so that the final 
concentration of DMSO in working solutions was less than 0.5%. Cells were exposed to 
inhibitors for 1 hour prior to exposure to cyclic strain and were present in the media 
during the course of the mechanical strain experiment. Following 24 h of 5% cyclic strain 
cells were harvested for total RNA/protein and conditioned media. Inhibitors used were 
pertussis toxin (100 ng/ml), NF023 (10 fxM), captopril (10 jaM), phosphoramidon (10
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(xM), bestatin (10 |.iM) and cFP-AAF-pAB (4.00 fimol/L). Concentrations used were 
taken from current literature or based on manufacturers recommendations.
2.2.6 Preparation of Whole Cell Lysates
Following trypsinisation as described in section 2.1.1, the cell pellet was washed 
in IX PBS to remove any trace levels of FBS. The cell suspension was then centrifuged 
at 3500 rpm for 5 min. The PBS supernatant was removed and the cells were 
resuspended in IX lysis buffer (20 mM Tris, 150 mM NaCl; ImM Na2 EDTA; 1 mM 
EGTA; 1% Triton X-100 (v/v); 2.5 mM sodium pyrophosphate; 1 mM p- 
glycerophosphate; ImM sodium orthovanadate; lfxg/ml leupeptin). The resulting lysates 
were frozen and thawed three times followed by three cycles of ultrasonication for 5 sec 
on ice using a sonic disembrator (Vibra Cell, Sonics and materials Inc). In the case of 
samples to be assayed for cellular EP24.15/EP24.16 activity pellets were resuspended 
vigorously in PBS, as the presence o f zinc chelators in lysis buffer affected enzyme 
activity. These samples were then frozen and thawed five times followed by three cycles 
o f ultrasonication for 5 sec on ice using a sonic disembrator (Vibra Cell, Sonics and 
materials Inc). All samples were stored at 20°C for short-term storage or -80°C for long­
term storage, until required for analysis.
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2.2.7 Bicinchoninic Acid (BCA) Protein Microassay
In this assay Cu"1"1" reacts with protein under alkaline conditions to produce Cu+, 
which in turn reacts with BCA to produce a coloured product (Pierce., 1997). Two 
separate reagents were supplied in this commercially available assay kit (Pierce 
Chemicals), A; an alkaline bicarbonate solution and B; a copper sulphate solution. 1 part 
solution B is mixed with 50 parts solution A; 200 ¡j.1 o f this mixture is added to 10 ¡xl of 
protein lysate or BSA standards (standard curve in the range 0-2 mg/ml). The plate is 
incubated at 37°C for 30 min and the absorbance read at 560 nm using a microtitre plate 
reader.
2 .2 .8  L a cta te  D eh y d ro g en a se  (L D H ) A ssa y
Lactate dehydrogenase (LDH) is a cytosolic enzyme present within all 
mammalian cells. Frequently used as a marker for plasma membrane damage or 
“leakage”. In vitro release of LDH from cells subsequently provides an accurate measure 
of cell membrane integrity and cell viability (Racher et al., 1998). As such, this assay was 
used to assess the effects of mechanical strain on viability of BAECs. This assay is based 
upon the ability of LDH to catalyze the reaction:
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Pyruvate + NADH + H(+) —> Lactate(+) + NAD(+)
Briefly, 5 p.1 of cell lysate or 50 jxl of conditioned media was added to 900 jxl of 
0.2M Tris-HCl pH7.3, 100 ^il o f l.lm M  (3-NADH and 20 \jl\ o f 115 mM sodium 
pyruvate. The samples were mixed by inversion and the absorbance read at 340 nm every 
20 sec for 5 min. LDH activity can be derived from the rate o f changes in optical 
absorbance (AOD/sec/fxg cellular protein/ml) (Cao et al., 1993).
2.3 RNA Prepartion Methods
2.3.1 RNA Isolation
Trizol is a ready to use reagent for the isolation of total RNA, DNA and/or protein 
from cells and tissues. RNA isolation was based on the method of Chomczynski and 
Sacchi (Chomczynski et al., 1987). Trizol reagent maintains the integrity of the RNA 
while disrupting the cells and dissolving the cell components.
After washing briefly with HANKS, cells were lysed directly in culture plates by 
the addition of 1ml of Trizol per 10 cm2. A volume less than this can result in 
contamination of the RNA with DNA. To ensure complete homogenization, cells were 
lysed by titurating through a pipette a number of times. The samples were then incubated 
for 5 min at room temperature to allow complete dissociation of nucleoprotein 
complexes. 0.2 ml of chloroform was added per ml of Trizol reagent used and was then
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mixed vigorously for 15 sec before being incubated for 5 min at room temperature. 
Samples were then centrifuged at 12,000 g for 15 min at 4“C. The mixture separated into 
a lower red, phenol-chloroform phase, an interphase and an upper colourless aqueous 
phase. RNA remains exclusively in the aqueous phase.
The aqueous phase was carefully removed and transferred to a fresh, sterile tube. 
The RNA was precipitated out of solution by the addition of 0.5 ml of isopropanol per 
lm l of Trizol used. Samples were incubated for 15 min at room temperature and then 
centrifuged at 12,000 g for 10 min at 4°C. The RNA precipitate forms a gel-like pellet on 
the side of the tube. The supernatant was removed and the pellet washed in 1 ml of 75% 
ethanol per ml of Trizol used followed by centrifugation at 7,500 g for 5 min at 4°C. The 
resultant pellet was air-dried for 5-10 min before being resuspended in DEPC-treated 
water. The sample was then stored at -8 0 “C until used. The concentration of total RNA 
was determined by UV spectrophotometry as outlined in section 2.3.2.
2.3.2 Spectrophotometric Analysis of Nucleic Acids
DNA or RNA concentrations were determined by measuring the absorbance at 
260 nm, the wavelength at which nucleic acids absorb light maximally (k max). A 50 
Lig/ml solution of DNA or 40 ¡ig/ml solution of RNA has an absorbance of reading of 1.0 
at this wavelength. In order to calculate the concentration of DNA/RNA in samples the 
following calculations were used;
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DNA; Abs @260[im x 50 x 200 (dilution factor, i.e. 5 |a1 of sample in 995 |il H ,0 ) = ng/ml 
RNA ; Abs @260™ x 40 x 200 (dilution factor, i.e. 5 ¡.il of sample in 995 i^l H2O) = ¡.ig/ml
The purity of the DNA or RNA samples was established by reading the 
absorbance at 260 nm and the absorbance at 280 nm and then determining the ratio 
between the two (ABS26o/ABS2so). Pure DNA which has no protein impurities has a ratio 
o f 1.8 whereas pure RNA has a ratio o f 2.0. Lower ratios indicate the presence of 
proteins, higher ratios imply the presence o f organic reagents.
2.3.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Real Time 
PCR
PCR has over the last 20 years proved to be an important and powerful tool for 
amplifying small quantities of DNA for analysis. RT-PCR is a modification of this 
technique in which small quantities of specific messenger RNA (mRNA) are analysed. 
Total RNA is converted to copy DNA (cDNA) using the oligo dT12_18 primers enzyme 
reverse transcriptase. cDNA of interest can subsequently be amplified by PCR using gene 
specific primers. The PCR was semi-quantitative. GAPDH (a house-keeping gene) 
expression was monitored in tandem with the gene of interest, the ratio of gene X to 
GAPDH served as a means of determining relative amounts of the target genes in each 
reaction.
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A recent development in PCR technology has been Real-Time PCR technology. 
This allows monitoring of DNA amplification throughout the polymerase chain reaction 
by the use of a fluorescent dye (SYBER green), which binds to the double stranded DNA 
product. The advantages of this technique over standard RT-PCR is that it is fully 
quantitative, allowing either quantification using an appropriate DNA standard curve or 
relative quantification by comparison with GAPDH expression. In addition automatic 
melt curve analysis at the end of the reactions indicates if non-specific product has been 
formed during the reaction.
2.3.4 Reverse Transcription
Reverse transcription was preformed using Moloney Murine Leukemia Virus 
Reverse Transcriptase (M-MLV RT) in accordance with manufacturers specifications 
with some minor modifications (Roth et al., 1985; Sambrook et al., 1989). 0.5 ¡o.g of total 
RNA (isolated as described in section 2.1.9) was mixed with 0.125 ^ig oligo dTi2-is 
primers and the reaction mixture brought to a final volume of 12 jxl with DEPC water. 
This mixture was heated for 10 min at 70°C to allow annealing o f oligo dT^-is primers to 
polyA tail of mRNA. Following this, tubes were immediately cooled on ice and the 
remaining components of the reaction were added as follows:
MMLV 5X Reaction Buffer 5 [a1
lOmM dNTP 3 p,l
MMLV-RT 200 units
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The mixture was then made up to a final volume of 25 [a1 using DEPC water and 
incubated for 60 min at 42°C. Contaminating RNA was subsequently removed by the 
addition of l[xl of RNase H (2 units/nl) at 37°C for 20 min. cDNA samples were then 
either used immediately or stored at -80°C until required.
For real-time PCR reverse transcription was also carried out using the proprietary 
¡Script™ cDNA synthesis kit (BioRad, Ca, USA). Using 0.5 j.ig of total RNA template 
the reaction was performed as per manufacturers directions;
15 (xl DEPC water/RNA 
1 |xl iScript reaction buffer 
1 [xl Reverse Transcriptase
The mixture was held at 25"C for 5 min to allow for oligo dT12.l(t annealing, a 30 min 
incubation at 42"C to allow for cDNA formation. cDNA samples were either used 
immediately or stored at -80“C until required for analysis.
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2.3.5 Polymerase Chain Reaction
A. Standard PCR
A 50 |.il PCR reaction mixture was prepared as follows;
RNase-free water 36.5 |4l
10X reaction buffer 5 ul
10 mM dNTP 1 u 1
25 mM MgCl 3 ,ul
10 iiM Forward primer 1 ul
10 uM Reverse primer 1 ul
Taq Polymerase 0.5 nl
cDNA sample 2/rl
The mixture was overlaid with 50 ,ul of mineral oil and then placed in a Hybaid 
PCR Thermocycler. Samples were subjected to an initial incubation of 92°C for 2 min 
followed by 30 cycles comprising of the following steps: 92°C for 1 min, annealing 
temperature for 2 min and 72°C for 3 min. PCR products were removed from beneath the 
mineral oil and placed in fresh tubes before being subjected to agarose gel electrophoresis
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B. Real-Time PCR
Reactions for real time PCR were prepared as follows as per manufacturers directions;
RNase -free water 8.5 j.il
SYBERgreen Jump Start™ Taq Ready Mix 12.5 ul
cDNA 2 ill
10 uM Forward primer 1 ul
10 uM Reverse primer 1 [.il
The sample were made in triplicate and placed in a Rolor-Gene RT3000 real time PCR 
machine, which subjected them to the following regime;
Dénaturation step; 95"C 15min 
Cycling (up to 40 cycles)
- dénaturation 95°C 10 sec
- primer annealing 55°C 30 sec
- elongation/data acquisition 72°C 30 sec
Hold 60°C Imin
Melt Curve Generation; increase temperature from 50°C to 90°C at a rate of PC/5 sec.
The excitation and emission wavelengths of SYBER green are 470 nm and 510 nm 
respectively.
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Table 1 Primers used with standard and Real Time PCR
Target Gene Primer Sequence Product
size
Annealing 
Temp O’C)
THOP
(EP24.15)
For. 5 ’-tga agg tea ccc tea agt a-3’ 
Rev. 5 ’-tcc acc tgg ttc atg tag ta-3’
401bp 55°C
Neurolysin
(EP24.16)
For.5’-tgg aaa ctg act ttg tag agg-3’ 
Rev.5’-aaa agt age tgg cat att tgt-3’
308bp 55°C
GAPDH For. 5 ’agg tea tcc atg acc act tt 3 ’ 
Rev. 5 ’ttg aag teg cag gag aca a 3 ’
337 bp 54°C
COXII For. 5'-ttt gaa gaa ctta cag gag-3' 
Rev. 5’-tat tgc aga tga gag act ga-3’
280bp 55°C
2.3.6 Agarose Gel Electrophoresis
Agarose gels were prepared by boiling the appropriate quantity of agarose in 100 
ml of IX TAE buffer (40 mM Tris-Acetate pH 8.2, 1 mM EDTA), gels were generally 1­
2% (w/v) depending on the size of the DNA fragment being visualised. Gels contained 
0.5 fig ethidium bromide per 1 ml of agarose for visualization of DNA within the gel. 
W hen the gel was hand-hot the gel was cast in a Gibco-BRL Horizion-20.25 gel 
electrophoresis apparatus.
Samples were mixed with 6X gel loading buffer (40% w/v sucrose, 0.25% w/v 
bromophenol blue). 12.5 [xl of PCR product from standard RT-PCR was mixed with 3 |il
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of loading buffer and subsequently loaded. The gel was run at 100 V in IX TAE buffer 
until the blue dye front was approximately 0.5 cm from the end of the gel. DNA was 
visualized on a transilluminator and photographed for densitometric analysis using the 
Kodak ID gel documentation system (Scientific Imaging Systems, Eastman Kodak 
Group, Rochester, NY).
2.4 Polyacrylamide Gel Electrophoresis
2.4.1 Western Blotting
SDS-PAGE was performed as described by Laemmli using 10% polyacrylamide 
gels (Laemmli, 1970). 10% resolving and 5% stacking gels were prepared as follows:
Resolving Gel: 1.5 ml Buffer A (1.5M Tris pH8.8)
1.5 ml 40% bisacryl stock
3 ml distilled water
60 nl 10% (w/v) SDS
30 nl 10% (w/v) ammonium persulphate
7 \il TEMED
Stacking Gel: 0.75 ml Buffer B (0.5 M Tris pH6.8)
0.375 ml 40% bisacryl stock
100
1.85 ml distilled water
30 |il 10% (w/v) SDS
15 |il 10% (w/v) ammonium persulphate
7 nl TEMED
Samples were mixed with 4X loading buffer (8% SDS, 20% |3-mercatoethanol, 
40% glycerol, Brilliant Blue R in 0.32 M Tris pH6.8) and boiled at 95°C for 5 min, then 
immediately placed on ice. Typically 2-10 (j.g of protein per well was added, with equal 
amounts o f protein added to each well. The gel was electrophoresed in reservoir buffer 
(0.025 M Tris pH 8.3; 0.192 M Glycine; 0.1% (w/v) SDS) at 40 milliamps (mA) per gel 
using an Atto vertical mini-electrophoresis system until the dye front reached the bottom 
of the gel.
Following electrophoresis the gel was soaked for 15 min in cold transfer buffer 
(0.025 M Tris pH8.3; 0.192 M Glycine; 15% v/v methanol). During this time 
nitrocelluose membrane and 16 sheets of Whatmann filter paper were cut to the same size 
as the gel and soaked in transfer buffer. Apparatus was set up according to manufacturers 
protocol. Proteins were transferred to the membrane for 30 min at 100V in an ATTO 
semi-dry transfer system. Following transfer membranes were soaked in Ponceau S 
solution to confirm transfer of protein to the membrane and also to normalize for 
variations in protein loading between lanes.
Membranes were blocked for 1 hour in blocking solution [5% (w/v) skimmed 
milk in Tris Buffered Saline [TBS]; lOmM Tris pH8.0; 150mM NaCl)]. Membranes were
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then incubated either overnight at 4°C or for 3-4 h at room temperature, with primary 
antibody diluted according to manufacturers instructions in blocking solution. Primary 
antibodies used were anti-Gial, anti-Gia2, and anti-Gia3 rabbit polyclonal IgG (1:500) (CN 
Biosciences - Nottingham, UK) and anti-endothelial nitric oxide synthase (eNOS) rabbit 
polyclonal IgG (1:1000) (Cayman Chemicals - Ann Arbor, MI. The blots were then 
vigorously washed in thee changes o f TBST (0.05% (v/v) Tween in TBS) and then 
incubated for 2 h at room temperature with a suitable HP linked secondary antibody 
diluted in blocking solution. Following incubation in secondary antibody, the blots were 
again washed in three changes of TBST.
Antibody-antigen complexes were detected by incubation in West Pico 
Supersignal reagent (Pierce Chemicals). Briefly, an equal volume of solution A and B 
were mixed and the incubated with blot for 5 min at room temperature. Blots were 
exposed to autoradiographic film  (Amersham Hyperfilm  ECL) and developed 
(Amersham Hyperprocessor Automatic Developer). Bands of interest were identified 
either by use of an antigenic positive control or based on molecular weight markers. 
Exposure times varied depending on the antibody being used but were typically between 
1-2 min.
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2.5 DNA Preparation Methods
2.5.1 Transformation of Competent Cells
100 [¿I of competent JM109 and/or XLl-Blu E.Coli. cells were placed in a sterile 
microfuge tube, to which approximately 10 ng of plasmid DNA, typically encoding 
ampicillin resistance was added. The cells and plasmid were mixed by moving a sterile 
pipette tip gentle though the cells, after which the cells were subsequently heat shocked 
by placing a tube in a waterbath at 42°C for 45-50 sec. Cells were then immediately 
placed on ice for 2 min.
Cells were grown for 1 h at 37°C with agitation (200 rpm) in 1ml of sterile Luria 
Bertram (LB) broth (1% (w/v) tryptone; 0.5% (w/v) yeast extract; 1% (w/v) NaCl; pH 
7.5). The cells were then centrifuged at 12000 g for 1 min and the supernatant removed. 
The resultant pellet was resuspended in 0.2 ml of LB broth and spread plated either 100 
|al and 50 jil on LB-Amp agar. The plates were incubated at 37°C overnight and for no 
longer than 18 h to prevent colasence o f colonies. As a control for each transformation a 
mock transformation was included, in which no DNA was added to the competent cells.
N.B. Plasmid maps o f  all vectors used are included in the appendix
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2.5.2 Plasmid DNA Mini-Preparation
Plasmid DNA was isolated as specified by Qiagen Plasmid Kit protocol 
(Sambrook et al., 1989; Ausubel et al., 1991; Bimboim et al., 1983). Single colonies of 
transformed cells were removed from plates and grown in 3 ml of LB broth supplemented 
with 35pg/ml ampicillin. These mini-cultures were grown at 37°C for 8 h with gently 
agitation (<200 rpm). 1.5ml o f the final culture was used for the generation of glycerol 
stocks. The remainder was diluted in 100 ml of LB-amp broth and grown at 37°C 
overnight at 250 rpm. The following day the cells were harvested by centrifugation at 
6000rpm for 15 min at 4°C.
The pellet was resuspended in 4 ml o f Buffer P I (50 mM Tris-HCL), pH 8.0; 10 
mM EDTA; 100 |ig/ml RNase A). The resuspended cells were lysed by gentle inversion 
with 4 ml o f Buffer P2 (200 mM NaOH; 1% SDS), and was incubated at room 
temperature for 10 min. Protein was precipitated by the addition of 4 ml of pre-chilled 
Buffer P3 (3M potassium acetate, pH5.5), gentle mixing and incubation on ice for 5 min. 
Protein precipitates were removed by high-speed centrifugation, 13000 g for 30 min at 
4°C. The supernatant was removed and centrifuged at 13,000 g for 30 min at 4°C to 
ensure complete removal of all protein.
Once the supernatant had been removed it was applied to a Qiagen tip-100, which 
has been equilibrated with Buffer QBT (750 mM NaCl; 50 mM MOPS, pH 7.0; 15% 
isopropanol; 0.15% triton X-100). The sample was allowed to enter the column by
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gravity flow and the column washed with 2 x 10 ml washes o f Buffer QC (1M NaCl; 
50mM MOPS, pH 7.0; 15% isopropanol). Finally, DNA was eluted from the column 
using 5 ml o f Buffer QF [1.25M NaCl; 50mM Tris-HCl, pH 8.3; 15% isopropanol].
DNA was precipitated from the eluate by the addition o f 3.5ml o f isopropanol at 
room temperature. The mixture was centrifuged at 12,000 g for 30 min at 4°C, to yield a 
glassy pellet. The supernatant was removed carefully so as not to disturb the isopropanol 
pellet. The pellet was then washed in 2 ml of 70% ethanol, (to remove precipitated salts 
and to make reconstitution o f the DNA easier) and then centrifuged at 12,000rpm for 10 
min. The DNA was air-dried for 5-10 min after removal of the supernatant and then 
redissolved in sterile Tris-EDTA (TE) buffer (lOmM Tris-HCl pH8.0; ImM EDTA).
2.5.3 Restriction Digests
DNA was digested with restriction endonucleases for identification of purified plasmid 
DNA. 1 fig  of DNA was prepared in a reaction solution containing 10X reaction buffer 
(supplied with each enzyme, by the manufacturer) along with 1 /¿I of restriction enzyme. 
The digest was incubated at a suitable temperature (enzyme-specific) for 30 min to one 
hour, the reaction was typically stopped by heating the reaction mixture to 72°C. In the 
case of multiple digests, following incubation with the first enzyme, linearised DNA was 
precipitated and then exposed to subsequent enzymes to overcome problems with 
differing reaction buffers. The products of the digest were then resolved by 
electrophoresis on a 2% agarose gel with appropriate size standards.
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2.5.4 Transient Transfection
Lipofectamine™ reagent is a polyeationic liposome as such it is suitable for 
transfection of DNA into eukaryotic cells (Invitrogen-Groningen, Netherlands). The day 
prior to transfection, cells were seeded into a bioflex plate at a density of approximately 
6X105 cells/well, and grown overnight in RPMI-1640 supplemented with serum and 
antibiotics.
When cells had reached approximately 70% confluency they were transfected 
with plasmid DNA. For transfection purposes plasmid DNA was diluted in 150 pi of 
DMEM without FCS or antibiotics such that there would be 1 pg of DNA per 10 cm2 of 
surface area (In the case o f a six well plate, 1 pg DNA per well). In a separate tube 10 pi 
o f lipofectamine reagent (4 pi per 10 cm2) was diluted in 150 pi of DMEM without FCS 
or antibiotics. The diluted DNA was then mixed with diluted lipofectamine reagent and 
incubated at room temperature for 30 min. This time permits the formation of DNA- 
liposome complexes.
While the DNA complexes were forming the cells were washed thee times in 
HBSS followed by one wash in DMEM. This was to remove any antibiotics from the 
flask, which may impede transfection efficiency. The DNA/lipofectamine mixture was 
made up to a final volume o f 0.5 ml, which is just enough media to cover the surface 
area of the well. The contents of the tube were then added to the well. The cells were 
incubated for 4 h in transfection media, following which the media was removed and
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replaced with normal RPMI-1640 growth media. Cells were subsequently allowed to 
recover overnight before they were exposed to experimental conditions. Cells were 
routinely co-transfected with either a Lac Z or green fluorescent protein (GFP) encoding 
plasmid as a means of estimating approximate transfection efficiency.
2.5.5 Monitoring of Transfection Efficiency
Co-transfection with either Lac Z, a plasmid encoding (3-galactosidase, or a 
plasmid encoding GFP was used to monitor transfection efficiency.
Increased levels of (3-galactosidase activity was attributed to successful 
transfection of the gene of interest. Following trasnsfection and cell lysis, a 30 ¡A sample 
was added to 3 ]A of 100X Mg solution [0.1 M MgCl2 and 4.5 M |3 mercaptoethanol], 66 
]A of IX  OPNG (o-nitrophenyl-(3-D-galactopyranosidase)[4 mg/ml ONPG in 0.1 M 
sodium phosphate, pH 7.5] and 201 ja \  of 0.1M sodium phosphate. The reaction was 
incubated for 4-6 h at 37°C until a yellow colour developed. The reaction was 
subsequently stopped with 500 jA of Na2C 0 1( and optical density read at 420 nm. Suitable 
positive and negative controls were included in this assay.
Transfection efficiency was monitored using co-transfection with a plasmid 
encoding GFP. Cells successfully transfected with this plasmid, and expressing GFP, 
could be viewed under using a fluorescent microscope (excitation 395 nm/ emission 508
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nm). Comparison of fluorescent and bright field images allowed degree of transfection to 
be approximated. Typically 50-60% of the cells were seen to express GFP.
2.6 Transfection with siRNA
siRNA mediated gene silencing has grown rapidly in popularity as a method of 
analyzing gene function. This procedure involves the transfection of cells with small 
interfering RNA (siRNA) duplexes. These duplexes are 21 nucleotides in length and are 
designed to specifically target an individual mRNA of interest, in our case that of 
EP24.15. siRNA are effective at much lower quantities than other gene silencing methods 
including antisense and ribozyme based protocols (Yu et al., 2002; Yang et al., 1999). 
siRNA used in these studies was supplied as a 2 ’-deprotected, annealed oligonucleotide 
in a desalted form.
This method of gene silencing is derived from a cellular defense mechanism 
probably evolved to deal with RNA viral infection. Mammalian cells typically show a 
characteristic “acute phase response” when transfected with small amounts of viral 
dsRNA. This involves the interferon-mediated activation of dsRNA responsive protein 
kinase (PKR) leading to a cascade that ends in global non-specific gene silencing and 
apoptosis. However this process can be circumvented to prevent the acute phase response 
and still attain specific gene silencing by altering the length of dsRNA. In the cell gene 
specific silencing begins with the RNase III activity of the enzyme DICER. This enzyme 
cleaves the dsRNA molecules into 19 base pair fragments in a random fashion. These
small interfering RNAs (siRNAs) induce the formation of the RISC (RNA induced 
silencing complex) complex of proteins. This RISC complex with bound siRNA is 
capable of interacting with the specific mRNA complementary to the anti-sense strand of 
the siRNA. This interaction of RISC/siRNA complex to the specific mRNA induces an 
endonuclease specific cleavage of mRNA in the siRNA targeted sequence leading to the 
full-length degradation of the mRNA (see Fig 2.1).
2.6.1 Design of siRNA Duplex
A sequence is selected in the open reading frame of the cDNA which is at least 
75-100 bp downstream of the start codon. Untranslated regions near the start codon may 
be richer in regulatory protein binding sites, which may interfere with binding of the 
siRNA endonuclease complex. The first A A dimer is located and the next 19 nucleotides 
are recorded. The G/C content of the AA-N19 base sequence is determined. Ideally the 
G/C content must be greater than 30% and less than 70%. If the sequence does not meet 
these criteria, a sequence further downstream starting with an AA dimer is analysed. This 
is continued until a sequence is found which meets all of the above conditions. Following 
this the 21 base sequence is subjected to a BLAST search to ensure that only one gene is 
targeted.
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Figure 2.1 M ode of action  of siRNA; introduction of siRNA duplexe leads to the formation of RNA 
induced silencing complexes (RISC), which bind specifically to the mRNA of interest leading to it’s 
degratdation by endonucleases, (www.mwg.com)
2.6.2 Transfection with siRNA Duplex:
siRNA was transfected into BAECs using lipofectamine™ 2000. siRNA was 
diluted in 5X universal buffer (200 mM KC1; 30 mM HEPES-KOH pH 7.5; ImM MgCl2) 
and RNase-free water to a final concentration of 20 ^iM (20 pmoles/|xl). The following 
procedure is for transfection in a 6-well format. 8X105 cells were plated per well to 
achieve 70-80%  confluency at time of transfection. siRNA/lipofectamine ™ 2000 
complexes were prepared as follows:
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Table 2.2 siRNA Sequences
N am e S eq u en ce  o f  S iR N A  D u p lex G C
C on ten t
M ol. W eigh t
EP24.151 5 ’-C CUG CUG AAG GAG UAC UUC UU-3’ 
3’-UUG GAC GAC UUC CUC AUG AAG -5’
48% 13,323.2g/mol
EP24.16 5 ’ - C UGA CUU GAA CCA CGA GAA UU-3 ’ 
3 ’-UUG ACU GAA CUU GGU GCU CUU-5’
42% 13,373.0g/mol
EP24.15 II 5 ’- C UGU CGC UGC AAG GAG GAG UU-3’ 
3’-UUG ACAGCG ACG UUC CUC CUC -5’
57% 13,353.0g/mol
scrambled 5’- AUU CUA UCA CUA GCG UGA C UU-3’ 
3 ’-UU UAA GAU AGU GAU CGC ACU G-5’
42% 13,373.0g/mol
Firstly, 5[il (100 pmoles/10 cm2) of siRNA was diluted in 395 jaI of DME medium 
without serum or antibiotic (the presence of antibiotics during transfection causes cell 
death). The mixture was then gently mixed. Lipofectamine ™ 2000 was mixed prior to 
use and subsequently 5 ul was diluted in 395 ixl of DME medium and incubated for 5 min 
at room temperature. The two mixtures were then combined and mixed gently. The 
mixture was incubated for 30 min at room temperature to allow the formation of 
siRNA/lipofectamine ™ 2000 complexes. The 800 (il of siRNA/lipofectamine ™ 2000 
complexes were added to the well and mixed gently by slowly rocking the plate back and 
forward to ensure complete coverage of the cells. Cells were incubated for 3 h at 37°C in 
a C 0 2 incubator. After the 3 h incubation the media was removed and replaced with
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growth medium and cells were recovered overnight. Following recovery, media was 
replaced with fresh growth media and cells and media were harvested 24 h later for 
analysis.
A commercially available non-specific control siRNA sequence (scrambled) (MWG- 
Biotech) was transfected into BAECs.
2.7 Enzymatic Assays
2.7.1 Flourometric Plate Assay for EP24.15/EP24.16
Enzymatic activities of EP24.15 and EP24.16 were routinely determined using a 
quenched fluorescent substrate (QFS), 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D- 
Lys(2,4-dinotrophenyl) (Bachem - Meyerside, UK), according to the method of Crack 
and co-workers with modifications for assay in 96-well format (Crack et al., 1999). 
Briefly, subcellular fraction (5 (iL) or media (50 fiL) was incubated at 37 C with 4.28 
,umol/L QFS in reaction buffer to a final volume of 218 uL. Specific inhibitors of both 
EP24.15 and EP24.16 were incorporated into the assay to delineate the relative 
contributions of each enzyme to total QFS hydrolysis. These included the active site- 
directed inhibitor, N-[l-(R,S)-carboxyl-2-phenylethyl]-Ala-Ala-Phe-p-amino-benzoate 
(cFP-AAF-pAB) (4.00 [imol/L) (Orlowski et al., 1988), which selectively inhibits both 
endopeptidase activities, and the dipeptide, Pro-Ile (Bachem - Meyerside, UK)(4.82 
mM), an EP24.16-specific inhibitor (Dauch et al., 1995). Reactions were terminated after
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60 min with 32 f.iL of 0.5 M sodium formate, pH 3.5. Liberated 7-methoxycoumarin-4- 
acetyl-Pro-Leu was subsequently measured on a Perkin Elmer LS-50B fluorescence 
spectrophotometer plate reader at excitation and emission wavelengths of 328 and 393 
nm, respectively. Enzyme activities were determined from a standard curve prepared 
under identical assay conditions with the aforementioned product. Suitable negative 
controls were included in each assay. Total substrate hydrolysis was typically <10% in all 
assays.
2.7.2 Whole Cell in situ Cleavage Assays
2.7.2.1 Quenched Fluorescent Substrate Assay
For monitoring QFS cleavage by BAECs a modified version of the assay 
described by Norman and co-workers was employed (Norman et al., 2003). Approx 
6.5X105 BAECs per well were plated onto Bioflex™ plates and left for 24 h. The media 
was then removed and the cells washed with HBSS. Cells were incubated with QFS (7.4 
¡.iM, 100 (j,L added to give a final volume of 2 ml) in the presence and absence of cFP- 
AAF-pAB (3.4 |J,M), which selectively inhibits EP24.15 and EP24.16. All assays 
included phosphoramidon (10 [.iM) and captopril (10 fxM) to selectively inhibit ACE, 
ECE and NEP, metalloendopeptidases known to degrade QFS. All assays were carried 
out in RPMI(-serum/-antibiotics). Following addition of substrate, straining commenced 
(5%, 24 h). Unstrained plates were included as controls. Prior to addition of substrate all 
plates were incubated with inhibitor for lh. At each time point (3, 6, 12 and 24 h) 100 iiL
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of media from three identical wells was harvested and combined, centrifuged to remove 
cell debris, and snap frozen in liquid N 0 2 and stored at -80°C until required for analysis. 
At t=24h the cellular protein was also harvested and assayed for normalization purposes. 
To monitor QFS hydrolysis 109 uL of each sample was added to 16 [¿L of sodium 
formate in a 96-well plate and its fluorescence read on a Perkins Elmer fluorimeter at 
excitation 328nm/emission 392 nm. All samples were added in duplicate.
2.1.2.2 BK/Ang-I Assay
For moitoring BK and Ang-I cleavage by BAECs a modified version of the assay 
described by Norman and co-workers was employed (Norman et al., 2003). Approx 
6.5X105 BAECs per well were plated onto Bioflex™ plates and left for 24 h. The media 
was then removed and the cells washed with HBSS. Cells were incubated with BK or 
Ang-I (100 uM, 100 uL added to give a final volume of 1ml) in the presence and absence 
of cFP-AAF-pAB (3.4 |xM), which selectively inhibits EP24.15 and EP24.16, or 
following prior transfection with EP24.15-FLIP or mock transfection. EP24.15-FLIP is 
an antisense construct against EP24.15 consisted of a vector containing 45 nucleotides of 
the EP24.15 promoter sequence “flipped” in an antisense conformation and cloned into a 
pMV12 vector containing two long terminal repeats with ampicillian resistance to 
propagate the plasmid in bacterial cells (Glucksmann and Roberts, 1995). All assays 
included phosphoramidon (10 fiM) and captopril (10 jxM) to selectively inhibit ACE, 
ECE and NEP, metalloendopeptidases known to degrade BK/Ang-I. The aminopeptidase 
inhibitor bestatin (10 |iM) was also included. All assays were carried out in RPMI (-
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serum/-antibiotics). Following addition of substrate, straining commenced (5%, 24h). 
Unstrained plates were included as controls. Prior to addition of substrate all plates were
Figure 2.2 Diagram of Experimental Approach for BK/Ang-I Degradation Assays
incubated with inhibitor for 1 h. At time point (t= 24 h) 300 ¡_iL of media from three 
identical wells was harvested and combined, centrifuged to remove cell debris, and snap 
frozen in liquid N2 and stored at -80°C until required for analysis (see Fig 2.2).
2.7.2.3 HPLC Analysis for Peptide Substrate Hydrolysis
HPLC analysis was carried out using a Varian Inert 9012 pumping system with a 
Varian 9050 UV/VIS detector and Varian Star Workstation analysis/control software.
1 1 5
BK/Ang-I and Inhibitors
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Determination of BK/Ang-I concentration from chromatogram
Prior to analysis harvested media samples were thawed and acidified by addition of TFA 
to a final concentration of 0.1% v/v. 50 uL of each sample were loaded in triplicate on a 
Waters Symmetry C-18 reverse phase column at room temperature in a running buffer 
composed of 1.8% v/v acetonitrile, 0.1% TFA, 0.02% Acetic Acid at 1 ml/min and eluted 
with a 30min linear gradient to 60% acetonitrile/0.1% TFA. Peptides and peptide 
fragments were detected at 208 nm.
Experimental peptide concentrations were determined with reference to 
appropriate standard curves of peak area versus concentration for 0-100 [iM BK/Ang-I 
Generally less than 10% of the exogenous peptide was degraded under assay conditions.
2.8.3 Scratch-Wound Healing Assay
Endothelial cell migration was observed using the scratch-wound healing assay, 
modified from the method of de Jonge and co-workers (de Jonge et ah, 2002). Briefly, 
post-strain approximately 2x l05 BAECs were harvested and transferred into 24 well 
plates, 2 wells per treatment. Plates were incubated for 12 h (37°C/5% C 0 2), and then 
scratched with a modified yellow pipette tip across the diameter of the well. The cells 
were then washed with Hanks to removed resultant cell debris. At t=0 scratch was 
photographed using an Olympus microscope DP50 controlled with AIM imaging 
software at 3 distinct fields (top, middle and bottom of scratch) at 100X magnification. 
Fresh media containing serum (10% FBS) was then added and the cells incubated for 4 h. 
Following incubation the cells were washed and the scratch closure monitored by digital
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photography as described. NIH image was used to calculate the distance between the 
wound edges at T=0 and T=4 and the migration judged to be the reduction in the width of 
the scratch. The contribution of cell proliferation to the wound healing involved was 
controlled for by serum starving cells for 24 h in order to quiesce them, and then 
performing assay as described above in both serum free and serum containing media. The 
presence of serum, a known endothelial cell mitogen, was not seen to significantly 
increase the rate of wound closure in the time period observed. This indicated that cell 
proliferation did not significantly contribute to the wound closure observed.
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Figure 2.3 Representative micrographs (100X) of wound healing assay at t=0 and t=4. The reduction 
in scratch width can be clearly seen.
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2.9 In vitro Tube Formation Assay
2.9.1 Preparation of Three-Dimensional Collagen Gels
Collagen gels were prepared as previously described (Yang et cil., 1999; Zheng el  
al.,  2001). Briefly, a neutralized collagen mixture was prepared by mixing stock (1.5 
mg/ml in 10 mM acetic acid) type I rat t:iil collagen (Sigma, Dorset, UK), with growth 
medium and I M NaOH. Typical mixture: 600 |.il o f  collagen+ 60 ul o f  culture medium+ 
50 ¡.il o f  1 M NaOH. The mixture was poured into 24-well tissue culture plates (100 
//l/vvel!) and allowed to solidify in an incubator containing 5% C 0 2-95% ambient air at 
37°C for I h. After polym erization the gels were then incubated with growth medium 
overnight at 37°C before use.
Unstrained Strained
Figure 2.4 Representative micrographs (200X) showing increased endothelial cell tubule formation in 
response to exposure to cyclic strain. The tubules are clearly marked with arrows in the “strained" panel.
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2.9.2 Tlibe Formation Assay
Following treatment under differing experimental conditions, ie unstrained versus 
strained, BAECs were trypsinized as previously described. Cell counts were performed 
and 1.5X104 cells were seeded per well in RPMI 1640 supplemented with 10% FBS. 
Cells were incubated overnight for 16-18 h before assessment of tube formation. Cells 
were photographed at 3 distinct fields using an Olympus microscope DP50 controlled 
with AIM imaging software. Four random fields of vision were photographed (200X) 
from each gel. Endothelial cell tubule formation was determined using NIH image. 
Briefly the length of the cell was determined at its longest point by drawing a line, which 
was subsequently measured using NIH image. Three such cells were analysed per image, 
and an average value for endothelial cell tubule length determined.
2.10 Immunocytochemical Staining
2.10.1 Preparation of Cover Slips
Experimental samples (i.e. unstrained vs. strained cells) were trypsinised post 
treatment and transferred to sterile 6 well plates into which sterilized glass cover slips had 
been placed (1 slide per well). Cells were allowed to adhere for 10-12 h. The cells were 
then stained as described below. Cover slips were precoated with gelatin to aid cell 
adhesion as follows; briefly glass cover slips were acid washed (1 M HC1, 10 min) to 
remove any other coatings, washed several times in HBSS, sterilized by washing in IMS
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and then transferred to sterile 6 well plates. 1ml of sterile 2% gelatin was added to each 
well and left for 10 min at room temperature. Excess gelatin was then removed and cover 
slips left to air dry for approximately 1 hour. Plates/cover slips were then stored at 4°C 
until required. If unused within 48 h plates/cover slips were discarded and fresh ones 
prepared.
2.10.2 Whole Solubilised (Dead) Staining
This staining protocol was designed to stain all the protein present in the cell. 
Cover slips of experimental samples were prepared as described above and stained using 
the following protocol; (all solutions/antibodies were prepared in PBS unless otherwise 
indicated, and, where possible, procedures were carried out on ice). Cells were first 
washed several times in 5% bovine serum albumin (BSA). Following washing cells were 
fixed by treatment with 3% formaldehyde for 15 min, washed again in 5% BSA solution, 
and solublised using 2% Triton-X for 5min. Cells were again washed before being 
incubated with primary antibody for 1 h (rabbit anti-EP24.15 polyclonal IgG 1/1000, 
rabbit anti-eNOS polyclonal IgG 1/2000). Cells were washed stringently to remove any 
unbound primary antibody, and then incubated in secondary antibody for 30 min 
(AlexaFluor 488 conjugated anti rabbit IgG 1/800). Cells were also treated solely with 
secondary antibody as a control for non-specific staining. After washing cells were 
counter-stained with the nuclear-specific DAPI (Molecular Probes, Oregon USA) stain 
for 2 min. Cover slips were then washed once more, partially dried by holding at an angle 
and allowing excess liquid to be absorbed by tissue held at the bottom edge of the cover
120
slip and finally mounted on glass slides using Dako (Molecular Probes, Oregon USA) 
mounting media. Slides were kept at room temperature for 1 hour to allow Dako to set 
before being refrigerated until imaged.
2.10.3 Extracellular Unsolublised (Live) Staining
All solutions/antibodies were prepared in PBS unless otherwise indicated, and, 
where possible, procedures were carried out on ice. Cells were first washed several times 
in 5% bovine serum albumin (BSA). Cells were then incubated with primary antibody for 
1 h (rabbit anti-EP24.15 polyclonal IgG 1/1000). Following washing cells were fixed by 
treatment with 3% formaldehyde for 15 min. Cells were washed stringently to remove 
any unbound primary antibody, and then incubated in secondary antibody for 30 min 
(Alexa 488 conjugated anti rabbit IgG 1/400). Cells that were untreated with primary 
antibody were also treated with secondary antibody as a control for non-specific staining. 
After washing cells were counterstained with the nuclear specific DAPI stain for 2 min. 
Cover slips were then washed once more, partially dried by holding at an angle and 
allowing excess liquid to be absorbed by tissue held at the bottom edge of the cover slip 
and mounted on glass slides using Dako mounting media. Slides were kept at room 
temperature for 1 hour to allow Dako to set before being refrigerated until imaged.
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2.10.4 Imaging
2.10.4.1 Fluorescent Microscopy
Whole cell staining preparations were photographed with Olympus microscope 
DP50 fitted with an Olympus U-RFLT (Olympus Corporation, USA) fluorescent light 
source and controlled with StudioLite™ imaging software. The microscope was fitted 
with two filters Green (Excitation Wavelength 460-490 nm, Emission Wavelength 515 
nm) used for alexafluor 488 labelled antibodies (Excitation Wavelength 488 nm, 
Emission Wavelength 515 nm), and a blue filter (Excitation Wavelength 360-370 nm, 
Emission Wavelength 420 nm) used for DAPI stained cells.
Typically cells were located using the DAPI filter, which allowed visualization of 
the cell nucleus, and photographed (typically 1/60 sec, sensitivity 400), before changing 
to the green filter in order to visualize and photograph alexafluor 488 staining (1/1.5 sec, 
sensitivity 400). Cells were photographed at 200x and lOOOx. Photographs were saved as 
.jpeg files for the purpose of reporting and image overlay.
2.10.4.2 Confocal Microscopy
Confocal microscopy of whole and extracellularly stained preparations was 
carried out on a Zeiss LSM-510 META Axioplan 2 upright confocal microscope with a 
Plan NeoFluor 40x/1.3 oil DIC objective lens. Cells were located and photographed
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under bright field before being photographed at excitation 488nm/emission 515nm to 
visualize immunostaining. Resulting images were analysed and overlayed in Zeiss LSM 
Image Browser. Confocal microscopy was carried out at the Royal College of Surgeons, 
Dublin.
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Chapter 3; Results Section 1 
Examination of the Effects of Cyclic 
Strain on EP24.15 and EP24.16 mRNA
Levels
and Both Cellular and Secreted 
Enzymatic Activity in BAECs
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3.1 Introduction:
Blood flow results in the generation of hemodynamic forces, namely cyclic strain 
and shear stress (see section 1.2). Blood vessels are chronically exposed to these stresses 
and, as such, both of these forces are required for maintaining vascular homeostasis. It 
has been demonstrated that hemodynamic forces can induce changes at the expressional 
and functional level for a number o f physiologically relevant genes (Traub et al., 1998; 
Papadaki et al., 1997).
The closely related members of the clan MA family of zinc metallopeptidases, 
EP24.15 and EP24.16, are known to be expressed within the vasculature and to cleave a 
number of vasoactive peptides, such as BK and Ang-I. Other members of the Clan MA 
family (ECE and ACE) involved in the processing o f vasoactive peptides have been 
shown to be regulated by hemodynamic forces. Moreover, EP24.15 and EP24.16, as well 
as the latter enzymes have a single copy shear stress response element (SSRE) 
[GAGACC] in their promotors (McCool etal., 1998; McCool et al., 2000; Li etal., 1995; 
Shinoki etal., 1998). As such, EP24.15 and EP24.16 are prime candidates for regulation 
by hemodynamic forces.
The aim o f  this chapter was to examine the effects o f  nhxsioloeical levels o f  
cyclic strain on the expression, subcellular localization and activity o f  EP24.15 and 
EP24.16 in BAECs.
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3.2.1 Hemodynamic regulation of EP24.15 and EP24.16 mRNA expression
The regulatory effects of 5% equibiaxial cyclic strain (24 h) on EP24.15 and 
EP24.16 mRNA expression in BAECs was monitored using semi-quantitative RT-PCR 
and agarose gel electrophoresis with gene-specific primers for EP24.15, EP24.16 and 
cycloxygenase II (COX-II). The levels of the housekeeping gene GAPDH, unaffected by 
hemodynamic forces, were included to act as a control and for normalization purposes for 
start mRNA concentration. The levels of EP24.15 and EP24.16 (Fig 3.1 a, b) increased in 
response to cyclic strain by 1.41 ± 0.2 and 1.55 ± 0.3 fold respectively relative to 
untreated control (n=3, P^0.05). The levels of COX-II were also increased in response to 
exposure to strain (1.91 ± 0.4 fold relative to control, P-sO.OS),
Both EP24.15 and EP24.16 PCR primers were checked for specificity and 
potential cross-reactivity using pGEX plasmid constructs containing both genes (Rioli, et 
al., 1998). Both sets of primers produced product of correct size when appropriate 
construct was used as DNA template in a PCR reaction, while neither primer pair showed 
any cross reactivity (see Fig. 3.1 c).
3.2 Results
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Figure 3.1 Cyclic strain-dependent increase in EP24.15 and EP24.16 mRNA 
expression in BAECs. Cyclic strain (0% or 5%) was applied to BAECs for 24 h. 
Following mRNA extraction and RT-PCR (as described in METHODS), all amplified 
products were analysed by agarose gel electrophoresis on 2.5% gels and visualized by 
ethidium bromide staining. Representative gels (inverted) shown are as follows; Lanes 1­
4 for each of the three gels are GAPDH. Lanes 5-8 are EP24.15, EP24.16 and COX-II
(a). Densitometric analysis of individual gels is summarized in the graph beneath the gels
(b). GAPDH was used for normalization of gel loading. Statistical differences were
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es tab lished  at * />s0 .0 5  versus unstra ined  control. Data are the result o f  3 sets o f  
experiments. Primers for E P 2 4 .15 and E P 2 4 .16 were checked for specificity using pGEX 
plasmid constructs containing the gene for each enzyme. Representative gels are shown; 
Left hand gel shows o p G E X E P 2 4 .15 and p G E X E P 2 4 .16 constructs probed with E P 2 4 .15 
primers. Right hand gel shows pG E X E P24.16  and p G E X 2 4 .15 constructs probed with 
E P 2 4 .16 p rim ers (Fig 3.1 c). Images are representa tive o f  a num ber o f  independent 
experiments
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unstrained 5%strain
Figure 3.2 Cyclic strain does not significantly alter levels of lactate dehydrogenase 
(LDH) activity in experimental media samples. BAECs were exposed to cyclic strain 
(5%, 24 h) and samples of media were collected and assayed for LDH activity. Graph 
represents fold change in LDH activity in experimental media samples relative to 
unstrained control. All data is the result of two independent experiments ± SEM.
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3.2.2 Hemodynamic regulation of EP24.15 cellular and membrane- associated 
protein levels as monitored by immunocytochemistry
F ollow ing  exposure to cyclic  strain  (5% , 24 h) BAECs were 
immuncytochemically stained by incubation with a rabbit primary antibody specific to 
either EP24.15 or eNOS, followed by incubation with an Alexafluor 488 conjugated anti­
rabbit secondary antibody, using techniques for both whole cell and extracellular staining. 
The cells were also counterstained with the nuclear-specific DAPI stain, which allowed 
confirmation of cell position. A control for non-specific staining was also carried out by 
incubation of cells with secondary antibody only (Fig 3.3 a). The cells were imaged using 
fluorescent and confocal microscopy (Fig 3.3, Fig 3.4).
A clear increase in the total cellular levels of EP24.15 can be observed in response 
to cyclic strain (Fig 3.3 b, c; Fig 3.4 a, b). This increase was particularly evident in the 
cytoplasm, The cellular levels of eNOS can also be seen to increase significantly in 
response to exposure to strain (Fig 3.3 d, e).
Using confocal microscopy in conjunction with live (non-fixed) staining 
techniques, an increase in extracellular levels of EP24.15 in response to cyclic strain was 
observed, with an evident increase in punctate staining at the cell extremities (Fig 3.3 c, 
d). Due to limitations on the amount of EP24.15 antisera available it was only possible to 
perform this procedure once.
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Due to the lack of suitable antisera, we were unable to ascertain the effects of 
cyclic strain on EP24.16 protein expression in BAECs.
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Figure 3.3 Immunocytochemical staining shows an increase in BAEC protein 
expression levels of EP24.15 in response to cyclic strain. Following exposure to cyclic 
strain (5%, 24 h) cells were stained with antisera for EP24.15 (b, c) and eNOS (d, e), 
before being stained with Alexafluor 488-labelled antibody. Cells were also strained with 
secondary antibody only as a control for non-specific staining (a). The nuclear specific 
DAPI stain was also included. Nuclear and cytoplasmic associated areas of staining are 
indicated with yellow and red arrows respectively. Cells were then photographed using a 
fluorescent microscope. AH images shown were photographed at lOOOx magnification. 
All images are representative of at least three individual experiments.
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Figure 3.4 Immunocytochemical staining and confocal microscopy reveal an 
increase in total and extracellular membrane-associated EP24.15 in BAECs in 
response to cyclic strain. Following exposure to cyclic strain (5%, 24 h) cells were 
stained with antisera for EP24.15, using both whole (dead a, b) and extracellular (live c, 
d) techniques, before being stained with alexafluor 488-labelled antibody. Cells were also 
strained with secondary antibody to remove, non-specific background fluorescence. Cells 
were then photographed using confocal microscopy. Areas of cytoplasmic, nuclear and 
extracellular membrane associated areas of staining are indicated with red, yellow and 
blue arrows respectively. All images shown were photographed at 1600x magnification. 
Images are representative of one experiment.
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3.2.3 Exposure to cyclic strain causes a time- and force- dependent increase in 
EP24.15 and EP24.16 cellular and secreted activity in BAECs:
The regulatory effects of cyclic strain on EP24.15 and EP24.16 activity in cell 
lysate and conditioned media was routinely determined using a 96 well fluorometric 
assay. A standard curve for MCA-Pro-Leu, the fluorescent product of QFS cleavage by 
EP24.15/EP24.16, is shown in Fig 3.5. Both endopeptidase activities were routinely 
detected in the soluble fraction of BAECs cultured under static (unstrained) conditions. 
Basal levels were determined to be 4.4 ± 0.6 and 6.6 ± 0.6 nmoles QFS hydrolyzed.h‘ 
‘.mg'1 protein for EP24.15 and EP24.16, respectively. Initial experiments clearly 
demonstrated a strain-dependent up-regulation of soluble EP24.15 and EP24.16 activity 
in BAECs, with maximal inductions of 2.3 ± 0.35 and 1.9 ± 0.35 fold respectively at 10% 
strain (P<0.05) (Fig 3.6 a). eNOS protein expression was also monitored and found to 
increase significantly (1.9 fold) in response to chonic cyclic strain (Awolesi et al., 1995). 
Strain-dependent up-regulation of both endopeptidase activities was also found to be 
time-dependent, with induction of activity observed after 3 h strain, both increasing to 
maximal levels at 24 h for EP24.16 and 12 h EP24.15 (1.69 ± 0.13 and 1.9 ± 0.46 
respectively) (Fig 3.6 b).
The effect of cyclic strain on the levels of secreted enzyme activity was also 
determined. Exposure of BAECs to 5% cyclic strain led to a time-dependent increase in 
EP24.15 and EP24.16 activity in BAEC-conditioned media, increases which were 
significantly in excess of constitutive endopeptidase release (0%). Differences between
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constitutive and force-dependent endopeptidase release were apparent for both enzymes 
after 3h o f  strain and, after 24 h. fold differences o f  2.6 ±  0.02 and 3.6 ± 0.2 fold were 
observed for E P 2 4 .15 and E P 2 4 .16. respectively (PsO.05) (Fig 3.7 a, b). To determine if 
the increase in secreted activity observed  was due to a s tra in-m ediated  loss o f  cell 
m em brane integrity the levels o f  lactate dehydrogenase (LDH) were also determined in 
the media. Analysis o f  media from control and strained samples showed no increase in 
levels o f  LDH activity as a result o f  straining (Fig 3.2).
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Figure 3.5 Fluorescent standard curve for 7-methoxycoumarin-4-acetyl-Pro-Leu 
(MCP-Pro-Leu). A standard curve for MCP-Pro-Leu was prepared in the concentration 
range 0-130 nM, both in the presence and absence of the EP24.16 inhibitor Pro-ile (4.82 
raM). Graph represents fluorescence units versus MCP-Pro-Leu concentration. Graph is 
representative of two experiments.
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Figure 3.6 Cyclic strain-dependent increase in EP24.15 and EP24.16 enzymatic 
activity in BAECs. (a) Force-dependent elevation of endopeptidase activities in BAECs 
following exposure to varying levels of cyclic strain (0-10%) for 24 h. Insert shows a 
representative gel displaying 1.9 fold up-regulation of eNOS protein expression in 
BAECs in response to cyclic strain (5%, 24 h), as monitored by Western blotting (7 
Hg/lane). (b) Time dependence of cyclic strain-mediated elevation of endopeptidase 
activities in BAECs following exposure to cyclic strain (0 or 5%) for varying times (0-24
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h). Results are expressed as fold change in specific activity relative to control (unstrained 
cells). Statistical differences were established at *P<0.05, **P<0.()1, and ***P<0.001 
versus unstrained control. Data are the result of 3-4 sets of experiments.
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Figure 3.7 Cyclic strain-dependent increase in EP24.15 and EP24.16 secretion from 
BA ECs. Elevation of (a) EP24.15 and (b) EP24.16 enzymatic activities in BAEC- 
conditioned media following exposure to cyclic strain (0 or 5%) for varying times (0-24 
h). Results are expressed as pmoles substrate hydrolyzed.m in'.m L^ixg'1 protein. 
Statistical differences were established at *F^0.05 and **Ps0.01 versus unstrained 
controls. Data are the result 3 sets of experiments.
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3.3 Discussion
Peptidase-mediated metabolism of bioactive peptide hormones plays a vital role in 
endothelial cell-mediated vascular events. As shear stress and cyclic strain likely 
represent the principle regulatory stimuli influencing vascular homeostasis and associated 
pathologies, we postulated that metalloendopeptidase expression and activity in vascular 
endothelial cells (ECs) may be regulated by these hemodynamic variables. To further 
investigate this hypothesis, we examined the relationship between cyclic strain and the 
mRNA expression, protein levels, and enzyme activity of both EP24.15 and EP24.16, 
homologous members of the thermolysin-like zinc metalloendopeptidase family, within 
vascular ECs. A flexwell in vitro culture system which uses vacuum to mechanically 
strain or deform cells cultured on a flexible, matrix-bonded growth surface was 
subsequently employed for culturing vascular ECs under conditions of defined cyclic 
strain (Banes et al., 1985).
Initially it was decided to investigate if exposure to physiological levels of cyclic 
strain (5%, 24h) affected changes at the level of the transcription of EP24.15 and EP24.16 
mRNA. It was observed that exposure to cyclic strain significantly increased the levels of 
mRNA for both enzymes relative to unstrained controls. In addition the levels of 
cycloxygenase II (COX-II) mRNA were seen to increase relative to controls, a well- 
characterized response to strain (Kito et al., 1998).
To our knowledge no other studies have examined on the effects of hemodynamic 
forces on the expression levels of EP24.15/EP24.16 in the vasculature. Numerous studies
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have demonstrated the ability of hemodynamic forces to regulate the mRNA expression 
of ECE-1 and ACE, which are structurally related to EP24.15/EP24.16 (Masatsugu etal., 
2003; Reider et al., 1997).
This result suggested that cyclic strain might also alter levels of EP24.15/EP24.16 
protein and enzymatic activity. In this regard, exposure to cyclic strain altered the levels 
of EP24.15 protein, as measured immunocytochemically using fluorescent and confocal 
microscopy. Total levels o f EP24.15-specific immunostaining were dramatically 
increased in both the cytoplasm and nucleus. In addition, a robust increase in the levels of 
eNOS staining, a well-characterized response to cyclic strain was observed (Awolsei et 
al., 1995). Immunostaining was also carried out with non-permeabilised (non fixed) 
BAECs at 4°C, in which internalization of the antibody was prevented. This appeared to 
indictate the presence of EP24.15 on the extracellular plasma membrane surface, albeit at 
very low levels. The levels of extracellular staining for EP24.15 were also increased in 
response to strain, suggesting a putative influence on the enzymes extracellular function.
Crack and co-workers have employed similar immunostaining strategies in their 
investigations of EP24.15 in mouse neuronal AtT-20 cells. Their studies also revealed the 
presence of membrane-bound and cytoplasmic EP24.15 (Crack et al., 1999). However 
their studies did not indicate significant levels of nuclear EP24.15. In contrast our studies 
revealed that in BAECs much of the EP24.15 staining occurs in the nuclear region. This 
may be due to cell/species specificity, and the different roles of EP24.15 in both tissue 
types.
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Both endopeptidase activities were routinely detected in the soluble fraction of 
BAECs cultured under static (unstrained) conditions. Basal levels were determined to be 
4.4 ± 0.6 and 6.6 ± 0.6 nmoles QFS hydrolyzed.h '.mg'1 protein for EP24.15 and 
EP24.16, respectively. Initial experiments clearly demonstrated a strain-dependent up- 
regulation of soluble EP24.15 and EP24.16 activity in BAECs, with maximal inductions 
of 1.9 ± 0.4 and 2.3 ± 0.4 fold, respectively (at 10% strain). In concurrence with previous 
reports, eNOS protein expression was also monitored and found to increase significantly 
(1.9 fold) in response to chronic cyclic strain. Strain-dependent up-regulation of both 
endopeptidase activities was also found to be time-dependent, with induction of activity 
observed after 3 h strain, both increasing to maximal levels at 24 h. These observations 
lead us to conclude that cyclic strain can potentially regulate the levels of EP24.15 and 
EP24.16 activity within BAECs in a dose- and time- dependent manner.
Although predominantly cytosolic, secreted forms of EP24.15 and EP24.16 have also 
been widely reported for various cell types, including endothelial cells, subsequently 
enabling them to function extracellularly (Acker et al., 1987; Crack et al., 1999; Ferro et 
al., 1999; Cotter et al., 2004). Recently Jeske and co-workers have demonstrated EP24.15 
association with and extracellular release from lipid rafts in mouse neuronal GT1-7 cells, 
indicating a putative mechanism for its constitutive release. (Jeske et al., 2003; Jeske et 
al., 2004). Several studies have previously detailed the effects of cyclic strain on 
secretory processes in vascular cells. Considering the regulatory influence of cyclic strain 
on soluble levels of EP24.15 and EP24.16 activity described here, it was decided to 
examine its potential influence on endopeptidase release from BAECs. Exposure of
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BAECs to 5% cyclic strain led to a time-dependent increase in EP24.15 and EP24.16 
activity in BAEC-conditioned media increases which were significantly in excess of 
constitutive endopeptidase release. Differences between constitutive and force-dependent 
endopeptidase release were apparent for both enzymes after 3 h of strain and, after 24 h, 
fold differences of 2.6 and 3.6 fold were observed for EP24.15 and EP24.16, respectively. 
Based on these observations, we can conclude that cyclic strain potentially modulates 
release of EP24.15 and EP24.16 from BAECs, suggesting a putative influence on their 
extracellular functions.
In conclusion therefore, it was our intention to examine the effects of 
cyclic strain on the mRNA/protein expression and enzymatic activity of EP24.15 and 
EP24.16. We observed a clear up-regulation of EP24.15/EP24.16 mRNA expression and 
both cellular and secreted activity of both enzymes in response to cyclic strain. The 
increase in activity was found to be time- and force- dependent with maximum increases 
observed at 24 h and at 10% strain. In addition strain was seen to clearly increase the total 
cellular levels of EP24.15 immunostaining, both nuclear and cytoplasmic, and to increase 
the amount of membrane-bound EP24.15. These changes occurred in parallel with 
increases in the levels of eNOS protein, and of COX-II mRNA, both of which are well 
characterized responses to exposure to cyclic strain. It is our conclusion therefore that 
both EP24.15 and EP24.16 are putatively regulated by physiological levels of equibiaxial 
cyclic strain.
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Chapter 4; Results Section 2 
The Involvement of Gia and GPy 
Signaling Pathways in the Strain 
Mediated Regulation of EP24.15 and 
EP24.16 Activity in BAECs.
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4.1 Introduction
Having demonstrated the regulatory effects of cyclic strain on EP24.15 and 
EP24.16 expression and specific enzymatic activity in BAECs, it was decided to 
delineate the specific cell signaling pathways involved in the transduction of this 
stimulus.
The intracellular transduction of hemodynamic forces in vascular ECs, manifested 
though changes in gene expression and protein function, remains poorly understood. 
Several protein candidates have been implicated in this process and include PTX- 
sensitive (Gi) and -insensitive (Gq) heterotrimeric G-proteins, G-protein-coupled 
receptors (GPCRs), ion channels, integrins and receptor tyrosine kinases (RTKs) (Traub 
et al., 1998; Papadaki et al., 1997; Redmond et al., 1998). Inhibitory guanine nucleotide 
regulatory G-protein (Gi) signalling pathways are of particular interest. Activation of Gi- 
protein subunits and increased GTPase activity occur immediately (within sec) following 
mechanical loading, suggesting that these ubiquitous regulatory proteins are strategically 
located within vascular ECs to facilitate transduction of mechanical stimuli.
The. objective o f  this S££lUW  was to investigate the putative role o f  Gi„ and G fy  
subunits in putativelv mediating th e c yclic strain-dependent effects observed for 
EP24.15 and EP24.16 in BAECs.
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4.2.1 Pharmacological inhibition of Gia protein signaling attenuates the strain 
dependent increase in EP24.15 and EP24.16 activity in BAECs.
Cells were subjected to 5% cyclic strain (24 h) in the presence and absence of 
pharmacological inhibitors of Gia signaling, namely pertussis toxin (PTX-100 ng/ml) and 
NF023 (100 (.iM). Pertussis toxin, which catalyzes the ADP-ribosylation of the a-subunit 
in the intact heterotrimer, thereby uncoupling the G-protein from its receptor, and NF023, 
a suramin analogue which blocks GDP dissociation from the a-subunit, have been 
extensively employed by others for the inhibition of Gi-protein mediated signaling 
(Labrador et al., 2003). In our studies both agents were demonstrated to strongly 
attenuate strain-dependent up-regulation of activity for both endopeptidases, suggesting a 
role for Gi-protein signaling in these events.
Specifically PTX treatment was seen to considerably attenuate the strain 
dependent increase in activity of both EP24.15 and EP24.16 in BAECs, by 74.4 ± 34.9%, 
and 89.9 ± 36.8% respectively (P<0.01). Treatment with NF023 was also seen to 
attenuate the strain dependent increase in EP24.15 and EP24.16, with a 91.2 ± 32.3% 
attenuation observed with EP24.15 and 91 ± 37.7% attenuation observed with EP24.16 
(P<0.01) (Fig. 4.1 a, b).
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Figure 4.1 Attenuation of the cyclic strain-dependent increase in EP24.15 and 
EP24.16 activity by pharmacological inhibition of Gi-protein function. BAECs were 
strain in the presence or absence of either PTX (a) or NF023 (b) (0 or 5%) for 24 h. 
Results are expressed as fold change in specific activity relative to unstrained control. 
Statistical differences were established at *-P-s0.05, **.P<0.01, and ***Pi?0.001 versus 
unstrained control. Significant differences were also established at sPs0.05 and 5SP«0.01 
versus strained control (no PTX/NF023, cells at 5%). Data are the result of 3 sets of 
experiments.
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Following transient transfection of BAECs with plasmid constructs encoding wild 
type and dominant-negative mutant Gial 3 subunits; cells were exposed to cyclic strain 
(either 0 or 5%) for 24 h. A consistently high (approx. 40-50%) transfection efficiency 
was achieved thoughout these studies and over-expression of transfected Gi-protein 
subunits (both wild type and mutant) was subsequently confirmed by Western 
immunoblotting (data shown for Giga2 , Fig 4.2). Cyclic strain-dependent elevation of 
cellular EP24.15 activity in BAECs was found to be attenuated by Gia2-G203T (81.9 ± 
36.3%) and Gia3-G202T (102.9 ± 21.8%), whereas Gial-G202T had no significant effect 
(P=0.46). Interestingly, force-dependent increase in cellular EP24.16 activity was 
strongly attenuated by Gial-G202T (69.6 ± 18.6%) and Gia2-G203T (101.7 ± 26.7%), 
whereas Gio3-G202T had no significant effect (P=0.29) (Fig 4.3) (Inhibition data for 
above experiments is tabulated in Table 4.1). In contrast to the dominant negative 
mutants, over-expression of the Gia]_3 wild type subunits had no negative impact on 
cyclic strain-dependent increases in the activity of either endopeptidase in BAECs, and in 
some instances actually resulted in further, albeit slight, increases in activity.
4.2.2 Attenuation of Cyclic Strain-Dependent Increases in EP24.15 and EP24.16
Activity in BAECs by Molecular Inhibitors of Gi„-Subunit Function
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Figure 4.2 representative western blot confirming protein over-expression following 
transient transfection of either wild type or mutant Gia-subunit constructs.
I mrmi nob lotting was performed using an anti-Gitl2 rabbit polyclonal IgG selective fo r  
both wild type and mutant form s of the Gi(<2-subimit. Protein loading was 10 ug/lane. 
Over-expression of Gia,-G204A and Gi(I,-G203T (null mutant and dominant negative 
forms of Gif[>, respectively) are shown in lanes 2 and 3. Over-expression of wild type Giu2 
is shown in lane 5.
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Figure 4.3 Attenuation of the cyclic strain-dependent increase in EP24.15 and 
EP24.16 activity by molecular inhibition of Gia-protein function. Following transient 
transfection of BAECs with plasmid constructs encoding Gial-G202T, Gia2-G203T or 
Gia3-G202T, dominant-negative mutant forms of the associated wild type subunits, cells 
were allowed to recover overnight before applying cyclic strain (0 or 5%) for 24 h. 
Results are expressed as fold change in specific activity relative to unstrained control 
(mock transfected cells at 0%). Statistical differences were established at *P£0.05, 
**F^0.01, and ***Ps0.001 versus unstrained control. Significant differences were also 
established at “fsO.OS and “ P^O.Ol versus strained control (mock transfected cells at 
5%). Data are the result of 3-4 sets of experiments.
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Following transfection of BAECs with [iARK.ct, cells were exposed to cyclic 
strain (either 0 or 5%) for 24 h. Cyclic strain-dependent elevation of EP24.15 activity in 
BAECs was only slightly attenuated in cells (12.7 ± 7.3%) by fiARK.ct. In contrast, 
strain-dependent increases in EP24.16 activity were substantially attenuated in BAECs 
(86.4 ± 2.6%) by fSARK.ct (Fig 4.4; Table 4.1).
4.2.3 Attenuation of Cyclic Strain-Dependent Increases in EP24.15 and EP24.16
Activity in BAECs by Molecular Inhibitors o f GPy-Dimer Function
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Figure 4.4 Attenuation of the cyclic strain-dependent increase in EP24.15 and 
EP24.16 activity by molecular inhibition of GPy-protein function. Following transient 
transfection of BAECs with |3ARK.ct, cells were allowed to recover overnight before 
applying cyclic strain (0 or 5%) for 24 h. Results are expressed as fold change in specific 
activity relative to unstrained control (mock transfected cells at 0%). Statistical 
differences were established at ***P^0.001 versus unstrained control and at 8P<0.05 and 
8SP<0.01 versus strained control (mock transfected cells at 5%). Data are the result of 3 
sets of experiments.
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Table 4.1 Summary of findings of molecular inhibition studies. Figures represent 
percentage attenuation of cyclic strain-dependent increase in enzyme activity for both 
endopeptidases.
Gla1-G202T GI(J-6203T G^-KOZT pARK-ct
EP24.15 No
significant
inhibition
81.9±36.3 102.9 ±21.8 12.7±7.3
EP24.16 69.6±18.6 101.7±26.7 No
significant
inhibition
86.4±2.6
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4.3 Discussion
The observation in the previous chapter that exposure to cyclic strain could 
putatively up-regulate EP24.15/EP24.16 expression and activity in BAECs raised the 
issue as to which signaling pathway was involved in the transduction of this response.
A number of pathways have been implicated in the transduction of hemodynamic 
forces in the endothelium. These include ion channels, integrins, tyrosine kinases and G- 
protein coupled receptors (GPCR) (Papadaki etal., 1997). G-protein signaling represents 
a highly sophisticated molecular system with the ability to receive, integrate, and process 
information from extracellular stimului. G-protein coupled receptors (GPCRs) constitute 
a large family of single polypeptide chain receptors, with seven trans membrane a -  
helices composed primarily o f hydrophobic residues looping between the extracellular 
and intracellular phases. GPCRs couple to hetrotrimeric G-proteins, which consist of the 
a , (3, and smaller y subunits (Seifert et al, 2003). A role for G-protein involvement was 
first suggested after it was found that intracellular messengers associated with G-protein 
pathways were also activated in response to flow. These included inositol triphosphate 
(IP3), diagycerol (DAG), protein kinase C (PKC) and a rise in intracellular calcium. 
Involvement of the Giai subunits was suggested by the pertussis toxin sensitivity of shear 
induced NO release in some experiments (Poston, 2002; Ohno et a l, 1993). Later studies 
by Gudi and co-workers demonstrated the rapid activation of endothelial Gaq/au and 
Gia3/a0 proteins by shear, with activation occurring as little as one second after onset of 
flow (Gudi et a l, 1996). This group also demonstrated that treatment of endothelial cells
154
with antisense Gaq oligonucleotides inhibited shear stress-induced ras-GTPase activity, 
while scrambled oligonucleotide treatment had no effect. Further studies on G-proteins 
reconstituted on liposomes in the absence of protein receptors showed an increase in 
activity in response to shear stress (Gudi et al., 1997; Frangos et al., 1997). In addition 
co-culture studies, using both ECs and SMCs, by Redmond and co-workers demonstrated 
a shear strain induced increase in Gia 2 expression in ECs coupled with a decrease in Giai-2 
expression in SMCs (Redmond et al., 1998).
Our study focused on the effects o f both pharmacological and molecular 
inhibition o f G^-subunit and G^y-mediated signaling on the strain-induced increase in 
cellular activity of both enzymes. Pharmacological inhibitors of Gi-protein signaling 
were initially employed to investigate this role. Pertussis toxin, which catalyzes the ADP- 
ribosylation of the a-subunit in the intact heterotrimer, thereby uncoupling the G-protein 
from its receptor, and NF023, a suramin analogue which blocks GDP dissociation from 
the a-subunit, have been extensively employed by others for this purpose (Labrador et 
al., 2003; Beindl et al., 1996). Both agents were demonstrated to strongly attenuate 
strain-dependent up-regulation of activity for both endopeptidases, suggesting a role for 
Gi-protein signaling in these events. The use of pharmacological tools to delineate G- 
protein-mediated signaling events must be interpreted with caution however, as potential 
effects on Gi-protein-independent pathways cannot be ruled out.
Further inhibition studies therefore focused on selective ablation of individual Gi- 
protein subunits at the molecular level. Plasmids encoding dominant negative mutants of
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GiaUJ subunits (i.e. Gial-G202T, Gia2-G203T, and Gia3-G202T) were subsequently 
employed to selectively ablate the function of their endogenous wild type counterparts in 
BAECs (Cullen et al„ 2002). A plasmid encoding the carboxyl terminus of (3-Adrenergic 
Receptor Kinase ((3ARK.ct), a well-known Gpy-subunit scavenger (Koch et al., 1994), 
was also employed to selectively inhibit G|3y signaling pathways. Strain-dependent up- 
regulation of both endopeptidase activities was found to be strongly attenuated (80­
100%) following over-expression of Gia2-G203T. By contrast, only strain-dependent 
elevation of EP24.15 activity was inhibited by Gia3-G202T (100%), whilst EP24.16 
activity was significantly inhibited by Gial-G202T (69.6 ± 18.6%). A putative role for 
G(3y-signaling is also implicated in these events. |3ARK.ct, whilst only marginally 
blocking the strain-dependent increase in EP24.15 activity in BAECS (12.7 ± 7.3%), 
substantially blocked increase in EP24.16 activity (86.4 ± 2.6%). These findings confirm 
our earlier observations with PTX and NF023, and reinforce the involvement of multiple 
Gi-protein subunits in transduction of these strain-induced responses.
Interestingly, the differential requirements of Gi-protein subunits for the strain- 
dependent changes in either endopeptidase suggests distinct signal transduction 
pathways. The reason(s) for this divergence are presently unclear, however, significant 
differences exist between EP24.15 and EP24.16, despite their structural and functional 
similarities, which may underline this divergence. In addition to differences in their 
substrate specificities, both enzymes are separate gene products (approx. 60% homology) 
under the control of distinct promoters, with additional evidence to indicate that EP24.16 
expression is subject to alternative promoter usage, thereby enabling targeting of some
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EP24.16 to the mitochondrial compartment (Kato et al., 1997). Mechanoregulation in 
vascular endothelial cells by divergent signaling pathways has also been reported by 
other workers; Jo and co-workers demonstrated that expression o f |3ARK-ct inhibits the 
shear stress activation of HA-JNK, whereas blockade of Gai2 with the dominant negative 
mutant Gai2-G203T or antisense Gai2 prevented shear dependent activation of HA-ERK 
(Jo et al., 1997). Also significant is the ability of hemodynamic forces to regulate 
expression of vasoactive enzymes such as eNOS by divergent signaling pathways 
(Davies et al., 2001). Hemodynamic forces also modulate the expression and function of 
G-proteins themselves (Redmond et al., 1998).
In conclusion, having demonstrated that exposure of BAECs to cyclic strain up- 
regulates the mRNA levels and activity of EP24.15 and EP24.16, and increases EP24.15 
protein levels, the aim of the studies detailed in this section was to ascertain the 
mechanism by which the effects of cyclic strain on these enzymes are transduced.
It was observed that pharmacological and molecular inhibition of Gi-protein 
subunit signaling differentially attenuated the cyclic strain-dependent increase in cellular 
EP24.15 and EP24.16 activity; with the increase in EP24.15 activity displaying greater 
sensitivity to inhibition of Gia2/Gia3 signaling, while the increase in EP24.16 activity was 
significantly attenuated by inhibition of Gial/Gia2 and Gffy subunit mediated signaling.
These findings lead us to the conclusion that Gi-protein mediated signaling plays 
a significant role in the transduction of the regulatory effects of cyclic strain on both
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EP24.15/EP24.16. Moreover, different G-protein components appear to mediate the up- 
regulation of either enzyme.
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Chapter 5; Results Section 3
Examination of the Influence of Cyclic 
Strain on the Cleavage of Synthetic 
and Natural Peptide Substrates of 
EP24.15 and EP24.16 in BAECs.
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5.1 Introduction
Having demonstrated that EP24.15 and EP24.16 are regulated at the functional 
and transcriptional levels by cyclic strain putatively via a G-protein dependent pathway in 
BAECs our attention turned to the analysis of the effects of strain on the EP24.15- and 
EP24.16- mediated cleavage of exogenously added substrates. Although primarily 
cytosolic, both secreted and membrane bound forms of both enzymes have been 
identified (Crack et al., 1999; Acker et al., 1987; Ferro et al., 1999; Cotter et al., 2004). 
EP24.15, and EP24.16 specific extracellular cleavage of exogenously added substrates, 
including BK, Ang-I and QFS, has also been reported by Norman and co-workers 
(Norman etal., 2003).
Ang-I and BK are physiologically relevant peptide substrates of EP24.15 and 
EP24.16 (Cummins et al., 2004; Shrimpton et al., 2002). Both enzymes convert Ang-I to 
Ang-(l-7) and hydrolyse BK to inactive fragments (Rioli et al., 1998; Shimpton et al., 
2002). Both BK and Ang-(l-7) are considered to have an important regulatory functions 
in the vasculature, impacting on a number of vascular processes, including the 
maintenance of blood pressure (Duffy et al., 2004) and the regulation of angiogenesis 
(Machado et al., 1999; Ishihara et al., 2002),
The objective o f this section was to examine the effects o f  exposure to cyclic 
strain on the ability o f  BAECs in culture to cleave both synthetic (QFS) and natural 
peptide (BK. Ane-I) in an EP24.15IEP24.16 dependent manner.
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5.2.1 Exposure to cyclic strain increases EP24.15 and EP24.16 specific cleavage of an 
exogenously added fluorescent substrate in a time-dependent fashion in BAECs.
BAECs were exposed to cyclic strain (5%, 24 h) in the presence of an inhibitor 
cocktail containing 10 fxM Captopril/Phosphoramidon (to inhibit non-specific cleavage of 
QFS) and the fluorometric substrate (QFS) to a final concentration of 7.4 uM. cFP-AAF- 
pAB (3.4 ^M) was also used to specifically inhibit EP24.15/16. Unstrained cells were 
included as controls. Media samples were collected at 0, 3, 6, 12 and 24 hour and assayed 
for fluorescence (Fig 5.1 a, b).
Strain was seen to induce a time-dependent increase in QFS cleavage over 
unstrained controls in the time period examined (Fig. 5.1 a), with an almost two-fold 
strain-induced increase in cleavage relative to unstrained control after 24h; 20.1 ± 4.77 
pmole/nl/fxg protein for strained, versus 10.5 ± 2.45 pmole/|j.l/[Ag for unstrained cells 
(*P^0.05). This increase in cleavage was significantly attenuated (74% ,8 P<0.05) with 
the addition of cFP-AAF-pAB (Figure 5.1 b).
5.2 Results
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Figure 5.1 Exposure to cyclic strain increases EP24.15 and EP24.16 specific cleavage 
of an exogenously added fluorometric substrate, (a) BAECs were subjected to cyclic 
strain (5%, 24 h) in the presence of an inhibitor cocktail containing 10 [iM 
Captopril/Phosphoramidon (to prevent non-specific QFS cleavage) and the fluorometric 
substrate (QFS) to a final concentration of 7.4 jaM. cFP-AAF-pAB (3.4 jxM) was also 
used to specifically inhibit EP24.15/16 (b). Unstrained cells were included as controls.
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(a) Graph represents QFS hydrolysis by strained and unstrained cells over time, (b) 
Graph represents QFS hydrolysis by strained and unstrained cells at 24 h, in the presence 
and absence of cFP-AAF-pAB. Results are expressed as QFS hydrolysis (pmoles/ml/ug 
protein) ± SEM. Statistical differences were established at *P£0.05 versus unstrained 
control, significant differences were also established at APs0.05 versus strained control. 
All data are the mean of 4 independent experiments.
IfcS
5.2.2 HPLC analysis of BK and Ang-I concentration
The levels of BK and Ang-I in experimental samples were routinely determined 
by reverse phase HPLC using a method adapted from Norman and co-workers (Norman 
el ciL, 2003). Typical chromatograms for BK and Ang-1 are shown in Fig 5.2 a. and Fig
5 .2  b respectively. The peak for BK typically eluted at 22-23 min, while that for Ang-I 
typically eluted at 16-17 mi».
The concentrations of BK and Ang-1 in experimental samples was calculated with 
use of previously prepared standard curves of peak area versus concentration. The 
standard curves for BK (F ig  5 .2  c) and Ang-I (F ig  5.2 d) are shown.
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B K  C d n e c i i ln i l in u  ( jiM ) A n jj 't  C o n c c n lra lin n  | | tM )
F igure 5.2 H P L C  a n a ly s i s  o f  B K  an d  A n g -I  c o n c e n t r a t io n .  BK and Ang-1 
concentration was routinely determined in experimental samples by the use of reversed 
phase HPLC with appropriate standards, (a, b) representative chromatograms for BK and 
Ang-I (100 ,uM). BK/Ang-I elution peaks are clearly labeled. Data are expressed at 
Absorbance Units (AU) versus retention time (min). (c, d) HPLC standard curves for BK 
and Ang-I for the concentration range 0-100 uM. Data are expressed as Peak Area versus 
Concentration (|iM).
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5.2.3 TVansfection with the antisense FLIP significantly reduces EP24.15 mRNA 
expression and cellular protein levels in BAECs.
BAECs were transfected with an antisense construct (EP24.15-FLIP) targeted to 
the promoter region of EP24.15 and either stained immunocytochemically using EP24.15 
specific antisera or harvested for RNA and analysed for EP24.15 mRNA levels using 
Real-Time PCR with EP24.15-specific primers.
The effect of Flip-ci transfection on EP24.15 protein and mRNA levels in BAECs 
is clearly displayed in Fig 5.4 a, b. The reduction in protein levels is demonstrated 
immunocytochemically in Fig 5.4 a; both cytoplasmic and nuclear staining decreases 
significantly from mock transfected control cells to FLIP transfected cells. This 
attenuation is also evident at the mRNA level; transfection with FLIP was seen to 
significantly reduce the levels of EP24.15 mRNA (>65% attenuation, *Ps0.05) (Fig 5.4 
b), while no significant reduction of EP24.16 mRNA levels was observed (Fig 5.4 c).
The molecular inhibition of both EP24.15 and EP24.16 was also attempted using siRNA 
(Fig 5.3 a, b) (see section 2.6). However none of the siRNA duplexes designed were seen 
to in h ib it  E P 2 4 .1 5  or E P 2 4 .1 6  m R N A  ex p ress io n  s ig n ifican tly
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Figure 5.3 Transfection with siRNA targeted to EP24.15 and EP24.16 fails to 
significantly reduce mRNA levels for either enzyme in BAECs. BAECs were 
transfected with either EP24.16, EP24.15 I, EP24.15 II, siRNA duplexes or a scrambled 
(control) sequence. 24 h post-transfection cells were harvested for mRNA, and 
EP24.15/EP24.16 mRNA levels subsequently determined using Real-Time with EP24.15 
and EP24.16 specific primers, (a) Graph represents fold change in EP24.16 mRNA levels 
relative to scrambled transfected control in BAECs transfected with siRNA targeted to 
EP24.16. (b) Graph represents fold change in EP24.15 mRNA levels relative to 
scrambled transfected control in BAECs transfected with two different siRNA s targeted
1.2
(b)
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to EP24.15, EP24.15 I and EP24.15 II. All data are expressed as the mean of two 
independent experiments ± SEM.
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Figure 5.4 Transfection with the antisense FLIP significantly reduces EP24.15 
mRNA expression and cellular protein levels in BAECs. BAECs were transfected with 
a specific antisense construct (EP24.15 FLIP)targeted to the promoter region of EP24.15, 
and allowed to recover for 48 h before being immunocytochemically stained for EP24.15. 
Post recovery, BAECs were also harvested for RNA and EP24.15 mRNA levels 
determined using Real-Time PCR with EP24.15 specific primers, (a) Representative 
fluorescent micrographs (lOOOx) of mock and FLIP transfected BAECs stained with
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rabbit anti-EP24.15 primary antibody and goat-anli-rabbit Alexafluor488 conjugated 
secondary antibody, and the nuclear specific DAPI stain. Areas of staining are indicated 
with red arrows. Pictures of secondary only control for non specific staining are also 
included (b) Real-Time PCR data showing EP24.15 mRNA levels in both mock and FLIP 
transfected cells, (c) Real-Time PCR data showing EP24.16 levels in both mock and 
FLIP transfected cells. Data is expressed as fold change relative to mock-transfected 
controls. Significance was established at *P<0.05 versus mock transfected control. Data 
represent the mean of two experiments ± SEM.
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After exposure of BAECs to cyclic strain (5%, 24 h) in the presence and absence 
of cFP-AAF-pAB and also in the presence of an inhibitor cocktail containing 10 
Captopril/Phosphoramidon/Bestatin, to prevent non-specific peptide hydrolysis, media 
samples were collected and monitored for hydrolysis of exogenously added BK and Ang- 
I by HPLC.
Cyclic strain (5%, 24 h) was observed to significantly increase hydrolysis of 
exogenously added BK in BAECs by 2.22 ± 0 .1  fold relative to control (*Pf£0.05, n=3). 
This strain-depepndant increase in BK degradation was significantly attenuated by 
addition of CFP-AAF-pAB (>100%, CTP<0.05). Addition of cFP-AAF-pAB, did not 
however significantly alter the levels of BK hydrolysis in unstrained BAECs (Fig 5.5 a).
Cleavage of exogenously added Ang-I in BAECs was also significantly up- 
regulated by exposure to cyclic strain (5%, 24 h), 1.45 ± 0.09 fold relative to control 
(*P=s0.05, n=3). As was the case with BK, this strain-depepndant increase in Ang-I 
degradation was significantly attenuated by addition of cFP-AAF-pAB (>90%, “P s0.05). 
cFP-AAF-pAB was also seen to reduce the levels of Ang-I hydrolysis by unstrained cells 
by 35 ± 10.6% (*Pfs0.05, n=3) (Fig 5.5 b).
5.2.4 Exposure to Cyclic Strain Increases EP24.15/EP24.16-specific Degradation of
Exogenously Added BK and Ang-I -Inhibition by cFP-AAF-pAB
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Figure 5.5 Exposure to cyclic strain increases EP24.15/EP24.16 specific degradation 
of exogenously added BK and Ang-I. BAECs were subjected to cyclic strain (5%, 24 h) 
in th e  p re se n c e  o f an in h ib ito r  c o c k ta il c o n ta in in g  10 |iM  
Captopril/Phosphoramidon/Bestatin, to prevent non specific peptide hydrolysis and either 
BK (100 nM) or Ang-I (100 fxM). cFP-AAF-pAB (3.4 jxM) was used to specifically 
inhibit EP24.15/16. Unstrained cells were included as controls. After treatment media 
samples were analysed for BK and Ang-I concentration using HPLC with appropriate BK 
and Ang-I standards, (a) Cyclic strain induced increase in EP24.15/EP24.16 specific
1 7 2
degradation o f BK. (b) Cyclic strain induced increase in EP24.15/EP24.16 specific 
degradation of Ang-I. All data are expressed as fold change in peptide degradation 
relative to unstrained control. Statistical differences were established at *P<(.).05 versus 
unstrained control. Significant differences were also established at 0.05 versus 
strained control. All data are the mean of 3 independent experiments ± SEM.
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After exposure of BAECs to cyclic strain (5%, 24 h) after either prior transfection 
with FLIP or mock transfection, and also in the presence of an inhibitor cocktail 
containing 10 (xM Captopril/Phosphoramidon/Bestatin, to prevent non-specific peptide 
hydrolysis, media samples were collected and monitored for hydrolysis of exogenously 
added BK and Ang-I by reverse phase HPLC.
Cyclic strain (5%, 24 h) was observed to significantly increase hydrolysis of 
exogenously added BK in BAECs by 1.73 ± 0.02 fold relative to control (*Ps0.05, n=3). 
This strain-depepndant increase in BK degradation was significantly attenuated by prior 
transfection with FLIP (>100%, °P<0.05). Prior transfection with FLIP, did not however 
significantly alter the levels of BK hydrolysis in unstrained BAECs (Fig 5.6 a).
Cleavage of exogenously added Ang-I in BAECs was also seen to be significantly 
up-regulated by exposure to cyclic strain (5%, 24 h), 1.49 ± 0.02 fold relative to control 
(*P<0.05, n=3). As was the case with BK, this strain-dependent increase in Ang-I 
degradation was significantly attenuated by prior transfection with FLIP (>100%, 
aP=s0.05). Prior transfection with FLIP was also seen to reduce the levels of Ang-I 
hydrolysis by unstrained cells by 45±15% (*P«0.05, n=3) (Fig 5.6 b).
5.2.5 Exposure to cyclic strain increases EP24.15-specific Degradation of
Exogenously Added BK and Ang-I -Inhibition by FLIP
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Figure 5.6 Exposure to cyclic strain increases EP24.15 specific degradation of 
exogenously added BK and Ang-I. BAECs were subjected to cyclic strain (5%, 24 h) in 
the  p re se n c e  o f  an in h ib ito r  c o c k ta il  c o n ta in in g  10 |x M 
Captopril/Phosphoramidon/Bestatin, to prevent non specific peptide hydrolysis and either 
BK (100 [aM) or Ang-I (100 pM). Prior tranfection with FLIP was used to specifically 
inhibit EP24.15. Unstrained cells were included as controls. After treatment media 
samples were analysed for BK and Ang-I concentration using HPLC with appropriate BK 
and Ang-I standards, (a) Cyclic strain induced increase in EP24.15 specific degradation 
of BK. (b) Cyclic strain induced increase in EP24.15 specific degradation of Ang-I. All 
data are expressed as fold change in peptide degradation relative to unstrained control.
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Statistical differences were established at *P<0.05 versus unstrained control. Significant 
differences were also established at 5P<0.05 versus strained control. All data are the mean 
of 3 independent experiments ± SEM.
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5.3 Discussion
The demonstration in previous chapters that both EP24.15 and EP24.16 cellular 
and secreted activity is up-regulated by cyclic strain combined with the observed increase 
in both cellular and membrane-associated EP24.15 immunostaining after exposure of 
BAECs to strain led us to examine the potential effects of cyclic strain on the 
extracellular hydrolysis of exogenously added substrates by BAECs in culture.
Both the synthetic substrate, QFS, and the natural peptides BK and Ang-I were 
employed. Both BK and Ang-I are important regulators of vascular function. BK is 
inactivated by EP24.15/EP24.16, resulting in the specific peptide fragments BK-(l-5) and 
BK-(6-9). Ang-I is also cleaved by both endopeptidases to produce the vasoactive peptide 
Ang-(l-7) (Chappell et al., 1998), which numerous studies have shown to have opposing 
actions to Ang-II, the main product of Ang-I hydrolysis by ACE (Chappell et al., 1998; 
Rioli, et al., 1998; Machado et al., 1999; Shimpton et al., 2003).
The effects of strain on endopeptidase-specific cleavage of QFS were examined 
over a 24 h period. cFP-AAF-pAB was used to specifically inhibit activity of both 
endopeptidases. Inhibitors specific to other related peptidases were also included to 
prevent non-specific QFS cleavage. In unstrained cells, QFS cleavage increased over the 
24 h period, while cFP-AAF-pAB significantly attenuated any cleavage, indicating strong 
involvement of EP24.15/EP24.16. This finding was in agreement with the observations 
by Norman and co-workers who observed that under basal conditions Ea.hy926 cells
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could cleave exogenously added QFS in an EP24.15/EP24.16 specific manner (Norman 
et al., 2003). Exposure to cyclic strain was seen to significantly increase the levels of 
QFS cleavage relative to unstrained cells, while the ability of cFP-AAF-pAB to 
significantly decrease cleavage indicated that the observed QFS cleavage was 
EP24.15/EP24.16 mediated. Thus it appears that cyclic strain can putatively alter the 
ability of EP24.15/EP24.16 to cleave exogenous synthetic peptide.
We next decided to extend these investigations by determining the effects of strain 
on the ability of EP24.15/EP24.16 to hydrolyse exogenously added natural substrates BK 
and Ang-I. BAECs were strained for 24 h in the presence of either peptide with the 
inclusion of inhibitors appropriate to prevent non-specific cleavage of these peptides. 
cFP-AAF-pAB was included to specifically inhibit both EP24.15 and EP24.16, while 
prior transfection with FLIP, an antisense construct specifically targeted to the EP24.15 
promoter, was used to selectively inhibit EP24.15.
A significant increase in the hydrolysis of both exogenously added BK and Ang-I 
was observed in response to BAEC exposure to cyclic strain. Treatment with cFP-AAF- 
pAB, and prior transfection with EP24.15 specific FLIP, reduced these strain-dependent 
increases in cleavage to basal levels in the case of BK, and to below basal levels in the 
case of Ang-I. This would appear to indicate that the increase in BK and Ang-I hydrolysis 
observed in response to strain is most likely due to the increase in EP24.15 expression 
and activity. It was also observed that both cFP-AAF-pAB and EP24.15 knockout with 
FLIP significantly reduced the amount of Ang-I cleavage by unstrained BAECs.
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However no similar reduction in levels of BK cleavage in unstrained cells was observed 
following EP24.15/EP24.16 inhibition. This may potentially be due to the relative affinity 
of the extracellular forms of both endopeptidases for BK and Ang-I. It has been 
previously demonstrated by Rioli and co-workers that recombinant forms of rat EP24.15 
and porcine EP24.16 display a greater affinity for BK than Ang-I (Rioli et al., 1998); 
however in the whole cell assay format employed by our study it may be that the relative 
affinities of the bovine endothelial forms both endopeptidases for BK and Ang-I differ 
significantly from those previously described
The complete attenuation of these increases by FLIP suggested, that despite the 
broadly similar levels of cellular and secreted activity of EP24.15 and EP24.16, the 
attenuation observed with cFP-AAF-PAB was largely due to the inhibition of EP24.15 
rather than EP24.16. It is possible however that in the experimental paradigm employed, 
(i.e. living whole cell studies versus studies with harvested cellular proteins), that cFP- 
AAF-PAB inhibits only EP24.15. cFP-AAF-pAB was initially developed as an EP24.15 
specific inibibitor, but was later shown to inhibit EP24.16, albeit at a higher 
concentration. (Orlowski et al., 1988; Shimpton et a l, 2002). It has since been shown to 
be unstable in vivo (Telford et al., 1995) and has been superceded by its more stable 
analogue, JA2, which has been successfully employed as an inhibitor of both enzymes in 
whole cell cleavage assays (Shimpton, et al., 2002; Norman et al., 2003). Although 
attempts were made to inhibit EP24.16 expression using siRNA transfection, no 
significicant reduction in EP24.16 mRNA levels were observed. This may be due to the 
fact that because the bovine EP24.16 sequence is unpublished it was necessary to design
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this siRNA by looking for regions of consensus between the, rat, mouse and human 
EP24.16 gene. Also, pharamcological inhibitors for this enzyme proved commercially 
unavailable. Moveover their synthesis was beyond the scope and resources of this project. 
In the absense of a method of specifically inhibiting either EP24.16 expression or activity 
it is impossible to completely ascertain its precise contribution to the strain-induced 
peptide cleavage events observed. Also, although we were able to demonstrate an 
apparent increase in extracellular membrane association of EP24.15 in response to cyclic 
strain, the lack of availability of a suitable antisera against EP24.16 meant we were 
unable to ascertain if the basal levels of extracellular membrane-bound EP24.16 (if any) 
increase in response to cyclic strain. It is wholly possible that this ability to associate with 
the extracellular plasma membrane affects the ability of the endopeptidase to cleave 
peptide substrates extracellularly. It remains to be determined, however, if this is a 
significant factor in these events.
The apparent involvement of EP24.15 in strain-mediated BK and Ang-I 
hydrolysis is in contrast somewhat with the observation by Norman and co workers that 
EP24.15 plays a minor role in the extracellular processing of BK relative to that of 
EP24.16 (Norman et al., 2003). However this disparity in the findings may be explained 
in part at by the different cell types employed, and the fact that the latter study employed 
only basal “unstimulated” conditions.
In conclusion, having demonstrated that the secreted activity of both EP24.15 and 
EP24.16, and the degree of extracellular membrane association of EP24.15 increases in
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response to exposure cyclic strain in BAECs, the effects o f  cyclic strain on the ability o f  
the two enzymes to cleave exogenous substrates in BAECs in culture was investigated. It 
was clearly demonstrated that cyclic strain induced significant increases in the cleavage 
o f  QFS. BK, and Ang-I, increases that could be attenuated by both cFP-AAF-pAB, in the 
case of all three, and prior transfection with FLIP, in the case o f  the natural substrates BK 
and Ang-I. T hese  observations lead us to conclude that exposure o f  BAECs to chronic 
cyclic strain putatively leads to an increase in cleavage o f  exogenously  added substrates 
in an EP24.15-specific manner.
1X1
Chapter 6; Results Section 4 
Examination of the Functional Impact of 
Cyclic Strain-Mediated Modulation of 
EP24.15/EP24.16 Specific Peptide 
Cleavage in BAECs.
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6.1 Introduction
Having investigated the putative effect of cyclic strain on the ability of EP24.15 to 
hydrolyse extracellular BK and Ang-I in BAECs it was a logical progression to study the 
potential phenotypic and functional effects of this phenomenon in BAECs. In this regard, 
we investigated the involvement of EP24.15 and EP24.16 in two important angiogenic 
processes, namely endothelial cell migration and tubule formation.
The main product of EP24.15/EP24.16 mediated cleavage of Ang-I is Ang-(l-7) 
(Chappell et al., 1998), which has been demonstrated to influence angiogenic events in an 
opposing manner to Ang-II (Machado et al., 1999). Ang-II has frequently been associated 
with the regulation of angiogenesis both in vitro and in vivo (Munzemaier et al., 1996; 
Desideri et al., 2003), although its exact role remains unclear. BK, which is cleaved to 
B K -(l-5) and BK-(6-9) by both EP24.15/EP24.16, has also been shown to have a 
significant pro-angiogenic role, both in vivo and in vitro. However, unlike the products of 
Ang-I cleavage, the cleavage products of BK are generally considered to be functionless 
with regard to the regulation of angiogenesis (Hu, et al., 1993; Ishihara, et al., 2002).
The hypothesis exam ined in this chapter is that cyclic strain influences 
endothelial cell phenotype (and potentially function) in BAECs via endopeptidase- 
mediated cleavage o f  peptide natural substrates such as BK  and Ane-I.
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6.2.1 Inhibition of EP24.15 attenuates cyclic strain induced tube formation in 
BAECs.
6.2 Results
BAEC tubule formation was measured using a collagen gel matrix assay as 
previously described. Following exposure to cyclic strain (5%, 24 h), either in the 
presence or absence of cFP-AAF-pAB or after prior transfection with the EP24.15 
antisense FLIP, BAECs were harvested and plated onto collagen and incubated for 24 h. 
Tube formation was subsequently recorded and quantified by digital image capture and 
NIH image analysis.
It was observed that BAECs exhibit a significant strain-induced increase in tubule 
formation (1.97 ± 0.18 fold relative to unstrained control, **Ps0.01). Treatment of cells 
during straining with the EP24.15/EP24. L6 specific inhibitor cFP-AAF-pAB led to a 
significant attenuation of strain-induced tube formation (>80%, °P<0.05) (Fig 6.1 a, 6.2). 
Prior transfection with the EP24.15 specific antisense FLIP was also seen to significantly 
attenuate the strain dependent increase in tube formation (>80%, OCTPs0.01) (Fig 6.1 b,
6.2). Neither inhibition strategy induced any significant changes on the basal levels of 
tube formation (Fig 6.1, 6.2).
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Figure 6.1 Inhibition of EP24.15 attenuates cyclic strain induced tube formation in 
BAECs. Cells were exposed to cyclic strain (5%, 24 h) either in the presence or absence 
of the EP24.15/EP24.16 specific inhibitor cFP-AAF-pAB (3.4 [xM) or following 
transfection with the EP24.15 specific antisense FLIP. Unstrained plates were included as 
controls. Following exposure to strain cells were harvested, plated onto collagen 
matrixes, and incubated for 24 h before being analysed using digital image capture and 
NIH image analysis. Representative pictures are shown for cFP-AAF-pAB and FLIP 
treated cells (a, b),
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Figure 6.2 Inhibition of EP24.15 attenuates cyclic strain induced tube formation in 
BAECs. Cells were exposed to cyclic strain (5%, 24 h) either in the presence or absence 
of the EP24.15/EP24.16 specific inhibitor cFP-AAF-pAB (3.4 ^iM) or following 
transfection with the EP24.15 specific antisense FLIP. Unstrained plates were included as 
controls. Following exposure to strain cells were harvested, plated onto collagen 
matrixes, and incubated for 24 h before being analysed using digital image capture and 
NIH image analysis. Graph represents fold changes in BAEC tubule length relative to 
unstrained control. Data are expressed as the mean of thee independent experiments ± 
SEM. Statistical differences were established at **P£0.01 relative to unstrained, 
untreated control, and significant differences established at 8SP<0.01 and8Ps0.05 relative 
to strained, untreated control.
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6.2.2 Inhibition of EP24.15 attenuates cyclic strain induced migration in BAECs.
BAEC migration was measured using a wound-healing (scratch) assay as 
described previously Following exposure to cyclic strain (5%, 24 h), either in the 
presence or absence of cFP-AAF-pAB or after prior transfection with the EP24.15 
antisense FLIP, BAECs were harvested and plated into 24-well plates, allowed to adhere 
for 12 h and then scratched. BAEC migration was subsequently recorded and quantified 
by digital image capture and NIH image analysis.
In response to exposure to cyclic strain BAEC migration increased by 1.58 ± 0.09 
fold relative to unstrained control (***Ps0.005). Treatment of BAECs with the 
EP24.15/EP24.16 specific inhibitor, cFP-AAF-pAB, led to a significant attenuation of the 
strain induced increase in migration ('T’eO.Ol), as well as inducing a smaller (>10%) 
decrease in the baseline levels of migration (Fig. 6.3 a, 6.4). Prior transfection of BAECs 
with FLIP completely attenuated the strain-induced increase in migration. However this 
attenuation, though total, was not deemed to be statistically significant (P=0.08) (Fig. 6.3 
b, 6.4).
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Figure 6.3 . In h ib it io n  o f  E P 2 4 .1 5  a t te n u a te s  c y c l ic  s tr a in  in d u c e d  m ig r a t io n  in 
B A E C s. Cells were exposed to cyclic strain (5%, 24 h) either in the presence or absence 
of the EP24.15/EP24.16 specific inhibitor cFP-AAF-pAB (3.4 ¡o.M) or following 
transfection with the EP24.15 specific antisence FLIP. Following exposure to strain cells 
were harvested, plated onto 24 well plates, incubated for 12 h and then scratched. The 
scratch was photographed immediately (t=0) and after 4 h incubation. Photographs were 
analysed using NIH image software, with the degree of migration judged to be the extent 
of reduction of the width of the scratch. Representative pictures are shown for cFP-AAF- 
pAB and FLIP treated cells (a , b).
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Figure 6.4. Inhibition of EP24.15 attenuates cyclic strain induced migration in 
BAECs. Cells were exposed to cyclic strain (5%, 24 h) either in the presence or absence 
of the EP24.15/EP24.16 specific inhibitor cFP-AAF-pAB (3.4 ¡xM) or following 
transfection with the EP24.15 specific antisence FLIP. Following exposure to strain cells 
were harvested, plated onto 24 well plates, incubated for 12 h and then scratched. The 
scratch was photographed immediately(t=0) and after 4 h incubation. Photographs were 
analysed using NIH image software, with the degree of migration judged to be the extent 
of reduction of the width of the scratch. Graph represents fold changes in BAEC 
migration. Data are expressed as the mean of thee independent experiments ± SEM. 
Statistical differences were established at ***P=s0.005 and *P<;0.05 relative to unstrained 
control and significant differences established at “ PsO.Ol relative to strained control.
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6.2.3 Incubation of BAECs with A ng-(l-7) and BK increases endothelial tubule 
formation.
B AECs were incubated for 24h in the presence of B K -(l-5 ) ,  Ang-II and Ang-(1- 
7) (10 ¡.iM). U ntreated  cells were included as controls . P ost- incubation  cells were 
harvested and assayed for tube formation as previously described.
B K -(l-5 )  had no significant effect on B A EC tubule formation. In contrast Ang- 
(1-7) and, the product o f  cleavage o f  Ang-I by EP24 .15 /E P24 .16, and BK to significantly 
increased B A EC tubule formation (1.63 + 0.61 fold and 1.49 ±  0,64 fold respectively 
relative to untreated control, ** /Js 0 .0 l ) .  In contrast incubation of the cells with Ang-II, 
was seen to induce a small but significant decrease in B A EC tubule formation (Fig 6.5 a, 
b).
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Figure 6.5. Effects of the addition of various vasoactive peptides on BAEC tube 
formation. BAECs were incubated for 24 h with either BK, BK-(l-5), Ang-I, Ang-II or 
A ng-(l-7 ) (10 fiM ), w ith an in an inhibitor cocktail containing 10 piM 
captopril/phosphoramidon/ bestatin and 3.4 uM cFP-AAF-pAB added to prevent peptide 
degradation. Untreated cells were also included as controls. Following treatment cells 
were harvested, plated onto collagen matrixes, and incubated for 24 h before being 
photographed. Representative photographs are shown in (a), with examples of significant
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tube formation indicated by arrows. Tubule length was determ ined using NIH image 
software. Graph, (b) represents fold change in tubule formation relative to untreated 
control. Data are expressed as the mean o f  thee independent experim ents  ±  SEM. 
Statistical differences were es tab lished  at * * * P s 0 .0 0 5  and * * / , s0 .01  and * P * 0.05 
relative to untreated control.
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6.2.4 Addition of A ng-(l-7), but not Ang-II, reverses the attenuation of strain 
induced tubule formation in BAECs by EP24.15 inhibition.
Having monitored the effect of addition of Ang-II and A ng-(l-7) on tubule 
formation in static BAECs, it was decided to investigate what effects, if any, these 
peptides had on the blockade of the strain-dependent increase in tube formation following 
EP24.15 inhibition by transfection with the antisense EP24.15-Flip. Addition of BK was 
not considered for this study as, although its addition significantly increases levels of 
BAEC tubule formation, it is cleaved and inactivated by EP24.15. BK-(l-5) and Ang-1 
were also ommitted from this study as they were shown to exert no influence on tubule 
formation in BAECs.
Briefly cells were subjected to strain (5%, 24 h) in the presence of either Ang-II 
or A ng-(l-7) (10 fxM). An inhibitor cocktail of bestatin/captopril/phosphoramidon (10 
uM) was also included to prevent non-specific peptide hydrolysis. Prior transfection with 
the antisense FLIP was used to inhibit EP24.15 expression. Untreated and unstrained 
plates were included as controls. After straining the cells were harvested are assayed for 
tubule formation as previously described.
In all experiments a somewhat lower than normal strain-induced increase in 
tubule formation was observed in untreated, mock transfected BAECs (1.51 ± 0.69 fold 
increase relative to control versus 1.98 ±0.18 fold increase in previous experiments, Fig
6.2). This was most likely due to the effect of the blockade of ACE, ECE, NEP and
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arainopeptidases (necessary to prevent unwanted peptide degradation) on basal 
vasoactive peptide processing. However in all experiments prior transfection of FLIP was 
seen, as before, to significantly attenuate strain induced tubule formation (>80% 
attenuation, SP>0.05).
In mock transfected BAECs the addition of Ang-II was seen to attenuate the strain 
dependent increase in tubule formation (>70% attenuation), while only marginally 
decreasing levels of tubule formation in unstrained cells. In the case of BAECs 
transfected with FLIP the addition of Ang-II neither significantly altered the levels of 
tubule formation in unstrained cells nor had any significant effect on the attenuation of 
the strain dependent increase in tubule formation resulting from FLIP transfection (Fig. 
6.6 b). By contrast the addition of Ang-(l-7) induced a significant increase in levels of 
tubule formation in unstrained mock and FLIP transfected BAECs (1.42 ± 0.1 fold and
1.34 ± 0.14 fold respectively relative to control, * /)<0.05) (Fig 6.7). In cells exposed to 
strain addition of Ang-(l-7) did not significantly alter levels of tubule formation in mock 
transfected cells but induced an increase in tubule formation in FLIP transfected BAECs 
(1.63 ± 0.03 fold versus 1.09 ± 0.04 fold relative to unstrained control *** P<0.005).
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Figure 6.6. Ang-II addition does not reverse the reduction in cyclic strain induced 
tube formation resulting from EP24.15 inhibition. Cells were exposed to cyclic strain 
(5%, 24 h) following transfection with the EP24.15 specific antisense FLIP, and in the 
presence of 10 |xM Ang-II (and an inhibitor cocktail containing 10 ¡,iM 
phosphoramidon/captopril/bestatin to prevent non specific peptide degradation). 
Following exposure to strain cells were harvested, plated onto collagen matrices, and 
incubated for 24 h before being analysed using digital image capture and NIH image
195
analysis. Representative pictures are shown in (a), with arrows indicating examples o f  
B A EC tubule formation. Graph (b) represents fold change in BAEC tubule formation. 
Data are expressed as the mean o f  thee experiments ± SEM. Statistical differences were 
established at * P a 0.05 relative to unstrained control and at “ PsO.OI relative to strained 
control.
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Figure 6.7 Addition of Ang-(l-7) reverses the reduction in cyclic strain induced tube 
formation resulting from EP24.15 inhibition. Cells were exposed to cyclic strain (5%, 
24 h) following transfection with the EP24.15 specific antisense FLIP, and in the 
presence of 10 uM Ang-II (and an inhibitor cocktail containing 10 liM phosphoramidon/ 
captopril/ bestatin to prevent non-specific peptide degradation). Following exposure to 
strain cells were harvested, plated onto collagen matrices, and incubated for 24 h before 
being analysed using digital image capture and NIH image analysis. Representative
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pictures are shown in (a), with arrows indicating exam ples o f  BAEC tubule formation. 
G raph  (b) represents  fold change  in B A EC tubule form ation relative to unstrained 
contro l.  Data are ex p ressed  as the m ean o f  thee expe rim en ts  ± SEM . Statistical 
differences were established at 0.05, and **’i:P<0.005 relative to unstrained control 
and significant differences established at **Ps0.01 relative to strained control.
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6.3 Discussion
Vasoactive peptides such as Ang-II, Ang-(l-7) and BK have been well characterized as 
modulators of a wide variety of vascular processes, including the control of blood 
pressure by invoking vasodilation/vasoconstriction and also in the regulation of new 
vessel formation (Duffy et al., 2004; Chappell et al., 2000). Our observation that the 
exposure of BAECs to cyclic strain leads to an apparent increase in the EP24.15 specific 
cleavage of exogenous BK and Ang-I led us to examine the possible implications this 
phenomenon may have on endothelial cell function.
Angiogenesis, the formation of new vessels, is a complex process initiated at the 
level of the endothelium. Endothelial cells “sprout” forming tubules into the extracellular 
matrix which grow to form capillary-like structures both though endothelial cell 
migration and proliferation. In the final stages, smooth muscle cells adhere to the newly 
forming vessel (Quarmbry et al., 2002).
Exposure to hemodynamic forces has been previously shown to increase both 
endothelial cell migration and tubule formation in vitro (Hsu et al., 2001; Von Offenberg- 
Sweeney et al., 2005). Our baseline findings of the effects of cyclic strain on migration 
and tube formation in BAECs reflect the findings of others, with chronic exposure to 
cyclic strain inducing a significant increase in migration and tube formation, as measured 
by a wound healing (scratch) assay and collagen matrix tube formation assay respectively 
(see Fig 6.1/ 6.2/6.3/6.4).
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Both the dual endopeptidase inhibitor, cFP-AAF-pAB, and the specific antisense 
construct targeted to the EP24.15 promoter, FLIP, were used to delineate the contribution, 
if any, of these enzymes to the observed increase in endothelial cell migration and tubule 
formation in response to strain.
Both cFP-AAF-pAB and FLIP attenuated strain-induced increases in both tubule 
formation and migration to near baseline levels. (The attenuation of strain-induced BAEC 
migration by FLIP, although total, was deemed to be statistically insignificant). The 
complete attenuation of these increases by FLIP suggested that, despite the broadly 
similar levels of cellular and secreted activity of EP24.15 and EP24.16, the attenuation 
observed in migration and tubule formation with cFP-AAF-pAB was largely due to the 
inhibition of EP24.15 rather than EP24.16. However it may be that in the experimental 
paradigm employed, (i.e. living whole cell studies versus studies with harvested cellular 
proteins), that cFP-AAY-pAB inhibits only EP24.15 to a significant degree. As previously 
discussed (section 5.4), although cFP-AAF-pAB can inhibit both enzymes, its inhibitory 
concentration is significantly higher for EP24.16 (Kj [EP24.15]= 19nM, K| [EP24.16] = 
700 nM (Dauch et al., 1991)). Cytosolic EP24.15 and EP24.16 also have been shown to 
display different affinities for a range of natural peptide substrates (Rioli et al. 1998), and 
it may be possible that secreted or extracellularly bound EP24.16 and EP24.16 display 
significantly different substrate affinities (with regard to Km and Kcat) for the test 
peptide substrates. Although attempts were made to inhibit EP24.16 expression using 
siRNA transfection, no significant reduction in EP24.16 mRNA levels were observed. In 
the absense of a method of specifically inhibiting either EP24.16 expression or activity it
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is impossible to completely ascertain its precise contribution to the strain-induced cell 
fate events observed.
Having shown that transfection with antisense FLIP significantly and specifically 
reduces EP24.15 mRNA and protein levels, and that FLIP significantly inhibits the 
increase in tubule formation and migration in response to cyclic strain, it appeal’s that 
EP24.15 plays an important role in strain-induced endothelial cell fate decisions.
Our previous observation of a strain-dependent increase in the cleavage of 
exogenously added BK and Ang-I by EP24.15 in BAECs (Fig. 5.5, 5.6) led us to 
hypothesize that EP24.15 may be exerting its effects on strain-induced BAEC migration 
and tubule formation though its cleavage of vasoactive peptides. EP24.15 cleaves Ang-I 
to produce A ng-(l-7), which has been demonstrated to have a number of important 
functions in the vasculature, often acting in opposition to the effects associated with Ang-
II, the product of cleavage of Ang-I by angiotensin converting enzyme (ACE) (Shimpton 
et al., 2002; Chappell et al., 2000; Fetterik et al., 2000). Machado and co-workers have 
demonstrated that Ang-II had a pro-angiogenic effect in vivo, while Ang-(l-7) reduced 
angiogenesis. Other studies have demonstrated that Ang-(l-7) induces the release of NO, 
which is known both to promote angiogenesis and to inhibit ACE activity (Machado et 
al., 1999; Fetterik, et al., 2000; Ackermann et al., 1998). The exact role of Ang-II in 
regulation of angiogenesis also remains unclear, with many studies indicating that it has a 
negative effect on angiogenic processes (Silvestre et al., 2001, Desideri et al., 2003). In 
contrast, BK, which is generally considered to be inactivated by cleavage by EP24.15,
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has a definite pro-angiogenic effect, inducing the release of pro-angiogenic NO (Ishihara, 
et al., 2002; Duffy et al., 2004).
Consequently, we examined the effects of addition of the products of Ang-I and 
BK cleavage by EP24.15 on the basal levels of tubule formation in BAECs. Cells were 
treated with Ang-I, Ang-(l-7), BK and BK-(l-5). Ang-II, the product of Ang-I cleavage 
by ACE, was also included.
A ng-(l-7) and BK were seen to significantly increase the levels of tubule 
formation in BAECs, while Ang-II induced a small but statistically significant drop in the 
levels of tubule formation relative to untreated control. BK -(l-5) however induced no 
significant change in the levels of tubule formation. These findings suggested a putative 
means by which the strain induced increase in EP24.15 activity and tubule 
formation/migration may be linked. Increased EP24.15 activity would not only lead to an 
increase in the levels of Ang-(l-7), but would also reduce the amount of Ang-I available 
for conversion to Ang-II by ACE, with the net effect of promoting angiogenesis. The 
reduction of ACE expression in the endothelium by hemodynamic forces has previously 
been demonstrated (Reider et al., 1997), while a co-worker has demonstrated that shear 
stress reduces the levels of ACE mRNA in BAECs (Fitzpatrick et al., 2005). These 
observations support this hypothesis; as reduced ACE activity would not only reduce 
Ang-II levels but would also reduce ACE-mediated degradation of Ang-(l-7). Given that 
BK is degraded by EP24.15, it was judged that, although it stimulated tubule formation, it
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played no significant role in the EP24.15-dependent increase in tubule formation 
observed in response to cyclic strain.
The possibility that EP24.15 derived A ng-(l-7) was responsible for the strain- 
induced increase in BAEC tube formation was further investigated by determining the 
effects of Ang-(l-7) addition to both FLIP- and mock-transfected cells exposed to cyclic 
strain. The effects of Ang-II addition were also investigated. Addition of Ang-(l-7), 
while increasing basal levels of tubule formation in both FLIP-transfected and mock- 
transfected cells did not significantly alter tubule formation in strained, mock-transfected 
cells. In contrast, addition of Ang-II actually attenuated the strain-induced increase in 
tubule formation. Moreover, in FLIP-transfected cells Ang-(l-7) reversed the effects of 
EP24.15 blockade on the strain-induced increase in tubule formation, again in contrast to 
Ang-II. These findings were in line with our hypothesis that EP24.15 influences 
endothelial tubule formation both directly though the production of Ang-(l-7), and 
indirectly though reduction in availability of Ang-I for conversion to Ang-II by ACE. As 
previously discussed, the possibility that ACE activity, and therefore Ang-II production, 
might be decreased in response to cyclic strain leading to an increase in available Ang-I, 
suggests that tubule formation (and other endothelial cell fate decisions) may be 
regulated, in part, by a balance between Ang-II and Ang-(l-7) production.
The apparent contribution of A ng-(l-7) to strain-induced endothelial tubule 
formation may not be solely due to its increased production by EP24.15. The number and 
activity of receptors for A ng-(l-7) may alter in response to strain. The number and
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activity of the receptors of a number of vasoactive peptides have been shown to alter in 
response to hemodynamic forces. For example the expression of the endothelin-1 ETb 
receptor was seen to increase at the level in response to laminar shear stress (Moraweitz 
et al., 2000). Studies have shown that although Ang-(l-7) mediates some of its effects in 
the vasculature though the BK B2 receptor, it also has its own distinct receptor, 
characterised by sensitivity to D-[Ala 7]-A ng-(l-7) (Neves et al., 2003; Fetterik et al., 
2000). Although yet to be determined, it is quite possible that cyclic strain increases the 
number of membrane bound receptors for Ang-(l-7), thus potentiating the effects of Ang- 
(1-7) production by EP24.15.
In conclusion, our studies have shown that exposure to cyclic strain induces a 
clear and significant increase in both BAEC migration and tubule formation in vitro. 
These increases are significantly attenuated by pharmacological and molecular inhibition 
of EP24.15. In addition, Ang-(l-7), the product of EP24.15 hydrolysis of Ang-I, induces 
an increase in tubule formation in static BAECs an is also able to reverse the attenuation 
of the strain induced increase in tubule formation resulting form FLIP-mediated EP24.15 
blockade. Therefore it is our conclusion that the increase in endothelial tubule formation 
and migration, observed in response to exposure of BAECs to cyclic strain, may 
putatively be caused by increased production of Ang-(l-7) from Ang-I by EP24.15.
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Chapter 7; Final Summary and 
Conclusions
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7.1 Final Summary
Hemodynamic forces, namely shear stress and cyclic strain, are considered to be 
important regulators of a number of vascular endothelial functions such as hemostasis, 
angiogenesis and the maintenance of blood pressure. The regulation of these events by 
hemodynamic forces is partly effected by inducing peptide synthesis and release, by 
inducing changes in the expression of peptide receptors, and by regulating both the 
expression and activity of peptide-degrading enzymes. These effects are mediated by a 
number of mechanotransducors, including Gi-protein coupled receptors, integrins and 
receptor tyrosine kinases (Duffy etal., 2004; Papadaki etal., 1997).
E P24.15 and EP24.16 are members of the Clan MA family of peptidases, the 
thermolysin-like zinc metallopeptidases which are known to be expressed in the 
vasculature and have been shown to cleave a number of peptides relevant to vascular 
endothelial function, including Ang-I and BK (Shimpton et al., 2003, Norman et al., 
2003). EP24.15 and EP24.16 are also closely related to ECE and ACE, both of which 
have been shown to be subject to mechanoregulation by hemodynamic forces (Reider et 
al., 1997; Moraweitz et al., 2000).
Angiogenesis, the formation of new vessels, is a complex process, initiated at the 
level of the endothelium. Endothelial cells “sprout”, forming tubules into the extracellular 
matrix, which grow to form capillary-like structures both though endothelial cell 
migration and proliferation. In the final stages smooth muscle cells adhere to the newly
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forming vessel (Quarmbry et al., 2002). Exposure to hemodynamic forces has been 
previously shown to increase both endothelial cell migration and tubule formation in vitro 
(Hsu et al., 2001; Von Offenberg-Sweeney et al., 2005). Peptidases, including 
amminopeptidase and the zinc metalloendopeptidase ACE, have been implicated in the 
regulation of angiogenic cell fate decisions in the endothelium via their cleavage of a 
number of vasoactive peptide substrates (Sato, 2004; Desideri et al., 2003).
Both EP24.15 and EP24.15 cleave Ang-I to produce Ang-(l-7), which has been 
demonstrated to have a number of important functions in the vasculature, often acting in 
opposition to Ang-II, the product of cleavage of Ang-I by ACE (Shimpton, et al., 2002; 
Chappell et al., 2000). Both enzymes also degrade BK to BK-(l-5). BK is an important 
mediator of a number of important endothelial functions, including maintenance of 
vascular tone and endothelial cell migration.
It was our hypothesis that cyclic strain regulated EP24.15/EP24.16 expression and 
activity in BAECs putatively via a G-protein dependent pathway, with consequences for 
endothelial cell-mediated peptide hydrolysis and cell fate decisions such as migration and 
tubule formation.
We have demonstrated that exposure to cyclic strain increases levels of EP24.15 
and EP24.16 mRNA in BAECs. A significant time- and force-dependent increase in 
cellular enzyme activity was also observed for both enzymes, along with an increase in 
secreted enzyme activity. Using im munocytochemical staining techniques with
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fluorescent and confocal microscopy we also demonstrated the apparent ability of strain 
to increase the levels of cytoplasmic, nuclear and extracellular membrane-associated 
EP24.15.
Although, to our knowledge, we are the first to have demonstrated the 
hemodynamic regulation of these enzymes in endothelial cells, other researchers have 
demonstrated the ability of hemodynamic forces to regulate the closely related peptidases 
ECE-land ACE. Masatsugu and co-workers demonstrated a significant time- and force- 
dependent decrease in expression of both E C E -la  and ECE-1|3 mRNA in response to 
shear stress in both human umbilical vein endothelial cells (HUVECs) and BAECs 
cultured in a parallel plate flow chamber (Masatsugu et al., 2003). Similar studies by 
Morawietz and co-workers showed a 63.8% and 37.8% decrease in levels of E C E -la  and 
ECE-1|3 mRNA in HUVECs in response to chonic laminar shear stress (Moraweitz et al 
2000). Rieder and co-workers have investigated the mechanosensitive properties of ACE 
by employing a cone-plate viscometer to expose bovine pulmonary artery endothelial 
cells (BPAECS) to chonic laminer shear stress (20 dynes/cm2, 18 h), ACE activity was 
reduced by 49.5% and ACE mRNA expression by 82% (Rieder et al., 1997). Our studies 
suggest, that unlike those concerning ACE and ECE-1, the expression and activity of 
EP24.15 and EP24.16 up-regulated by increasing hemodynamic force. However the 
degree of sensitivity to cyclic strain exhibited by EP24.15 and EP24.16 is comparable 
with that observed for ACE/ECE-1 with respect to shear stress in the above mentioned 
studies.
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Having determined that EP24.15 and EP24.16 expression and activity can be up- 
regulated in BAECs by chonic exposure to cyclic strain, we next tried to ascertain if the 
phenomenon was mediated by G-protein signaling. Our study focused on the effects of 
both pharmacological and molecular inhibition o f Gia- and GPy- mediated signaling on 
the increase in cellular activity of both enzymes. Pharmacological inhibitors of Gi-protein 
signaling were initially employed to investigate this role; pertussis toxin and NF023. 
Both agents were demonstrated to strongly attenuate strain-dependent up-regulation of 
activity for both endopeptidases, suggesting a role for Gi-protein signalling in these 
events. Further inhibition studies therefore focused on selective ablation of individual Gi- 
protein subunits at the molecular level. Plasmids encoding dominant negative mutants of 
Gia l ,2,3 subunits (i.e. Gial-G202T, Gia2-G203T, and Gia3-G202T) were subsequently 
employed to selectively ablate the function of their endogenous wild type counterparts in 
BAECs (Cullen et al., 2002). A plasmid encoding the carboxyl terminus of (3-Adrenergic 
Receptor Kinase (|3ARK.ct), a well known GPy-subunit scavenger (Koch et al., 1994), 
was also employed to selectively inhibit G|3y signaling pathways. The cyclic strain 
dependent increase in cellular EP24.15 was shown to be strongly attenuated by inhibition 
of Gia2/Gia3 signaling, while the increase in cellular E24.16 activity was significantly 
attenuated by inhibition Gial/Gia2 and G(3y subunit mediated signaling. The observation 
that EP24.15 and EP24.16 are up-regulated by cyclic strain via divergent G-protein 
signaling pathways is not with precedence; the ability of hemodynamic forces to 
differentially regulate signaling molecules by PTX-sensitive and insensitive pathways has 
been previously demonstrated; Jo and co-workers demonstrated that expression of 
|3ARK-ct inhibits the shear stress activation of HA-JNK, wheras blockade of Gia 2 with
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the dominant negative mutant Gia2-G203T or antisense Gia 2 prevented shear dependent 
activation o f HA-ERK (Jo et al., 1997). Also although closely related, EP24.15 and 
EP24.16 are significantly different. In addition to differences in their substrate 
specificities, both enzymes are separate gene products (approx. 60% homology) and are 
under the control of distinct promoters, with additional evidence to indicate that EP24.16 
expression is subject to alternative promoter usage, thereby enabling targeting of some 
EP24.16 to the mitochondrial compartment (Kato et al., 1997).
Although we can now state that G-protein signaling is involved in the 
transduction of the effects of cyclic strain on EP24.15 and EP24.16, the remaining 
downstream and upstream signaling mechanisms remain to be elucidated, and as such 
remain an area for possible future study.
The demonstration that cyclic strain could both increase the levels of secreted 
activity for both EP24.15 and EP24.16 and could putatively increase the amount of 
membrane-bound EP24.15 led us to examine the possibility that exposure to cyclic strain 
could affect the levels of endopeptidase-specific cleavage of extracellular synthetic and 
natural peptide substrates. The ability of cultured bovine and ovine endothelial cells to 
cleave exogenously added peptide substrates in an EP24.15/EP24.16-specific manner has 
previously been demonstrated by Norman and co-workers (Norman et al., 2003). We 
observed that exposure to cyclic strain increases EP24.15/EP24.16 specific cleavage of 
exogenously added QFS in BAECs. By employing both a pharmacological inhibitor of 
both enzymes (cFP-AAF-pAB) and an antisense construct to inhibit EP24.15 expression
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(EP24.15-FLIP) we also demonstrated that cyclic strain increases the EP24.15 specific 
cleavage of exogenously added BK and Ang-I in BAECs in culture. Our observations 
also suggest that EP24.16 appears to have no significant role in the strain-induced 
extracellular processing of BK and Ang-I. This contrasts somewhat with the findings of 
Norman and co-workers, who showed that EP24.16 had a greater role in the cleavage of 
extracellular peptides than EP24.15. However this divergence in findings may be 
explained in part by the different cell types used, and the experimental paradigm 
employed (Ovine versus Bovine endothelial cells, static versus unstrained cells). 
Although possessing broadly similar substrate specificities, EP24.15 and EP24.16 have 
been shown to display different affinities for a range of natural substrates, and it may be 
possible that the secreted or membrane-associated form of EP24.16 in BAECs displays 
significantly different substrate affinities than those displayed by EP24.15. Also, although 
an increase in extracellular membrane association for EP24.15 in response to cyclic strain 
was suggested by immunocytochemical studies, the unavailability of suitable anti- 
EP24.16 antisera made it impossible to observe if a similar increase occurs in the case of 
EP24.16. A further barrier to assessing the precise role (if any) played by EP24.16 in 
strain-induced extracellular peptide cleavage in BAECs was the unavailability of a 
suitable inhibition strategy specific for EP24.16 as stable, highly specific inhibitors of 
EP24.16 are commercially unavailable and attempts to inhibit EP24.16 by transfection 
with siRN A proved unsuccessful.
Our observation that exposure to cyclic strain can up-regulate the EP24.15 
specific cleavage of exogenously added peptide substrates in BAECs led us to investigate
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the possible effects of this phenomenon on endothelial cell function. Both Ang-I (and its 
derivatives), and BK are known to affect angiogenic cell fate decisions in endothelial 
cells. Again, our study used both a dual pharmacological inhibitor of both enzymes (cFP- 
AAF-pAB), and an antisense construct to inhibit EP24.15 expression (EP24.15-FLIP) to 
assess the contribution of both endopeptidases to cyclic strain-induced BAEC migration 
and tubule formation.
Treatment with cFP-AAF-pAB and prior transfection with FLIP significantly 
attenuated the strain-dependent increase in both migration and tubule formation in 
BAECs. This observation suggested that extracellular processing of peptides by EP24.15 
may impact on the strain-mediated cell fate decisions of BAECs in culture. In order to 
further investigate this hypothesis we treated static BAECs with Ang-I, Ang-II, Ang-(1- 
7), BK, and BK-(l-5), and analysed the effects on their tubule formation ability. Both 
A ng-(l-7) and BK were seen to significantly drive BAECs tube formation, while 
treatment with Ang-II induced a small but significant decrease in tubule formation. The 
ability of Ang-II to inhibit angiogenic processes has been demonstrated previously 
(Desideri et al., 2003), while Ang-(l-7) is generally considered to have opposing effects 
to those of Ang-II (Fetterik et al., 2000).
If the increased production of Ang-(I-7) from Ang-I by EP24.15 in response to 
cyclic strain is responsible, at least in part, for the increase in migration and tube 
formation in BAECs, then addition of exogenous Ang-(l-7) should be able to reverse the 
effects of EP24.15 inhibition. Although BK also induced a significant increase in BAEC
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tubule formation, it is degraded by EP24.15, and unlikely therefore to contribute 
significantly to the EP24.15-dependent increase in tubule formation observed in response 
to cyclic strain. We studied the effects of addition of Ang-II and Ang-(l-7) on the strain 
dependent increase in tubule formation in both mock and FLIP transfected BAECs. We 
observed that Ang-II addition failed to significantly reverse the effects of EP24.15 
inhibition on strain-induced tubule formation. In contrast, addition of Ang-(l-7) was seen 
to completely reverse the effects of FLIP transfection on strain-induced BAEC tubule 
formation. These observations suggested that the strain dependent increase observed in 
EP24.15 activity may putatively contribute to the strain-dependent increase observed in 
BAEC tubule formation by increasing the levels of production of Ang-(l-7) from Ang-I. 
Previous studies, demonstrating that shear stress reduces ACE expression and activity in 
the endothelium (Rieder et al., 1997), and the observation by a co-worker that shear 
stress reduces the levels of ACE mRNA in BAECs, supports this hypothesis (Fitzpatrick 
et al., 2005); the combined effect of a reduction in production of Ang-II by ACE, coupled 
with an increase in production of Ang-(l-7) by EP24.15 would have the net effect of 
encouraging angiogenic cell fate decisions in our model.
The combined observations of our studies lead us to propose the following model, 
a generalised version of which is shown in Fig. 7.1. Firstly the exposure of BAECs to 
cyclic strain leads to the up-regulation of EP24.15 and EP24.16 expression and both 
cellular and secreted activity. In addition it leads to a significant increase in nuclear, 
cytoplasmic and membrane-associated EP24.15 protein levels. This up-regulation is 
dependent on G-protein signaling, with EP24.15 and EP24.16 displaying differences in
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the G-protein subtypes involved. Specifically cyclic strain-dependent increase in cellular 
EP24.15 activity is strongly attenuated by inhibition of Gia2/Gia3 signaling, while the 
increase in cellular EP24.16 activity is significantly attenuated by inhibition Gial/Gi„2 and 
GPv subunit mediated signaling. Further study remains to be done on determining the 
down stream effectors of this phenomenon. Also, the possibility that the effects of cyclic 
strain on EP24.15/EP24.16 may also be mediated in part by other signaling mechanisms 
(e.g. integrins) remains to be investigated (Fig 7.2).
Gia2/3 (EP 24.15) 
GI«1/2 /GPy(EP 24.16)
Ras/jnk/erk ???
Increased; mRNA levels(EP24.15/EP25.16) 
Protein Levels(EP24.15) 
Activity(cellular/secreted)EP24.15/EP24.16 
membrane association(EP24.15)
T
I
AP1/Nîk B ??
Increased EP24.15 specific 
extracellular cleavage of BK/ 
Ang-I
Increased Ang 1 -7
At(1-7)??
Increased BAEC 
migration and 
tube formation
Figure 7.1 Suggested model of EP24.15/EP24.16 regulation by cyclic strain in BAECs; API, adaptor 
protein complex 1; Ras, small GTPase family; ERK, extracellular regulated kinase; JNK, c-jun terminal 
kinase; AT(1_7) Ang-(l-7) receptor.
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Cyclic strain also leads to an apparent increase in the extracellular cleavage of BK 
and Ang-I by EP24.15. In our studies, the contribution of EP24.16 to the extracellular 
cleavage of these peptides appears negligible. As discussed previously, the lack of a 
specific inhibition strategy for EP24.16 makes it difficult to conclusively determine its 
role in the extracellular hydrolysis of BK and Ang-I, and thusly this is an area that 
warrants further investigation. Also the fact that EP24.16 does not participate to a
Extracellular Matrix
Figure 7.2 Model for signaling pathways downstream of hemodynamic stimuli in endothelial cells. (1)
Integrin and (2) receptor tyrosine kinases (RTKs) which upon mechanical activation are believed to recruit 
the Shc.Grb.Sos signal complex, leading to MAP kinase (ERK, JNK) activation and subsequent regulation 
of gene expression. In addition, shear stress and cyclic strain may activate (3) G-protein coupled receptors 
(GPCRs) and (4) ion channels, which have also been shown to affect Ras-mediated cellular events, 
amongst others. Figure offers a simplified view of probable signaling pathways involved in hemodynamic 
regulation of metallo-endopeptidases in vascular ECs. NO, nitric oxide; PGE2 prostaglandin E2; PGI2 
prostaglandin I2; Flk-1, fetal liver kinase 1 (VEGF receptor); API, adaptor protein complex 1; Ras, small 
GTPase family; ERK, extracellular regulated kinase; JNK, c-jun terminal kinase (Kito et al., 2003).
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significant extent in the strain-mediated extracellular processing of BK and Ang-I in 
BAECs does not rule out the possibility that EP24.16 may be involved in the extracellular 
processing of other peptides, such as neurotensin, and this too remains an area for further 
study.
Our observations that specific inhibition of EP24.15 leads to attenuation of the 
strain-induced increase in BAEC migration and tubule formation suggests that EP24.15- 
mediated peptide cleavage plays a role in strain-induced endothelial cell fate decisions. 
Further studies demonstrated that Ang-(l-7), the main product of EP24.15 cleavage of 
Ang-I strongly increased BAEC tubule formation in static cells and could reverse the 
effects of EP24.15 inhibition on strain-dependent tubule formation. This suggested that 
EP24.15 influences endothelial cell fate decisions though its production of Ang-(l-7) 
from Ang-I. However, further studies using antagonists against Ang-(l-7) receptors to 
block A ng-(l-7) stimulation of BAECs are necessary to confirm the role of EP24.15 
derived Ang-(l-7) in strain-induced endothelial cell fate decisions.
The functional consequences of these collective findings remain as yet 
undetermined. They concur however with a likely role for hemodynamic forces in the 
collective regulation of the expression and function of an entire family of physiologically 
important metalloendopeptidases, including ACE, ECE and NEP, with consequences for 
the net vasoactive peptide balance within the endothelium, subsequently leading to 
downstream effects on vessel wall tone and vascular remodling. Our findings suggest 
increased production of Ang-(l-7) by EP24.15 in response to increased hemodynamic
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forces. A ng-(l-7) is known to induce the release of NO, a potent vasodilator and pro- 
angiogenic substance in endothelial cells (Fetterik et al., 2000). In contrast exposure to 
hemodynamic forces have been shown to reduce the activity and expression of ACE and 
ECE, leading to a reduction in the levels of Ang-II and ET-1, both of which are potent 
vasoconstrictors (Reider et al., 1997; Masatsugu et al. 2003). The combination of these 
synergistic events in vivo would be likely to have a net impact on the vessel wall 
consistant with an atheroprotective effect imparted typically by hemodynamic forces 
(Traub et al., 1998).
7.2 Further Work
Although we feel that this study serves its purpose in demonstrating the putative 
hemodynamic regulation of EP24.15/EP24.16 in the vascular endothelium, and indicating 
a role for EP24.15 in cyclic strain induced endothelial cell fate decisions, there are a 
number of areas where further study is warranted. In particular, the intracellular signaling 
pathways upstream of Gi-protein involved in regulation of EP24.15/EP24.16 requires 
further study. Also investigation of the involvement of EP24.16 in extracellular peptide 
cleavage remains to be elucidated. Finally, the exact mechanism by which EP24.15 exerts 
its influence on cyclic strain mediated endothelial cell fate decisions remains to be 
identified.
The investigation of the potential role of other mechanosensors, and of the 
intracellular signaling pathways involved in EP24.15/EP24.16 mechanoregulation
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represents what is potentially an extensive area of study. However it is an area of obvious 
interest for further study.
The first area of focus would be the role of other potential mechanosensors in 
EP24.15/EP24.16 mechanoregulation. It may be possible that one or more of these 
mechanisms either contribute directly to EP24.15/EP24.16 mechanoregulation, or lie up­
stream to Gi-protein activation by cyclic strain (see section 1.3). A relatively simple and 
straightforward series of experiments could be employed to investigate this hypothesis. 
There are a number of well-established methods available to block the action of tyrosine 
kinases, integrins, caveolae and ion channels. For example the use of RGD peptide to 
inhibit integrin binding to ECM proteins, and the blockage of Na+ channels with 
tetrodoxin (Traub et al., 1998; Papadaki et al., 1997). The proposed experiments (much 
like those involving the use of pharmacological agents to block Gi-mediated signaling) 
would involve subjecting BAECs to cyclic strain in the presence and absence of the 
various inhibitory agents and the monitoring of their effects on EP24.15/EP24.16 up- 
regulation, either by studying mRNA levels or enzyme activity. Using this approach, the 
involvement of integrins, tyrosine kinases, caveolae and integrins in EP24.15/EP24.16 
mechanoregulation could be rapidly determined.
Further study is also required to determine the intracellular signaling molecules, 
occurring downstream of Gi-proteins, involved in the transduction of the response to 
cyclic strain. Potential candidates include the PKC family, c-Src kinases, as well as small 
GTPases such as ras, which feed into the Raf/MEK/ERK/JNK signaling pathway (see
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section 1.3.6,1.3.7) (Traub et al., 1998). As with the potential mecahnosenors, a number 
of methodologies have been developed and employed to inhibit signaling by these 
various molecules, including pharmacological inhibitors such as staurosphine (inhibits 
PKCs), as well as antisense constructs and blocking type antibodies which can 
specifically inhibit signaling by one particular molecule (e.g. c-Src) (Chen et al., 1999). 
As with the potential signal transduction mechanisms lying up-stream of these molecules 
a logical experimental approach would involve exposing BAECs to cyclic strain in the 
presence and absence of the various inhibitory agents and the monitoring of their effects 
on EP24.15/EP24.16 up-regulation, either by studying mRNA levels or enzyme activity. 
By using this approach, beginning with, for the example inhibition of the PKC family, 
and working downstream through the MAP kinase signaling pathways to the level of 
ERK/JNK it would be possible to propose a pathway by which the physical stimulus of 
cyclic strain is transduced to the level of activation of transcription factors.
However to determine the means by EP24.15 and EP24.16 transcription is 
activated at the genetic level in response to cyclic strain would involved a different 
experimental approach, using novel materials and techniques. Although the promoter 
region of EP24.16 has not been extensively studied, and EP24.16 is considered to be 
under the control of multiple promoters, the promoter region of EP24.15 has been 
published and shown to contain the so called shear stress responsive element (SSRE), 
found in the promoters of a number of mechnosensitve genes (see section 1.4) (McCool 
et al., 1998). However inactive SSREs have been reported in the promoters of other 
genes, and it is possible that another motif is responsible for mediating cyclic strain
2 1 9
induced transcription in EP24.15. The role of the SSRE (or indeed of other motifs that 
may be present) in mediating cyclic strain induced transcription of EP24.15 could be 
established using constructs containing various truncation mutants of the EP24.15 
promoter attached to a reporter gene such a luciferase. Cells tranfected with these 
constructs could be exposed to strain and the levels of luciferase expression monitored. If 
the SSRE is responsible for mediating cyclic strain induced EP24.15 expression, then 
cells transfected with constructs containing mutants with an intact SSRE should display 
increased luciferase expression in response to cyclic strain, while those transfected with 
constructs containing a partial SSRE, or lacking a SSRE, should not.
Our studies indicated a clear increase in the ability of EP24.15 to cleave 
exogenous BK and ANG-I in response to cyclic strain. No such increase was observed 
for EP24.16. However it may be that EP24.16 plays an important role in the processing of 
BK/Ang-I in unstimulated conditions. It is also possible that EP24.16 may exhibit a strain 
dependent increase in its ability to cleave other exogenously added peptides such as NT.
As discussed previously, in the absence of a specific inhibition strategy for 
EP24.15, it is impossible to clarify this. It is clear that attempts to define an effective 
siRNA against EP24.16 should be continued. Also, alternative inhibition strategies, e.g. 
antisense, should be explored. In addition the, emerging roles for both enzymes in a 
variety of biologically relevant processes, such as antigen presentation, and processing of 
the [3-amyloid protein involved in alzheimers disease, make it increasingly likely that, in 
the near future specific and stable chemical inhibitors for both enzymes may be
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commercially available. Use of these inhibitory strategies could be used in whole peptide 
hydrolysis assays identical to those performed previously, allowing us to pin down the 
exact role of EP24.16 in extracellular peptide hydrolysis. Also the inclusion of peptides 
other than BK and Ang-I, such as NT, in these studies would allow us to build up a more 
complete picture of the role of both enzymes in vasoactive extracellular peptide 
processing.
The exact mechanism by which EP24.15 effects its role in cyclic strain induced 
tubule formation also needs to be further investigated. We have preliminary evidence 
which suggests that the strain dependent increase in EP24.15 activity results in an 
increase in the production of Ang-(l-7), which induces endothelial tubule formation. 
However it needs to be confirmed that increased EP24.15 activity increases tubule 
formation, as does the theory that it does this through increased Ang-(l-7) production. 
These issues can be clarified with the following series of experiments. Firstly a construct 
designed to over express EP24.15 could be transfected into BAECs, and endothelial 
tubule formation monitored. This would allow us to confidently link increased EP24.15 
activity with increased tubule formation. Secondly the previous experiment would be 
repeated in the presence of antagonists against receptors for Ang-(l-7), such as HOE404 
(B2 receptor antagonist), and D-[Ala 7]-Ang-(m l-7) (AT^7 antagonist). This would allow 
us to confirm if it is by increased Ang-(l-7) production that EP24.15 influences 
endothelial cell tubule formation, and to identify the receptor(s) involved.
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If EP24.15 is confirmed to influence angiogenic endothelial cell fate decisions in 
vitro, there is a possibility of in vivo studies. There are a number of in vivo models 
available for studying angiogenesis, including the sponge model. This involves 
implanting a sponge coated in extracellular membrane proteins subcutaneously in the test 
animals. After a defined time period of time the implants are removed and the degree of 
angiogenic growth in the sponge ascertained (Machado et al., 1999). The use of such a 
model, along with inhibitors for EP24.15 and Ang-(l-7) receptor antagonists, would 
allow us to investigate the in vivo relevance of the phenomenon observed in vitro.
7.3 Possible Clinical Implications
One of the main observation of this thesis is that an increase in EP24.15-mediated 
A ng-(l-7) production, in response to increasing hemodynamic force, can putatively lead 
to functional changes in endothelial cell fate decisions. This finding leads to the exciting 
possibility that this enzyme, like the closely related ACE and ECE plays an important 
role in the regulation of vascular function through its production of Ang-(l-7), with 
possible clinical implications. Ang-(l-7) has been shown act as vasodilator in vivo, with 
Ang-(l-7) infusion potentiating the effects of ACE inhibition and ATI receptor blockade, 
a finding with obvious implications for the role of A ng-(l-7) in the treatment of 
hypertension (Chappell et al, 2000). Elevated levels of Ang-(l-7) have also been detected 
in the rat myocardium after the experimental induction of myocardial infarction, leading 
to the suggestion that it may promote recovery by opposing the pressor, proliferative and 
profibrotic actions of Ang-II (Averill et al., 2003). More recent studies have supported
222
this hypothesis; Tallant and co-workers have demonstrated that the infusion of Ang-(l-7) 
following experimentally induced myocardial infarction in rats led to a reduction in 
myocyte size and attenuated ventricular dysfunction and remodeling (Tallant et al., 
2005).
A possible clinical application of our findings relates to cancer treatment. Steward 
and co-workers have recently demonstrated that treatment with BK receptor antagonists 
significantly attenuated the growth of prostate and lung tumors in a rat experimental 
model by attenuating tumor angiogenesis (Steward et ah, 2005). BK antagonists also had 
the advantage of being considerable less toxic than traditional anti-tumor drugs. Our 
finding that EP24.15 produced A ng-(l-7) putatively encouraged endothelial tubule 
formation, leads to the possibility that either EP24.15 inhibition or Ang-(l-7) receptor 
blockade (or a combination of both) alongside BK receptor blockade, may be a possible 
strategy for cancer treatment.
7.4 Conclusion
In conclusion, our studies have shown that cyclic strain increases EP24.15 and 
EP24.16 mRNA expression and both cellular and secreted enzyme activity in BAECs. 
The increases in cellular activity were dependent on G-protein signaling, with the 
increase in cellular EP24.15 activity shown to be strongly attenuated by inhibition of 
Gia2/Gia3 signaling, while the increase in cellular E24.16 activity was significantly 
attenuated by inhibition Gial/Gia2 and G(3y subunit mediated signaling. In addition cyclic
223
strain induced an apparent increase in the levels o f  extracellu lar m em brane associated 
E P 2 4 .15. Exposure to cyclic strain was also increased the EP24.15-specific cleavage of 
exogenously  added BK and Ang-I in cultured  BAECs. Inhibition o f  E P 2 4 .I5  also 
attenuated cyclic strain induced B A E C  tubule formation and migration, with further 
s tud ies  sugges t ing  that E P 2 4 .I5  may m ediate  its effects  on these s tra in-induced 
endothelial cell fate decisions via the increased production o f  A ng-( l-7 )  from Ang-I, with 
possible clinical implications in the treatment o f  hypertension and cancer.
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A .l Map of pcDNA3.1 Vector; used for Gia,, Gia, wild type and mutant constructs
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